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Abstract 
 
 
Caloric restriction (CR) without malnutrition is a robust dietary intervention that extends lifespan and 
improves health in virtually every species studied. Recently, some of the mechanisms for the effects of 
CR on ageing have been elucidated, including several cellular master switches collectively called 
“nutrient sensing pathways”. CR is not sustainable in humans, therefore research has begun to focus 
on developing ad libitum-fed diets that maximise lifespan and healthspan. Recently, it has been shown 
that ad libitum-fed mice on low protein, high carbohydrate diets have a longer lifespan compared to 
diets with other macronutrient ratios. These low protein, high carbohydrate diets therefore seem to 
recapitulate some of the benefits of CR.  
 
This thesis presents research on the effects of diets with differing ratios of macronutrients on nutrient 
sensing pathways, and their impact on ageing and age-related end points. This is achieved using the 
paradigm of the Geometric Framework (GF), an analytical tool used to disentangle the effects of 
various nutritional components such as macronutrient ratios and energy intakes on outcomes. Using 
the GF, the relationship between measured outcomes and experimental conditions is mapped on an 
n-dimensional nutritional space, where each dimension represents an intake axis; in this thesis, 
protein, carbohydrates and fat. The power of the GF is in its ability to both visually represent the 
data, as well as perform statistical analyses to uncouple the complexities of nutrition, through the 
creation of these response topologies. Using the GF, a large-scale nutritional study is used to examine 
the aging process through genotypic and phenotypic changes in nutrient sensing pathways, and their 
relationship with parameters of health and lifespan. 
 
This thesis contains three research chapters, each corresponding to a major set of work, with the 
overarching aim of better understanding the mechanisms involved in the relationship between 
nutrition and the ageing process: 
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Chapter 3 – Methods: The Geometric Framework 
There have been challenges with the statistical tools used to analyse experimental data 
according to the GF model. These include visualisation of the data in multiple dimensions, 
and the use of GF to interpret very large datasets. The R statistical language was used to 
develop algorithmic bioinformatic techniques to automate data handling, processing, analysis 
and visualisation, including three-dimensional models. Improvements in algorithmic 
efficiency were also studied to allow the automation of the GF across very large datasets, 
supporting, for example, the analysis of an entire transcriptome. These statistical advances 
underpinned the analysis of experimental data presented in Chapters 4 and 5.  
 
Chapter 4 – Nutrient Sensing Pathways 
This chapter involved investigation into the impact of macronutrient intake on nutrient 
sensing pathways and correlation with health and lifespan. The majority of experimental 
work was carried out on mouse tissue from a large-scale dietary intervention and longevity 
study in which 858 mice were fed one of 25 diets varying in protein, carbohydrate, fat or 
total energy content. Several experimental approaches were undertaken including primary 
analysis of gene expression and quantitative PCR in liver and hypothalamus. Analysis of gene 
expression was performed using both a univariate analysis and the GF multivariate approach 
developed in Chapter 3. By studying gene expression in the liver and hypothalamus, this 
section shows that low protein, high carbohydrate diets, which were associated with the best 
health outcomes and lifespan in the cohort, also significantly influenced nutrient sensing 
pathways, thereby providing a mechanism linking dietary macronutrients and ageing. In the 
liver, gene expression was mostly influenced by dietary protein intake. Biological pathways 
linked with protein intake included mitochondrial function, metabolic signaling (PI3K-Akt, 
AMPK, mTOR) and metabolism of protein and amino acids. Among the genes of interest 
with expression linked with dietary protein were Cth, Gls2, Igf1 and Nnmt, which were 
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increased with high protein intake, and Igf2bp2, Fgf21, Prkab2 and Mtor, linked with low 
protein intake. In the hypothalamus, gene expression was most influenced by fat and total 
energy intake. Using the GF analytical approach, there were a number of genes of interest: 
carbohydrate intake influenced expression of Igfbp2, Igf1 and Sirt2; protein intake significantly 
influenced Npy, Akt3, Sirt1; and the interaction between protein and carbohydrates Sirt5, 
Rps6a4/5, Igf2r, Igf1r and Sirt3. 
 
Chapter 5 – Phenotypic End Points Associated with Ageing 
This set of work focused on three phenotypic endpoints associated with ageing, namely 
hepatic telomere length (measured using a PCR method), mitochondrial function (measured 
using Seahorse technology and gene expression), and inflammation (determined by 
microscopy). Here, it is shown that low protein, high carbohydrate diets are associated with 
longer telomere lengths, improved mitochondrial function, and lower levels of organ level 
inflammation, even in short-term dietary studies. For each outcome, diets that were low in 
protein and high in carbohydrates were associated with results that are consistent with 
biological changes supportive of a longer lifespan. 
 
Taken together, the results presented here form a case that manipulation of the nutrient sensing 
pathways are a mechanism for the beneficial effects of dietary interventions on ageing and health. 
Further investigation of these growth pathways could help to develop guidelines for optimal 
nutritional intake, or form the basis for pharmacological interventions targeted at prolonging lifespan, 
healthspan, and promoting health in old age, without the use of long-term dietary manipulation. The 
algorithmic tools developed here, also have the potential to be applied to a wider array of 
experimental fields, supporting the overarching experimental model of comparing multi-dimensional 
inputs on responses, as opposed to the more commonly used control versus treatment model that is 
largely seen in scientific research.  
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Chapter 1: General Introduction 
 
 
Background 
In the ancient Indian epic, the Mahabharata, both heaven and earth combined forces to churn the 
ocean in order to find the Amrut, an elixir preventing ageing and granting immortality. Similar myths 
such as the Holy Grail, the philosopher’s stone, and many others, are found across virtually all 
cultures around the world. While ageing and immortality have fascinated humans since the beginning 
through the ages, there is no doubt that the ‘churning of the scientific ocean’ in the last few decades 
has produced a plethora of advances in the fields of biogerontology and geroscience.  
 
Despite ageing being one of the most fundamentally defining features of life, a universally accepted 
definition of ageing has been elusive (Medvedev 2008). Most definitions of ageing describe specific 
aspects such as phenotypic and physiological ageing, chronological ageing, or the change in likelihood 
of mortality over time [Figure 1.1, Table 1.1] (Le Couteur et al. 2014). 
 
In recent times, major advances have been made in terms of understanding the biological processes 
involved in ageing, largely through the use of model organisms such as yeast, worms, flies and mice, 
with many of these advances stemming from the discovery of the beneficial effects of caloric 
restriction on longevity (Heilbronn & Ravussin 2003). While the effects of caloric restriction on 
ageing have been described anecdotally for centuries, it was not until 1935 that the first formal 
publication in the scientific literature was reported (McCay et al. 1935). Since then, dietary 
interventions such as caloric restriction have been shown to be the most robust methods of 
prolonging lifespan across virtually all species, and have become one of the most important paradigms 
in biogerontological research (Solon-Biet et al. 2015b). 
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Figure 1.1 Various definitions of ageing.  
 
In humans however, the use of life-long, or long-term CR interventions to delay ageing have not been 
performed. This is partly because of the difficulty that humans have in adhering to low calorie diets, 
and partly because it is not feasible to continue human clinical trials over a lifetime. Additionally, long-
term studies on the scale of human lifespan are more likely to be influenced by confounding factors 
and thus are prone to develop experimental artifacts, making results difficult to interpret or reproduce 
(de Cabo et al. 2014). Instead trials have been undertaken with surrogate outcomes such as 
cardiometabolic parameters or biomarkers of ageing over shorter periods (Heilbronn et al. 2006). For 
example, intermediate length trials, such as the 2-year CALERIE (Comprehensive Assessment of 
Long-Term Effects of Reducing Intake of Energy) study have been performed to assess the impact of 
caloric restriction on age-related biomarkers (Ravussin et al. 2015). Trials such as these have provided 
support for the beneficial effects of dietary restriction in humans, despite not directly assessing their 
effects on lifespan. However, a widely used therapeutic approach to directly combat ageing in human 
populations has not been developed or implemented (Redman et al. 2018).  
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This is not to say that no change has been made to improve human lifespan over the course of 
history. In fact, over the last two centuries alone, global median life expectancy has increased from 30 
years to nearly 71 years [Figure 1.2], and in the case of Okinawan women, the group with the highest 
life expectancy at birth, this value has exceeded 89 years (Riley 2005; Vijg & Campisi 2008; D. C. 
Willcox et al. 2006). These results however, have stemmed through medical and technological 
improvements, especially over the late 19th and 20th centuries, with antibiotics, access to food and 
clean water, healthcare and infrastructure (Vaiserman et al. 2016). Such interventions have impacted 
primarily on infant mortality and the management of disease in adults, rather than influencing the 
ageing process directly per se. Even so, it should be pointed out that the increase in human lifespan in 
the last century equals or exceeds the increases in lifespan that have been achieved in the laboratory 
by manipulating the ageing process in animal models (Le Couteur et al. 2014). 
 
Figure 1.2. Life expectancy at birth over the ages. Adapted from (Riley 2005), and World  
Bank & Max Planck Research Institute websites.
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Table 1.1. Phenotypic changes associated with ageing, classified by physical, metabolic, and cellular levels. Table adapted from (Margolick & Ferrucci 
2015; Vijg & Campisi 2008). 
Phenotype Change with age H. sapiens M. musculus D. melanogaster C. elegans 
Physical/cognitive  Bone Density Decline Yes Yes NA NA 
 Changes in fat Varied Yes Yes Yes Yes 
 Muscle mass Decline Yes Yes Yes Yes 
 Dermatological changes Varied Yes Yes Yes Yes 
 Cognitive function Decline Yes Yes Yes Yes 
 Fitness Decline Yes Yes Yes Yes 
 Balance Decline Yes Yes Yes N/A 
Metabolic changes Insulin resistance Increase Yes Yes Yes Yes 
 Cardiac function Decline Yes Yes Yes N/A 
 Basal metabolic rate Decline Yes Yes Yes Yes 
 Mitochondrial function Decline Yes Yes Yes Yes 
 Cancer, hyperplasia Increase Yes Yes No No 
 Apoptosis, senescence Increase Yes Yes Yes Yes 
 Genome instability Increase Yes Yes Yes Yes 
 Protein aggregation Increase Yes Yes Yes Yes 
Cellular changes Immune system function Decline Yes Yes Yes Yes 
 Inflammation Increase Yes Yes No No 
 Neurodegenerative 
changes/atrophy Increase Yes Yes Yes Yes 
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The relationship between ageing and disease 
While there is semantic debate whether ageing is a disease, or simply a consequence of cellular 
degeneration over time, there is no doubt that disease and ageing are inextricably linked; old age being 
one of the most significant risk factors for most chronic diseases in the Western world (Le Couteur et 
al. 2011). Some diseases, such as diabetes mellitus and infection with the Human Immunodeficiency 
Virus are also claimed to accelerate the ageing process, however most only mimic some of the 
phenotypic changes seen in ageing, rather than accelerating the ageing process as a whole (Margolick 
& Ferrucci 2015). Despite the controversy over this classification, the consensus certainly exists that it 
is possible to distinguish between individuals and organisms of different age on the basis of biological 
changes; which are remarkably similar across taxa (Rattan 2006; Vijg & Campisi 2008).  
 
Old age is the most powerful risk factor for disease, especially chronic diseases, and increases the risk 
of mortality and morbidity associated with most diseases (Tacutu et al. 2011). While mortality is 
known to increase exponentially with age (until ~95 years), a function known as the Gompertz-
Makeham law (Missov & Lenart 2013), death itself is generally considered to be caused by diseases 
such as infections, diabetes, dementia, cancer, cerebrovascular stroke and heart disease [Figure 1.3]. A 
complementary pattern is also seen in late life, where the longest-lived groups display delayed 
manifestations of age-related diseases (Willcox et al. 2008). Targeting the ageing process therefore has 
the potential to reduce the incidence of all these diseases through one intervention, rather than 
targeting each pathological process directly; a strategy known as the compression of morbidity [Figure 
1.4] (Fries 1980; Guarente 2014; Seals & Melov 2014). Thus, understanding the ageing process is one 
of the most important challenges faced by the scientific community, and will be critical in alleviating 
the burden on healthcare systems predicted to occur in the coming century given the rapidly growing 
ageing population around the world (Tarry-Adkins & Ozanne 2016). 
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Figure 1.3. Age related morality. A) Chronological age group vs. death rate in the United States 
(2010). B) Age vs. rates of common chronic disease related mortality in the United States (2010-2012) 
Figures adapted from Harrison’s Principles of Internal Medicine (Le Couteur et al. 2012a). 
 
 
 
Figure 1.4 Compression of morbidity to decrease mortality. Slowing the processes of aging might 
prove to be the most effective method of reducing morbidly and mortality compared to disease 
prevention or treatment. Figure adapted from (Seals & Melov 2014). 
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It can be argued that ageing is an inevitable process, as the second law of thermodynamics 
necessitates increases in entropy over time. This definition however, does not directly correlate with 
biological ageing, where in many cases the entropy may remain unchanged or even decrease with age 
(Takahashi et al. 2012; Humeau et al. 2008). Furthermore, the timeframe in which the second law of 
thermodynamics applies is not limited by the lifespan of organisms, making it a weak argument for 
the basis of biological ageing (Le Couteur et al. 2012a). 
 
There is no reason why biological ageing must occur; and indeed, there are some species, which are 
biologically immortal such certain types of jellyfish and plants, and Hydra, which display negligible 
senescence perhaps related to their high numbers of stem cells. There are also species that die without 
typical features of ageing such as annual plants and semelparous animals (Le Couteur et al. 2011). 
Despite this, the evolutionarily dominant strategy for survival of a species is achieved through 
reproduction rather than immortality (Seals & Melov 2014). Thus there appears to be a trade-off 
between longevity and reproduction that might be the evolutionary foundation of ageing and 
mortality. 
 
In 1990, Zhores Medvedev published a widely cited paper attempting to classify the theories of 
ageing. In this paper, he cited over 300 theories, however concluded that it was unrealistic to expect 
any single theory to encompass all aspects of ageing (Medvedev 2008). This is primarily due to the 
fact that biological ageing is highly variable, not only between species, but even within a single species, 
organ, cell or organic molecule (Rattan 2006). Interestingly, most of the evolutionary theories of 
ageing seem to be connected by their attempts to explain trade-offs between reproduction versus 
longevity. Some of the main theories are briefly reviewed below. 
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Programmed death theory 
One of the first evolutionary theories of ageing was the programmed death theory, stating that natural 
selection, which was known to occur at multiple levels, favoured the removal of older individuals so 
resources could be allocated to younger individuals in order to optimise reproductive capacity 
(Weismann 1882; Longo et al. 2005). Therefore, death was hypothesised to be a programmed event 
that had evolved to benefit the species. Several lines of evidence have made this theory fall out of 
favour, especially given the fact that selection pressure at the group level is far less dominant than at 
the individual level (Shanahan 1998), however given the fact that no single theory can explain ageing, 
there is still debate about the merit of a programmed theory of age (Longo et al. 2005; Kirkwood & 
Melov 2011; Kowald & Kirkwood 2016).  
 
Some have suggested that the immune system, endocrine system, senescence pathways, and the 
Hayflick limit on cell divisions may provide potential mechanisms mediating programmed death of 
cells (apoptosis), or the entire organism (phenoptosis) (Jin 2010). Studies in the yeast, S. cerevisiae 
showed that the proteins BCL2 (B-cell leukaemia/lymphoma 2 protein) and BAX (BCL2-associated 
X protein) stimulated anti- and pro-apoptotic pathways respectively, rescuing the organism from 
death, or causing it (Longo et al. 1997).  
 
While this may be considered support for the programmed death theory, no correlate of this has been 
found to program phenoptosis in higher eukaryotes. Furthermore, given that ageing is seen to be 
more dominant in iterparous species, it was proposed that rather than being programmed per se, 
ageing was a response to an accumulation of damage over time that eventually overcomes an 
organism (Medawar 1952).  
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Mutation accumulation theory 
This theory focuses on the idea that natural selection is most powerful for traits favouring 
reproduction in early life (Darwin 1859). Therefore, the inability of natural selection to weed out 
mutations that are deleterious in later life would result in accumulation of these mutations in a species 
over time, leading to age-related decline (Medawar 1952; Kowald & Kirkwood 2016). This theory 
however would imply an increase in genetic variance in mortality rate in later life, and while some 
evidence has be circumstantially used to support this theory, most findings are better explain by the 
more contemporary theories discussed below (Kirkwood & Melov 2011).  
 
 
 
Table 1.2. Trade-offs between longevity, early fecundity, and resistance to stressors. Populations 
selected for increased longevity show increased resistance to stressors in later life, however most 
studies show a decrease in early fecundity as a result. Table adapted from (Kirkwood & Austad 2000). 
 
Organism Population selected 
Traits affected Resistance to stressors 
Longevity Early fecundity Early viability ROS Heat UV 
C. elegans  Dauer larvae ↑ ↓ ↑ ↑ ↑ ↑ 
C. elegans  Various mutants ↑ ↓ ↓ ↑ ↑ ↑ 
D. melanogaster  Artificial selection ↑ ↓ ↓ ↑ ↑ ↑ 
D. melanogaster  Methuselah mutant ↑   ↑ ↑  
M. musculus  Caloric restriction ↑ ↓  ↑ ↑  
M. musculus  p66shc mutant ↑   ↑  ↑ 
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Antagonistic pleiotropy 
An extension of the mutation accumulation, this theory goes one step further to propose that genes 
selected through natural selection which may be beneficial in early life may have negative effects in 
late life ( Williams 1957). Some lines of evidence for this theory include the fact that sex hormone 
genes, which are important for fertility in early life can contribute to the risk of cancer in old age 
(Gann et al. 1996), the findings that mutations promoting lifespan have been shown to exhibit a 
fitness cost in C. elegans (Jenkins et al. 2004; Walker et al. 2000), and the increase in longevity of fruit 
flies selected for late-life reproductive success (Sgro & Partridge 1999) [Table 1.2]. Once again 
however, given the scarcity of data in individual alleles supporting this theory, most of the evidence 
initially brought forward for antagonistic pleiotropy is now thought to be better explained by the 
disposable soma theory, which is a special case of the antagonistic pleiotropy theory which is 
conceptually similar to a redundancy model (Boonekamp et al. 2015; Kirkwood & Austad 2000). 
 
 
Disposable soma theory 
One of the most influential recent theories of ageing is the disposable soma theory of ageing, which 
hypothesises that ageing results from a trade-off in distribution of limited resources towards either 
reproduction (germ cells) or survival of the organism (somatic cells) (Kirkwood & Holliday 1979). 
Compared to the complexities involved in the creation of life, the ongoing maintenance of somatic 
cells is relatively straightforward (Gladyshev 2016; Kirkwood 2010). Freshwater hydra have the ability, 
not only to be immortal, but also to sustain regenerative abilities. This is due to the fact that the 
structure of the hydra is almost entirely comprised of germ cells and shows no signs of senescence 
(Martinez 1998). Germ cells are able to largely avoid the ageing process but they are unable to form 
significantly complex organisms, as this requires differentiation into neural, muscular, and other types 
of cells (de Cabo et al. 2014).  
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This provides a potential evolutionary basis for why caloric restriction (CR) can enhance lifespan, 
since limiting nutrient availability would cause the balance to shift towards survival over growth and 
reproduction [Figure 1.5].  This is thought to be an evolutionary response to periods of famine, where 
switching from reproduction to survival would increase the chance of an organism surviving until 
food is available, and reproduction can occur in an environment where the offspring is most likely to 
survive given the availability of nutrients after birth. An adjunct to the disposable soma theory 
suggests that this trade off influences the cellular growth pathways which mediate survival and 
longevity (Le Couteur et al. 2011). This theory is also congruous to data seen in CR animal models, 
since CR seems to alter the activation of cellular growth pathways (Longo et al. 2015). As discussed, 
many evolutionary theories of aging surmise that there is a trade-off between reproduction and 
survival, and the diminishing ability of natural selection to apply selection pressure post-reproduction 
that causes ageing.  
 
 
 
 
 
 
Figure 1.5. The disposable soma theory. Figure adapted from (Vijg & Campisi 2008). 
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Nutrition and ageing 
While the concept of caloric restriction has been around for centuries [Philipus Paracelcus (1493-
1541), Luigi Conaro (1466-1566)], it was McCay and colleagues from Cornell University, whose 
seminal work in 1935 provided scientific proof of the beneficial effects of CR on ageing and lifespan 
(McCay et al. 1935). Since then, dietary interventions such caloric restriction and intermittent fasting 
have been shown to be some of the most robust non-genetic interventions to delay the onset of age-
related disease and improve lifespan (Solon-Biet et al. 2015b). 
 
 
Table 1.3. The effects of caloric restriction and mutations/drugs influencing nutrient sensing 
pathways on lifespan and health in a variety of species. Table adapted from (Fontana et al. 2010).  
 Lifespan increase Beneficial health effects 
 CR Mutations/drugs CR Mutations/drugs 
Yeast 3-fold 10-fold Extended reproductive period 
Extended reproductive 
period, decreased DNA 
damage/mutations  
Worms 2- to 3-fold 10-fold 
Resistance to 
misexpressed toxic 
proteins  
Extended motility, resistance 
to misexpressed toxic 
proteins and germ-line 
cancer  
Flies 2-fold 60-70% Increased activity 
Resistance to bacterial 
infection, extended ability to 
fly  
Mice 30-50% 
30-50% (100% 
in combination 
with CR) 
Protection against 
cancer, diabetes, 
atherosclerosis, 
cardiomyopathy, 
autoimmune, kidney, 
and respiratory 
diseases; reduced 
neurodegeneration  
Reduced tumour incidence; 
protection against age-
dependent cognitive decline, 
cardiomyopathy, fatty liver 
and renal lesions. Extended 
insulin sensitivity  
Humans Not determined Not determined 
Prevention of obesity, 
diabetes, hypertension; 
reduced risk factors 
for cancer and 
cardiovascular disease  
Possible reduction in cancer, 
metabolic and 
neurodegenerative diseases 
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Caloric restriction has yielded beneficial effects on metabolic, cardiovascular, and neurological 
outcomes in virtually all species studied, and is typically accompanied by an extension of lifespan of 
up to 30-50% [Table 1.3] (Fontana et al. 2010). Growing evidence indicates beneficial effects in 
humans, on outcomes such as inflammation, hypertension, and cardiovascular and metabolic diseases 
(Cava & Fontana 2013). Compared to other interventions, by extrapolation of results from animal 
models to humans, CR, or interventions targeting the underlying mechanisms of CR could be 
estimated to produce one of the, if not the, most impact on longevity [Figure 1.6] (Baur et al. 2012). 
 
 
 
 
 
 
 
Figure 1.6. Estimated effects of a variety of interventions on human life expectancy. Figure adapted 
from (Baur et al. 2012).   
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One of the best pieces of evidence for this is from Okinawan population in south Japan, which boasts 
the highest rates of centenarians in the world (D. C. Willcox et al. 2006). This may be partly due to 
genetics, but seems to be primarily due to the higher than average levels of daily exercise, lower than 
average food intake, and the composition of dietary macro- and micronutrients (Le Couteur et al. 
2016). In order to disentangle the effects of genetics, a sub-population of Okinawans who had moved 
to Brazil was compared to the native population. On adopting a Western diet, this sub-population 
experienced a significant drop in life expectancy, by approximately 17 years compared to their 
counterparts who remained in Japan, providing evidence that the basis for their longevity is driven 
more by environment than by genetics (Mizushima et al. 1997). That being said, there is debate as to 
which dietary regimens are optimal, and the impracticality of human trials means that long-term 
dietary interventions are not likely to ever be a therapeutic methodology applied to humans (de Cabo 
et al. 2014). Therefore, it is critically important to understand the mechanisms by which diet mediates 
its beneficial effects on health and ageing, in order to directly target pathways through optimal short-
term interventions, or pharmaceutical agents such as CR mimetics [Table 1.4]. Although lifespan is an 
important outcome of interest, criticism towards ageing research has been generated by the notion 
that increasing lifespan may be accompanied by an increase in burden of disease carried by the elderly 
population (Seals & Melov 2014). While this is a valid concern related to the ageing population that is 
accruing throughout the modern world, this brings up the concept of optimal longevity, where 
lifespan increases are complemented by increased healthspan, or portion of life which is morbidity-
free (Longo et al. 2015). Research has also consistently shown that the increase in lifespan that occurs 
due to dietary interventions is accompanied by an increase in health outcomes through life, a term 
which is known as healthspan (Fontana et al. 2010), although there is some evidence that lifespan and 
healthspan can be dissociated depending on the intervention used (Hansen & Kennedy 2016). In 
humans, while median lifespan has increased drastically over the last century, this has not been 
matched by a proportional increase in healthspan (Mercken et al. 2012). However, as discussed earlier, 
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this is likely due to the fact that the changes in human longevity are primarily due to advances in 
medicine and development of treatments to diseases rather than interventions targeting the ageing 
process such as caloric restriction (de Cabo et al. 2014).  
 
Table 1.4. Effects of various interventions on lifespan and health in humans, or in mice where data in 
humans was not available. Table adapted from (de Cabo et al. 2014).  
Treatment Positive effects Negative effects 
Caloric 
restriction 
Decreased body fat, blood pressure, resting 
heart rate and improved lipid profile 
Danger of malnutrition (e.g. neurologic 
deficits, lowered fertility and libido, wound 
healing problems, amenorrhea, osteoporosis, 
decreased potential to combat infections) 
Fasting 
strategies 
Longer lifespan; decreased hypertension and 
of other features of metabolic syndrome; 
improved verbal memory loss in the aged and 
overweight; weight loss in the obese 
Limited if not integrated with health-
associated diets; might be harmful in 
children, underweight people and during 
pregnancy as well as in some disease states 
Exercise Prevents cardiovascular diseases, diabetes, 
osteoporosis, sarcopenia and depression; 
prolongs independent living by the elderly 
Excessive exercise in the elderly is correlated 
to mortality 
Resveratrol (in mice) prevents oxidative stress in the aging 
heart, neurodegeneration, vascular disease and 
diabetes; increases lifespan under metabolic 
stress conditions (high-fat diet or every other 
day feeding) 
(in humans) at high doses, nausea, 
gastrointestinal discomfort;  
(in mice) at high doses, nephrotoxicity 
Rapamycin (in mice) extends lifespan; exerts 
antiproliferative effects  
Potent immunosuppressive properties; long-
term administration has adverse effects (e.g. 
impaired wound healing, proteinuria, or 
pneumonitis)  
Spermidine (in mice) extends lifespan; inhibits 
neurodegeneration, induces cardiac autophagy 
(in mice) high doses can cause emaciation, 
aggressiveness, convulsions and paralysis 
Metformin (in humans) decreases hepatic 
gluconeogenesis; 
(in mice) increases insulin sensitivity; lifespan 
extension 
Gastrointestinal disturbances; at high doses, 
can cause tachycardia, hypoglycaemia; very 
small chance of lactic acidosis 
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Nutrient sensing pathways 
Recently, research has been undertaken to elucidate which components of dietary interventions are 
most beneficial and to determine the cellular pathways that mediate the response of ageing to changes 
in dietary composition. It has generally been concluded that it is simply the reduction of energy intake 
that increases lifespan, although recent research has focused on each of the macronutrients (protein, 
carbohydrates, fat) or the ratio of macronutrients, or even the effects of short periods of fasting and 
hunger (Mair et al. 2005; Solon-Biet et al. 2014; Solon-Biet et al. 2015c; Le Couteur et al. 2015).  
 
A recent meta-analysis of nearly 150 animal studies of CR concluded that protein restriction was more 
important for life extension than the degree of caloric restriction (Nakagawa et al. 2012). The benefits 
of dietary interventions seem to therefore be derived from some combination of CR and reduced 
macronutrient intake, and more recently the ratio of dietary protein-to-carbohydrates (P:C) (Le 
Couteur et al. 2015; Fontana et al. 2016). Interestingly, with the long-lived Okinawan population, the 
average ratio of P:C in the traditional diet was about 1:10, similar to that found to optimise lifespan in 
animal models (Le Couteur et al. 2015).  
 
While low-protein to high-carbohydrate (LPHC) diets are associated with longevity, high-protein to 
low-carbohydrate (HPLC) diets have been seen to be associated with higher rates of reproduction, in 
line with the evolutionary theories indicating there is a trade-off between reproduction and longevity 
(Le Couteur et al. 2015). Comparing LPHC diets to caloric restriction, studies have showed that many 
common pathways are involved, including downregulation of mechanistic target of rapamycin 
(MTOR), alteration to mitochondrial function and changes in metabolic regulation [Table 1.5] (Solon-
Biet et al. 2015a). 
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Table 1.5. Outcomes of studies in animals on LPHC ad libitum diets versus CR diets. Table from 
(Solon-Biet et al. 2015a; Solon-Biet et al. 2015b). 
 
Outcome  LPHC ad libitum diets CR diets 
Food intake  ↑ ↓ 
Body weight ↑ ↓ 
Body fat ↑ ↓ 
Temperature  ↑ ↓ 
Insulin ↓ ↓ 
LDLc ↓ ↓ 
HDLc ↑ ↑ 
Mitochondrial number ↓ ↑ 
Mitochondrial free radicals ↑ ↓ 
PGC-1α ↓ ↓ 
Uncoupling protein ↓ - 
mTOR phosphorylation ↓ ↓ 
AMPK phosphorylation ?↓ ↑ 
Reproductive fitness ↓ ↓ 
Lifespan ↓ ↑ 
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Figure 1.7. Proposed mechanisms mediating the beneficial effects of dietary restriction on ageing. 
Figure adapted from (Bonkowski & Sinclair 2016). 
 
Dietary studies over the years have also looked at mechanistic factors such as endocrine function, 
oxidative stress, inflammation, genetic and epigenetic changes. Despite this, no single mechanism has 
been found to be solely, or even mostly responsible for the lifespan extension seen in dietary studies 
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(de Cabo et al. 2014). Given however, a great deal of work has focused on studying nutrient sensing 
pathways, as these provide a potential mechanism linking diet with ageing (Finkel 2015). As these 
nutrient sensing pathways share common downstream targets influencing cellular processes such as 
mitochondrial function, metabolism, anabolic/catabolic balance and protein synthesis, they are able to 
control the balance between growth and reproduction versus survival and ageing [Figure 1.7] (Solon-
Biet et al. 2015b).  
 
In 2013, a workshop was held in Erice, Italy to bring together ageing research experts from a variety 
of disciplines in order to discuss potential interventions to delay ageing and improve healthspan in 
humans. While many pharmacological and gene targets were discussed, consensus was reached that 
the most promising interventions were primarily focused on modifying nutrient sensing pathways 
(Longo et al. 2015): 
 
1. Interventions mimicking dietary restriction (caloric, macronutrient, intermittent fasting, etc.) 
2. Inhibition of the Target Of Rapamycin - S6-Kinase (TOR-S6K) pathway 
3. Activation of the Sirtuin histone deacetylase pathways 
4. Inhibition of the Insulin-like Growth Factor 1 (IGF-1)/Growth Hormone (GH) axis 
5. Activation of the AMP-activated protein kinase (AMPK) pathway 
 
Given that long-term studies of caloric restriction are not feasible in humans, interest has shifted 
towards the drug and nutritional interventions that act on these nutrition sensing pathways but don’t 
involve reduced food intake (de Cabo et al. 2014). These signaling pathways are largely evolutionarily 
conserved, facilitating the study of diets, genes and pharmaceutical agents in simpler laboratory 
models such as yeast, worms and mice (Vaiserman et al. 2016). 
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MTOR-S6K pathway 
Formerly known as mammalian target of rapamycin, mTOR has been renamed as mechanistic target 
of rapamycin, after the discovery that it is highly conserved amongst eukaryotic cells (Wei et al. 2015). 
Related to the phosphoinositide 3-kinase (PI3K)-related protein kinases (PIKK) family, mTOR is the 
catalytic subunit of two individual complexes, mTOR complex 1 (mTORC1) and mTORC2. These 
form unique complexes; mTORC1 with Regulatory-associated protein of mTOR (RAPTOR), and 
mTORC2 with Rapamycin-insensitive companion of mTOR (RICTOR) (Zoncu et al. 2010). The 
mTOR pathway is activated by circulating amino acids through Rag-GTPase complexes, in addition 
to being responsive to insulin/IGF-1 signaling, circulating glucose, Wnt ligands, oxygen, and cAMP 
(Laplante & Sabatini 2009; Efeyan et al. 2015). Activation of mTOR is linked with anabolic cell 
growth through protein and lipid synthesis, while inhibition of mTOR is linked with cellular stress 
responses such as autophagy (Jewell et al. 2013). The mTOR pathway is one of the leading candidates 
thought to mechanistically link diet and ageing, as it is sensitive to circulating amino acids, and 
modification of this pathway has been shown to produce lifespan extension in many species [Table 
1.6] (Lamming et al. 2013; Johnson et al. 2013; Jia 2004; Kapahi et al. 2004). Caloric and protein 
restriction has also been shown to be associated with a decrease in mTOR activity in mice (Solon-Biet 
et al. 2014; Xiao et al. 2011). The mTORC1 complex has two major substrates, S6 kinase (S6K) and 
4E-BP1, both of which have been shown to be related to protein and lipid synthesis, and 
mitochondrial metabolism (Longo et al. 2015). The mTORC2 complex on the other hand is involved 
in the phosphorylation and activation of Akt and protein kinase C (PKC), which is involved in 
anabolism, cell survival and cell cycle progression, and inhibition of forkhead box protein O1 
(FOXO1), a transcription factor that regulates many cellular processes including apoptosis, 
metabolism and proliferation [Figure 1.8] (Zoncu et al. 2010).  
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Figure 1.8. The role of mTOR in metabolism. Figure adapted from (Zoncu et al. 2010). 
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Together, these mTOR complexes are a key target in ageing research, especially given the availability 
of the pharmacological agent rapamycin, which inhibits the complexes, and has been shown to 
produce a lifespan extension of up to 26% in mice (Harrison et al. 2009; Vaiserman et al. 2016). 
Rapamycin, despite being shown to increase longevity in a subset of animals [Table 1.6], has 
significant adverse effects, particularly through metabolic dysregulation (Lamming et al. 2012; Deblon 
et al. 2012), immunosuppression (Blagosklonny 2013) and haematopoetic proliferative disorders 
(Soefje et al. 2011). While rapamycin has been given FDA-approved status for immunosuppression 
following organ transplantation in humans, these side effects have precluded its use as an anti-ageing 
drug (Arriola Apelo & Lamming 2016). For this reason, despite the immense appeal of mTOR as a 
target for improving human longevity, robust safety studies must be performed to further understand 
the role and function of mTOR and its substrates in the ageing process (Longo et al. 2015).  
 
In animal studies, inhibition of mTORC1, mTORC2 and S6K and activation of 4E-BP1 and FOXO 
has displayed longevity benefits (Seo et al. 2013; Johnson et al. 2013; Kennedy & Pennypacker 2014; 
Kenyon et al. 1993; Melendez 2003). In fact, 4EBP deletion has been shown to block lifespan 
extension mediated by caloric restriction in D. melanogaster (Kapahi et al. 2004; Zid et al. 2009). Gene 
mutations of the mTOR signaling pathway in many model organisms have consistently shown 
increases in mean lifespan, thereby demonstrating the importance of understanding the interaction 
between diet, mTOR and ageing [Table 1.6] (Lamming et al. 2013; Evans et al. 2011). Reduced 
mTORC1 signaling has also been shown to be linked with upregulated autophagy (Laplante & 
Sabatini 2009; Salminen & Kaarniranta 2009), mitochondrial oxidative phosphorylation (Guarente 
2008; Bonawitz et al. 2007; Zid et al. 2009), and resistance to stress due to reactive oxidative species 
(Wei et al. 2009), all of which are potential mechanisms linking mTOR with ageing (Evans et al. 
2011). The role of mTOR, particularly due to its function as a dietary protein sensor is of significant 
interest, and is investigated throughout this thesis. 
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Table 1.6. The impact of mTOR-related genes and rapamycin on longevity in model organisms. 
Compiled from (Evans et al. 2011; Lamming et al. 2013; Vaiserman et al. 2016). 
 
Species Gene or drug Change in lifespan 
S. cerevisiae SCH9 (Akt/S6K homolog) 
mutant 
Increase in mean chronological lifespan (30%) 
 SCH9 (Akt/S6K homolog) 
deletion 
Increase in mean chronological lifespan (three-fold) 
 SCH9 (Akt/S6K homolog) 
mutant  
Increase in mean replicative lifespan (18%) 
 SCH9 (Akt/S6K homolog) 
deletion  
Non-significant increase in mean replicative lifespan 
 TOR1 deletion  Increase in mean and maximum replicative lifespan (20%)  
Increase in median chronological lifespan (2.7-fold) 
 Rapamycin Increase in chronological lifespan (54%)  
Increase in replicative lifespan (15-19%) 
C. elegans TOR (let-363) RNAi Increase in mean lifespan (2.5-fold) 
 Raptor (daf-15) heterozygous Increase in mean lifespan (30%) and maximum lifespan 
(19%) 
 S6K (rsks-1) RNAi Increase in mean lifespan (12%–47%) 
 S6K (rsks-1) deletion mutant Increase in mean lifespan (15%) 
 TOR (let-363) RNAi Increase in mean lifespan (15%–44%) 
 S6K (rsks-1) RNAi Increase in mean lifespan (22%) 
 S6K (rsks-1) deletion mutant Increase in mean lifespan (9%) 
 TOR (let-363) RNAi Increase in mean lifespan (10%) 
 Rictor (rict-1) deletion mutant  Decrease in median lifespan (24%–43%) and maximum 
lifespan (21%–32%; normal diet, 25°C) 
Increase in mean lifespan (4%–34%) and maximum 
lifespan (7%–39%; nutrient-rich diet, 25°C) 
 Rictor (rict-1) RNAi Increase in mean lifespan (12%–33%; normal diet, 20°C) 
 Raptor (daf-15) RNAi Increase in mean lifespan (7%–21%) 
 Rag-GTPase (raga-1) RNAi Increase in mean lifespan (9%–35%) 
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 Rag-GTPase (ragc-1) RNAi Increase in mean lifespan (13%–33%) 
 Rheb (rheb-1) RNAi Increase in mean lifespan (18%–25%) 
 Rapamycin Increase in mean lifespan (19%) 
D. melanogaster dTSC1 overexpression Increase in mean lifespan (14%; males) 
 dTSC2 overexpression Increase in mean lifespan (12% at 29°C, 20% at 25°C; 
males) 
 dTOR overexpression Prevention of eclosion 
 dTOR FRB domain (dominant 
negative) 
Increase in mean lifespan (24% at 29°C, 26% at 25°C; 
males) 
 dS6K dominant negative Increase in mean lifespan (22%; males) 
 dS6K constitutive active Decrease in mean lifespan (34%; males) 
 dTOR mutant (hypomorph) Increase in median lifespan (20%) 
 d4E-BP null Decrease in mean lifespan (males, 30%; females, 17%; 
yeast extract, 5%)  
 d4E-BP overexpression No effect on lifespan (males or females) 
 d4E-BP weak activated No effect (males) and increase in mean lifespan (females, 
14%) 
 d4E-BP strong activated Increase in mean lifespan (males, 11%; females, 22%) 
 dS6K constitutive active Slight, significant decrease in mean lifespan (females)  
 d4E-BP null Decrease in mean lifespan (39%; females) 
 Rapamycin Increases in mean and median lifespans (17%, 23%; rich 
media diet; females only), (54%, 36%; starvation diet; 
females only) 
M. musculus  Loss of S6K1  Increases in mean, median, and maximum lifespans (20%, 
18%, and 10%, respectively; females only) 
 Mtor+/–Mlst8+/– genotype  Increases in mean, median, and maximum lifespans (14%, 
13%, and 18%, respectively; females only) 
 Rapamycin Increase in mean lifespan (8%–26%) 
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Sirtuin pathway 
Since the discovery of the Silent information regulator 2 (Sir2) (Kennedy et al. 1995), genome-wide 
association studies (GWAS) have shown that the SIR2 locus one of the most important regulators of 
replicative lifespan in yeast (Stumpferl et al. 2012). Sir2 homologues in other taxa are collectively 
known as sirtuins, and are a family of NAD+-dependent histone deacetylases (HDAC) and ADP-
ribosyltransferases, which have since been shown to modulate stress responses, disease susceptibility 
and longevity in a variety of species (Giblin & Lombard 2016). In mammals, the sirtuin family 
comprises of seven proteins (SIRT1-7), has become one of the most widely studied nutrient sensing 
pathways (Houtkooper et al. 2012). The various sirtuin proteins localise to different parts of the cell 
and have functions including nutrient sensing, regulation of glucose and lipid metabolism, 
mitochondrial biogenesis and transcription regulation (Michán & Sinclair 2007).  SIRT1 and 6 are 
primarily found in the nucleus, SIRT2 is mainly cytosolic, SIRT3-5 localise to the mitochondria, and 
SIRT7 is found in the nucleolus (Houtkooper et al. 2012). The activity of each sirtuin protein is 
dependent on specific substrates based on its cellular localisation, but in general, regulation is 
controlled by gene expression in response to energy status; caloric restriction upregulates SIRT1 
expression (Nemoto 2004), while high dietary fat downregulates expression (Coste et al. 2008). SIRT1 
is also known to act through its multiple downstream targets, notably FOXO1 and p53, which are 
involved in metabolism and apoptosis respectively (Bonkowski & Sinclair 2016). In mice, SIRT1 
overexpression has also been shown to display a caloric restriction phenotype (Bordone et al. 2007), 
while downregulation has been shown to display an accelerated ageing phenotype (Sommer et al. 
2014). While SIRT1 rose to fame due to its relationship with longevity, studies in other species have 
showed mixed results, with many pro-longevity results being derived in metabolically stressed 
conditions with exposure to high fat diets [Table 1.7] (Bass et al. 2007; Scheibye-Knudsen et al. 2014; 
Kaeberlein & Powers 2007). In humans, gene association studies have found no polymorphisms in 
Sirt1 to be associated with longevity (Razi et al. 2017; Flachsbart et al. 2006). Therefore, while sirtuins, 
  49 
have been shown impact the ageing process, the focus is now on their role in ameliorating metabolic 
disease processes and affecting lifespan through their impact on health (Baur 2010). 
 
 
Table 1.7. The impact of Sirtuins and Sirtuin Activating Compounds (STACs) on longevity and 
caloric restriction. Table compiled from (Bonkowski & Sinclair 2016; Bhullar & Hubbard 2015). 
 
Species  
Sirtuin 
knockout 
shortens 
longevity 
Sirtuin 
overexpression 
extends longevity 
STACs extend 
longevity (% change 
in lifespan) 
Sirtuins 
mediate 
the effects 
of CR on 
longevity 
Sirtuin 
expression 
altered by 
CR 
S. cerevisiae Yes  (20–50%) Yes (30–50%) 
Resveratrol (30–70%; 
failed in other studies) 
Mixed 
(Sir2, Hst2) 
Yes; however 
other studies 
showed 
NAD+ levels 
unchanged 
C. elegans Yes  (~5–10%) 
High expression (2.1 
line 50%); low gene 
copy number (10-
25%), eleven 
independent low 
copy overexpressing 
lines (~5-15%) 
Resveratrol (9–65%; 
failed in other 
studies); SRT1720 
failed 
Mixed Not tested 
D. melanogaster 
Yes 
(~50%); 
No change 
in other 
studies 
Yes (~18–29%; dose 
dependant; fat-body 
type specific); No 
effect in other 
studies 
Resveratrol (8–29%; 
failed in other studies) 
Yes; Fat-
body type 
specific 
Yes 
A. mellifera  Not tested Not tested Resveratrol (33-38%) Not tested Not tested 
N. fuzeri Not tested Not tested Resveratrol (27-59%) Not tested Not tested 
N. guentheri  Not tested Not tested Resveratrol (19%) Not tested Not tested 
M. musculus 
Yes  
(~20– 
50%) 
Elevated 
embryonic/
postnatal 
mortality 
Brain specific Sirt1 
(9–16%); Sirt6 (9-
17%; males) 
Resveratrol (31%; 
high fat diets; failed in 
other studies); 
SRT1720 (~8–22%); 
SIRT2104 (~10%; 
males) 
Yes Yes 
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With regards to lifespan, SIRT1 in particular has been well studied, after its activator resveratrol was 
identified (Baur & Sinclair 2006). Resveratrol, a polyphenol found in red wine, has also been shown to 
improve insulin sensitivity, decrease inflammation, protect against neurodegenerative disorders and 
carcinogenesis, and promote cardiovascular health in both animal models and humans (Cottart et al. 
2013; Smoliga et al. 2013; Liu et al. 2014; Hausenblas et al. 2014). While the effects of resveratrol have 
been shown to mimic the effects of caloric restriction in mammals, the benefits to lifespan have only 
been seen in yeast, worms and flies, and in mice on high fat diets [Table 1.7] (Lagouge et al. 2006; 
Baur et al. 2006). Other sirtuin family members such as SIRT3 and SIRT6 have also been implicated 
in promoting longevity, however the bulk of evidence suggests that sirtuins act mainly to improve 
health outcomes rather than directly on lifespan (Guarente 2011). Furthermore, many Sirtuin 
Activating Compounds (STACs), including resveratrol, have been found to have multiple effects not 
directly related to SIRT1, raising the question whether the effects of these molecules on lifespan is 
dependent on SIRT1 (Pacholec et al. 2010).  
 
In humans, resveratrol is known to be safe in doses of 1-2mg/day, as these doses can be found in 
dietary sources consumed by the general population (Smoliga et al. 2012). On the other hand, while 
studies some have concluded that doses up to 450mg/day may be safe in 60kg individuals (Williams et 
al. 2009), the optimal dose remains unclear for healthy individuals (Brown et al. 2010). This is because, 
while resveratrol has been shown to ameliorate metabolic (Bhatt et al. 2012; Magyar et al. 2012; 
Crandall et al. 2012) and neurodegenerative disease processes ( Sun et al. 2010), human clinical trials 
have not shown the same degree of positive outcomes (Yoshino et al. 2012; Bo et al. 2013). These 
clinical trials have been thoroughly reviewed by (Novelle et al. 2015). Further studies are needed to 
evaluate optimal dosage, safety and efficacy of STACs prior to their use as a pro-longevity agent. The 
role of the sirtuin pathway in ageing, and its relationship with diet is therefore a key area of interest of 
this thesis.  
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Insulin, IGF-1 and growth hormone axis 
One of the first pro-longevity gene mutations discovered was a PI3K (age-1) mutation in C. elegans 
(Friedman & Johnson 1988), and subsequently the knockout of insulin receptor (daf-2), which is 
upstream of PI3K, was also shown double lifespan in the nematode (Kenyon et al. 1993). Similar 
results have been demonstrated in a variety of species, through various alterations to the insulin, 
insulin-like growth factor-1 (IGF-1) and growth hormone (GH) pathway; collectively known as the 
Insulin and IGF-1 Signaling (IIS)/GH axis (Tatar 2001; Svensson et al. 2011; Holzenberger et al. 
2003; Fontana et al. 2010). GH is secreted by the anterior pituitary gland in response to hypothalamic 
release of Growth Hormone Releasing Hormone (GHRH), and in turn induces production of IGF-1, 
primarily in the liver (Milman et al. 2016). Both GH and IGF-1 have pleiotropic effects on cells via 
GH receptors (GHR), and IGF-1R and insulin receptor (IR) respectively (Junnila et al. 2013). In 
humans, IGF-1 receptor gene polymorphisms have been shown to be correlated with longevity in 
studies of centenarians and octogenarians (Van Heemst et al. 2005; Suh et al. 2008), and life 
expectancy has been shown to be predicted by low circulating IGF-1 levels in long-lived individuals 
(Milman et al. 2014). Currently, the only pharmacological agents that target the IIS/GH axis are 
monoclonal antibodies (mABs) against IGF-1 receptor (IGF-1R), somatostatin analogues, and the 
GH receptor (GHR) antagonist pegvisomant used in the treatment of acromegaly (Longo et al. 2015). 
While multiple oncological clinical trials using IGF1R mABs have been performed (Warshamana-
Greene et al. 2005; Carboni et al. 2009), these agents have not received FDA approval for cancer 
treatment or ageing (Chen & Sharon 2013). Somatostatin analogues are known to have a significant 
side effect profile due to their activity on multiple endocrine pathways (Freda 2002). Pegvisomant has 
been demonstrated to have a much better tolerability (Burt & Ho 2003), and was shown to decrease 
circulating IGF-1 levels in a dose-dependent manner (Kopchick et al. 2002). Caloric restriction, has 
also been shown to reduce the activity of the IIS pathway (Bonkowski et al. 2006; Katic & Kahn 
2005), and transgenic mouse strains with alterations to the IIS/GH axis have been consistently 
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documented to modify lifespan [Table 1.8] (Junnila et al. 2013).  
 
Table 1.8. The impact of alterations to IIS/GH axis related genes on longevity in mice. Table 
compiled from (Junnila et al. 2013; Bartke 2005). 
 
Mouse model  
Sample size 
(% of 
control) 
Lifespan change (%)  
Lifespan (days) 
Mutant  Control  
Snell dwarf 25–33 F +42 M +42  F and M 1,178 ± 235  F and M 832 ± 158  
Ames dwarf 33 F +68 M +49  F 1,206±32 M 1,076±56  F 718±45 M 723±54  
lit/lit 50–67 F +25 M +23  F 1,070±127 M 1,093±186  
F 857±169 M 
886±148  
Ghr –/– <50 F +21 M +40  F 921±41 M 917±55  F 759±41 M 656±67  
Bovine GH 
transgenic 200 M –45 M 425±22  M 773  
GHR 
antagonist 
transgenic 
70 p<0.05 F 839±25 M 790±41  F 771±26 M 758±40  
LI-Igf1–/– 75–100 F +16  F 812±33 (800 ± 33)  F 700±21 (23.0 ± 0.7 months)  
Pappa–/– 40 F +38 M +38  F and M 960±28  F and M 698±23  
Igf1r+/– 90 F +33 M p<0.05  F 756±46 M 679±80  F 568±49 M 585±69  
Igf1r+/– 90 p<0.05 F 923±21 M 983±21  F 967±29 M 939±24  
Klotho 
transgenic  
(2 strains) 
100 F1 +19 F2 +19 M1 +20 M2 +31 
F1 829±32 F2 830±29  
M1 858±40 M2 936±47  F 697±45 M 715±44  
Irs1–/– 70 F +17 M p<0.05 F 891±39 M 897±41  F 763±21 M 786±21  
Irs2+/– 100 F +17 M +17  F and M 905±22  F and M 775±10  
Irs2+/– 100 p<0.05 F and M 788±17  F and M 755±22  
Irs2–/– 90 F –26 M –84  F 560±63 M 123±20  F 755±23 M 767±40  
Brain-specific 
Irs2+/– and  
Irs2–/–  
100 (+/–) F +18 M +18  (–/–) F +14 M +14 Raw data not presented 
Raw data not 
presented 
p66shc+/– and 
p66shc–/– 100 
(+/–) F +7 M +7 (+/–) F and M 815±37 
F and M 761±19  
(+/–) F +28 M +28 (–/–) F and M 973±37  
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AMP-activated protein kinase pathway 
Given that the IIS/GH axis acts upstream of mTOR, an integrated starvation response to CR may be 
the mechanism linking these pathways with ageing (de Cabo et al. 2014). Another nutrient-responsive 
sensor is the AMP-activated protein kinase (AMPK) pathway, which has been shown to inhibit 
mTOR through phosphorylation of the RAPTOR subunit of mTORC1 (Potter et al. 2010; Hardie 
2014).  AMPK is a serine/threonine kinase that is activated by increases in cellular AMP:ATP ratio 
(representing low energy states), and acts to increase ATP production  to maintain energy homeostasis 
by activating alternate catabolic pathways, while downregulating biosynthetic pathways such as mTOR 
dependent protein translation (Gowans et al. 2013). This results in increased glucose uptake into 
skeletal muscle via GLUT4 (Kurth-Kraczek et al. 1999; Holmes et al. 1999), increased fatty acid 
oxidation (Merrill et al. 1997), and decreased hepatic gluconeogenesis (Ruderman et al. 2013). In 
addition, AMPK is also known to be involved in metabolic regulation on a larger scale by acting both 
on the hypothalamus to control appetite (Kola 2008; Minokoshi et al. 2004), as well through its role in 
mitochondrial biogenesis and mitophagy via PGC1-α phosphorylation and SIRT1 activation (Cantó et 
al. 2010; Jager et al. 2007). Therefore, given its fundamental role as a sensor of cellular energy and 
nutrient status, AMPK has been implicated in mediating the beneficial effects of CR on ageing (Cantó 
& Auwerx 2011; Stenesen et al. 2013). A decline in AMPK signaling has also been demonstrated to 
occur during the ageing process (Reznick et al. 2007; Hardman et al. 2014; Salminen et al. 2016). 
Pharmacological activators of AMPK such as biguanides, have been shown to delay disease onset and 
ageing in nematodes and mice, but had mixed results in flies and rats [Table 1.9] (De Haes et al. 2014; 
Cabreiro et al. 2013). Metformin is a FDA-approved anti-diabetic biguanide currently being 
prescribed to more than 100 million people worldwide for type II diabetes mellitus (Hardie et al. 
2012), but has been shown to be possibly effective for other human age-related disease processes such 
as  cardiovascular and metabolic disease (Group 1998), cancer (Wu et al. 2014; Coperchini et al. 2015), 
cognitive decline (Ng et al. 2014; Foretz et al. 2014) and frailty (Wang et al. 2017; Valencia et al. 2017). 
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Due its widespread use, and favorable safety profile, a multi-center placebo controlled clinical trial has 
been proposed to study the effects of metformin on ageing (Barzilai et al. 2016; Barzilai et al. 2018). 
Given that microarray studies have shown strong similarities between gene expression patterns seen 
in metformin and CR interventions in mice (Dhahbi et al. 2005), it will be interesting whether similar 
findings occur in humans.  
 
Table 1.9. The impact of biguanides on longevity in model organisms. Table compiled from 
(Vaiserman et al. 2016; Burkewitz et al. 2014). 
 
Model Biguanide Impact on longevity 
AMPK 
involved Physiological effects 
C. elegans 
Metformin 36%-40% Yes 
Slowed lipofuscin accumulation; 
increased autophagy, respiration and 
metabolic heat production 
Metformin/
Phenformin 
Up to 36%; 
dose 
dependent 
Yes Altered microbial folate and methionine metabolism 
D. melanogaster Metformin No effect Yes Reduced lipid stores, increased autophagy 
M. musculus 
Metformin 
4%-38%; 
strain and 
dose 
dependent 
Yes 
Decreased appetite, blood glucose, 
body temperature; increased 
mitochondrial biogenesis, fatty acid 
oxidation, glycolysis and autophagy 
Phenformin 21% Yes No data 
R norvegicus 
Metformin 
No effect 
in Fischer-
344 rats 
No data Reduced body weight 
Buformin 9% No data 1.6 fold reduction in incidence of spontaneous tumours 
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Mechanisms of ageing 
Given that multiple dietary, pharmacological and genetic interventions have been shown to delay the 
ageing process in model organisms, the next important step in geroscience is to translate these 
discoveries into humans. Due to the difficulties involved with conducting life-long, or long-term 
studies measuring lifespan and ageing in humans, an approach to this problem is to interrogate the 
mechanistic physiological components involved with ageing as representative outcomes to parallel 
findings in animal models, i.e. surrogate outcomes for ageing. While improvement of lifespan and 
healthspan are the longer-term goals of biogerontology research, these processes can be 
independently studied in shorter time frames to find endpoints that can be therapeutically targeted to 
promote healthy ageing. In 2013, Lopez-Otin and colleagues suggested categorisation of the 
molecular processes underlying ageing into nine hallmarks based on three criteria [Figure 1.9, Table 
1.10] (López-Otín et al. 2013):  
1. Manifestation of the process during chronological ageing,  
2. Aggravation of the process should cause accelerated ageing,  
3. Interventions targeting the process should be seen to impede ageing.  
 
These hallmarks form potential endpoints for clinical trials, and have been found to be useful in 
assessing the impact of interventions on the ageing process (López-Otín et al. 2016). Similarly, the 
trans-NIH Geroscience Interest Group also classified physiological processes into seven ‘pillars of 
ageing’ based on conservation of mechanistic pathways through various species and 
interconnectedness in their impact on the ageing process (Kennedy et al. 2014). Notably, the common 
themes of metabolic and proteostatic imbalance, genetic and epigenetic changes, senescence, and 
intracellular communication have all been demonstrated to be altered through dietary interventions 
such as caloric restrictions in both animal models and humans (Civitarese et al. 2007; Astrup et al. 
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1999; Heilbronn et al. 2006; Lecoultre et al. 2011; Ravussin et al. 2015; Most et al. 2017; Fontana & 
Partridge 2015), thereby advancing the case to interrogate these mechanisms in the context of diet and 
nutrient sensing pathways. Together, Figures 1.8 and 1.10 outline the proposed mechanistic picture of 
how ageing occurs, and the physiological processes underlying it. 
 
 
 
 
 
 
Figure 1.9. The hallmarks of ageing. Primary hallmarks (negative correlation with ageing; source of 
damage) are shown grouped in the bottom right hand corner, antagonistic hallmarks (hormetic; 
responses to damage) are shown grouped in the top left hand corner, and integrative hallmarks 
(aggregated; resulting from changes in the other hallmarks) shown grouped in the top right hand 
corner. Figure adapted from (López-Otín et al. 2016; López-Otín et al. 2013). 
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Table 1.10. Evidence for hallmarks of ageing in S. cerevisiae. Compiled from (Hu et al. 2014; Austriaco 
& Guarente 1997; Kim et al. 1996; Dang et al. 2009; Feser et al. 2010; Reverter-Branchat et al. 2004; 
Erjavec et al. 2007; Unal et al. 2011; Lord et al. 2015; Aguilaniu 2003; Lin et al. 2001; Janssens et al. 
2015; Janssens & Veenhoff 2016; Hughes & Gottschling 2012; McFaline-Figueroa et al. 2011; Xie et 
al. 2012; Laun et al. 2005; Laun et al. 2001; Fehrmann et al. 2013; Kennedy et al. 1994; Smeal et al. 
1996; Mei & Brenner 2015; Dillin et al. 2014)  
Hallmark Observations 
Genomic 
instability 
Accumulation of extra-chromosomal rDNA circles (Sinclair & Guarente 1997) 
Amplification of chromosomal segments (Hu et al. 2014) 
Increase in DNA breaks and genomic translocations (Hu et al. 2014) 
Increase of retrotransposon DNA content (Hu et al. 2014) 
Telomere 
attrition 
Changes in telomere length alters lifespan (Austriaco & Guarente 1997)  
Sub-telomeric genes are subject to transcriptional silencing with age (Kim et al. 1996) 
Epigenetic 
alterations 
Modification to histone acetylation (Dang et al. 2009) 
Loss of silencing at chromosome ends (Kim et al. 1996) 
Histone mRNA and protein level changes (Feser et al. 2010) 
Histone occupancy reduction (Hu et al. 2014) 
Changes to nucleosome positioning (Hu et al. 2014) 
Loss of 
proteostasis 
Increased oxidative stress response proteins (Reverter-Branchat et al. 2004) 
Aggregation of carbonyl-damaged proteins (Erjavec et al. 2007; Unal et al. 2011)  
Altered nuclear pore complexes (Lord et al. 2015) 
Oxidative protein damage (Aguilaniu 2003) 
Deregulated 
nutrient sensing 
Increased gluconeogenesis, decreased glycolysis (Lin et al. 2001) 
Changes in energy metabolism pathways (Reverter-Branchat et al. 2004) 
Altered expression of genes related to metabolism (Janssens & Veenhoff 2016) 
Mitochondrial 
dysfunction 
Altered expression of genes related to mitochondrial function (Janssens et al. 2015) 
Decrease in vacuolar pH and mitochondrial membrane potential, and increased 
mitochondrial fragmentation (Hughes & Gottschling 2012) 
Mitochondrial redox potential decline (McFaline-Figueroa et al. 2011) 
Increased ROS (Z. Xie et al. 2012; Laun et al. 2001) 
Genomic translocations in mtDNA, increase in mtDNA content (Hu et al. 2014) 
Cellular 
senescence 
Induction of apoptotic phenotype and terminal senescence due to oxidative stress and 
ageing (Laun et al. 2005; Laun et al. 2001) 
Increased senescence with age (Fehrmann et al. 2013) 
Stem cell 
exhaustion 
Increased chance of symmetric divisions (Kennedy et al. 1994) 
Reduction in replicative lifespan of daughters (Kennedy et al. 1994) 
Altered 
intercellular 
communication 
Decreased pheromone response (Smeal et al. 1996) 
Altered metabolite levels seen in CR-mediated life extension (Mei & Brenner 2015) 
Benefits of CR seen on neighbouring cells (Mei & Brenner 2015) 
Altered cellular communication with age (Dillin et al. 2014) 
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These hallmarks are classified into primary hallmarks (those with a negative correlation with ageing), 
antagonistic hallmarks (those which are responses to damage, and show a hormetic response; i.e. 
beneficial in low doses, but detrimental in high doses), and integrative hallmarks (aggregated 
responses which resulting from changes in the other processes) (López-Otín et al. 2013). Given the 
focus of this thesis was to investigate the role of nutrient sensing pathways, and its relationship with 
ageing in the context of a large scale dietary study, four main end points; a combination of primary 
and antagonistic hallmarks; are investigated in an attempt to cover as many of the age-related 
physiological changes as possible within the scope of the study [Figure 1.10]. Due to the central role 
of the liver in metabolism and its effects in caloric restriction (Schmucker 1998; Le Couteur et al. 
2010), these four pathways were chosen as major research outcomes for this thesis, as they are known 
to demonstrate well-established age-related phenotypes in the liver (Cogger et al. 2014; McLean & Le 
Couteur 2004). These are discussed in detail in the following research chapters of this thesis: 
1. Gene expression – Chapter 4 
2. Telomere length – Chapter 5.1 
3. Mitochondrial function – Chapter 5.2 
4. Inflammation – Chapter 5.3 
 
Figure 1.10. Proposed end points to be studied to elucidate the mechanisms of for the effects of 
nutrition on ageing within this Thesis.  
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Genomic, epigenetic and proteostatic changes 
A plethora of evidence has shown changes in gene and protein expression during ageing, with over 
10,000 publications on PubMed, and over 2,000 reviews discussing these changes (Moskalev et al. 
2013). These include changes in both nuclear DNA (Gorbunova et al. 2007; Atamna et al. 2000; 
Trzeciak et al. 2012) and mitochondrial DNA (Gredilla et al. 2010; Yang et al. 2008), proteostasis 
(Sands et al. 2017; Rizzi et al. 2016; Labbadia & Morimoto 2015), and epigenetics (Fischer & Riddle 
2018; Schwörer et al. 2016). Many of these effects involve the cellular growth pathways, and are in line 
with changes seen in caloric restriction studies (Carrano et al. 2009; Bishop & Guarente 2007; Vilchez 
et al. 2014).  
 
With nuclear DNA, ageing is associated with accumulation of damage and mutations (Ou & 
Schumacher 2017; Fischer & Riddle 2018), loss of DNA repair mechanisms (Vermeij et al. 2016; Lord 
& Ashworth 2012), increased clonal mosaicism (Jones 2012; Laurie et al. 2012), and changes in gene 
expression patterns (Bahar et al. 2006; Melouane et al. 2018; Kyng & Bohr 2005). Epigenetic changes 
to post-translational histone modifications (Ashapkin et al. 2017; C. Jin et al. 2011), DNA methylation 
pattern shifts (Maegawa et al. 2010; Gopalan et al. 2017), chromatin remodeling (Oberdoerffer & 
Sinclair 2007; Schotta 2004), and transcriptional alterations (Bahar et al. 2006; Smith-Vikos & Slack 
2012), enzymatic modulation of sirtuins (Someya et al. 2010; Zhong et al. 2010) have all been shown 
to be related to ageing, and at the same time, are thought to link with the beneficial effects of CR on 
lifespan (Le Couteur et al. 2011; López-Otín et al. 2013).  
 
Homeostatic mechanisms to maintain the quality of the intracellular proteome including pathways 
related to protein folding, chaperoning, and degradation have also been shown to be altered by the 
aging process and can influence lifespan in animal models (Labbadia & Morimoto 2015; 
Chondrogianni et al. 2015; Yao et al. 2015). Activating enzyme mutations and supplementation of the 
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hexosamine pathway, which produces metabolites used in glycosylation in the endoplasmic reticulum 
and cytosol have demonstrated life extension benefits in C. elegans, (Denzel et al. 2014); 
supplementation of the metabolite glucosamine has been shown to extend lifespan in mice (Weimer 
et al. 2014), and glycoconjugates have even been hypothesised to act as predictive biomarkers for 
human ageing (Dall’Olio et al. 2013; Longo et al. 2015). In addition, genetic manipulation of 
autophagy; which is known to be altered in CR (Mariño et al. 2014; de Cabo et al. 2014);  for instance 
through the Atg5 or Lamp2a genes, have been shown to increase the lifespan of mice (Pyo et al. 2013; 
Zhang & Cuervo 2008). Given the role of AMPK and mTOR on autophagy, and sirtuins on 
epigenetic changes, the interplay between diet, the nutrient sensing pathways and the genome and 
proteasome, are key areas of investigation to improve the understanding of the molecular mechanisms 
underlying ageing (de Cabo et al. 2014; López-Otín et al. 2016).  
 
Telomere length 
Culturing most somatic cell lines have shown a limit to the number of mitotic replications possible 
before entering senescence due to the shortening of telomeres – a concept known as the Hayflick 
limit (Hayflick & Moorhead 1961). Loss of telomere length, is a major cause of replicative senescence 
in non-immortalised cell lines (Nehlin 2016), and telomere related pathologies are associated with 
early onset of diseases such as idiopathic pulmonary fibrosis, aplastic anemia, malignancies and liver 
fibrosis (Blasco 2005). Genetically modified mice with increased or decreased telomere lengths have 
also been shown to have extended or reduced lifespans respectively (Tomás-Loba et al. 2008; 
Armanios et al. 2009). Telomere shortening was therefore proposed as a possible mechanism 
contributing to ageing ( Johnson et al. 1999; Aubert & Lansdorp 2008), although the use of telomere 
length as a biomarker for ageing has shown mixed results in humans (Vidaček et al. 2017; Mons et al. 
2017). Telomere length is also known to vary amongst tissue types proportional to replicative activity, 
with longer telomere lengths in less proliferative somatic tissues such as liver and muscle, and shorter 
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lengths in haematopoeitic cells such as leukocytes (Yui et al. 1998; Gardner et al. 2007). However, 
while absolute telomere length is known to vary, growing evidence suggests that the rate at which 
telomere attrition occurs with age seems to be similar across tissue types (Daniali et al. 2013). The 
process of telomere attrition in ageing is faster in rodents than in humans, and CR and protein 
restriction have both been shown to be associated with longer telomere lengths in mice (Vera et al. 
2013; Tanrikulu-Kucuk & Ademoglu 2012). Taken together, studies in humans and mice have 
consistently shown that nutrition is correlated with changes in telomere length, therefore providing a 
plausible mechanistic link for the effects of nutrition on ageing and health. 
 
 
Mitochondria 
Mitochondria are intracellular organelles that generate chemical energy in the form of ATP. During 
this process, a proton gradient is formed that drives mitochondrial respiration through an electron 
transport chain (ETC), allowing ATP synthesis, while also creating reactive oxygen species (ROS) 
(Harbauer et al. 2014). While it is unclear if progressive mitochondrial dysfunction is a cause of ageing 
or a byproduct, old age is associated with alterations in mitochondrial phenotype, function and 
number, including impairments in ATP production and increased ROS production (Johnson et al. 
1999; Guarente 2008; Sahin & DePinho 2012). Mitochondrial respiratory thresholds are important 
regulators of CR mediated lifespan extension in yeast, while Complex I and IV of the ETC are 
required for the CR mediated lifespan extension in flies (de Cabo et al. 2014; Sahin & DePinho 2010).  
 
Interestingly, paradoxical findings in model species have shown that phenotypes considered to 
correlate with mild mitochondrial dysfunction can, in many cases produce longevity benefits in a 
hormetic fashion (Palikaras et al. 2015; Munkácsy & Rea 2014), through the promotion of longevity 
promoting pathways (Yee et al. 2014). The IIS pathway, mTOR, AMPK and sirtuins are all known to 
have downstream effects on mitochondrial autophagy, biogenesis and activity (Haigis & Yankner 
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2010). Given the complexity in regulation of these processes and their importance in diet and ageing, 
study of the nutrient sensing pathways in the context of mitochondrial biology is also an area of 
interest in this Thesis. 
 
 
Inflammation 
Inflamm-aging, the so-called chronic low-grade inflammation that is associated with ageing tissue is a 
well characterised process, and is associated with upregulation of a multitude of genes, cytokines and 
inflammatory pathways (Cevenini et al. 2013; Franceschi & Campisi 2014). This process is thought to 
be associated with many age-related disorders such as cardiac dysfunction, neurodegeneration, 
myelodysplastic pathologies, metabolic dysfunction, and various hepatic changes (Le Couteur et al. 
2010; Franceschi et al. 2007).  Given its relationship to a multitude of systemic processes, 
inflammation is closely intertwined with mitochondrial function, cellular senescence, gene expression, 
and has many common pathways of action with the aforementioned nutrient-sensing pathways that 
are implicated in ageing (Fulop et al. 2015). Cellular senescence is associated with a pro-inflammatory 
senescence-associated secretory phenotype (SASP), involving the release of cytokines such as 
interleukin 6 (IL6) and tumour necrosis factor-alpha (TNF-α) (Coppé et al. 2010). In humans, pro-
inflammatory glycosylated proteins, associated with changes in proteostasis, have been shown to be 
one of the most well correlated biomarkers of age (Dall’Olio et al. 2013), and inflammation has been 
linked with impairments in nutrient metabolism and metabolic function (Brestoff & Artis 2015; 
Umemura et al. 2014). Over-nutrition has also been seen to be linked with systemic inflammation 
(Franceschi et al. 2007), while CR seems to reduce inflammatory markers (Fontana et al. 2015). Given 
the strong relationship between inflammation, diet and ageing, and the availability of phenotypic 
changes to be studied, inflammation is another key area investigated in this Thesis. 
  
  63 
The Geometric Framework for Nutrition 
The traditional view of CR has undergone significant change over recent decades, with the role of 
specific macronutrient ratios and dietary regimens appearing to be as important in determining 
lifespan and health as total energy intake per se (Piper et al. 2011; Solon-Biet et al. 2015b). Given the 
complexity of the nutritional system, it has been difficult for reductionist models to analyse the effects 
of diet on ageing using simple control-versus-intervention dietary trials. Disentangling this complexity 
requires a systematic, integrated solution that goes beyond the simple control versus treatment group 
models used in most dietary studies, and a shift towards comparisons of the effects of a very wide 
range of environmental factors such as diet. The Geometric Framework (GF) is a method developed 
by Simpson and Raubenheimer, which was created to solve this problem (Simpson & Raubenheimer 
1993). This framework models the nutritional environment in a n-dimensional Cartesian space, whose 
dimensions correspond to intake variables such as protein, carbohydrates and fat (Raubenheimer et al. 
2016). An animal’s interaction with its nutritional environment can be then be analysed, with outcome 
measures represented as a topographical heatmap. The colour of the heatmap shows the strength of 
the response, for instance median lifespan in Figure 1.11, where red correlates to the highest lifespan, 
and blue represents the lowest lifespan, and the axes represent macronutrients eaten. Similarly, Figure 
1.12 shows the corresponding 3-dimensional representation across the three macronutrients: protein, 
carbohydrates and fat. The peaks and valleys in Figure 1.12 are indicative of the diets studied; since 
not all diets are possible due to certain nutritional balance causing morbidity, only a subset of the total 
space has data points, thereby creating a non-uniform intake space. The power of the GF lies not only 
in visualising the response surfaces, but also in its ability to apply statistical tests to determine 
significance of outcomes relative to the nutritional environment, and analyse optimal conditions to 
maximise these outcomes. This is done by fitting non-parametric thin-plate regression splines using 
generalised additive model (GAMs). A thorough description of the methods used by the GF, its 
development history and progress made in modeling and visualisation tools are discussed in detail in 
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Chapter 3. 
 
 
Figure 1.11. 2D GF response surfaces correlating median lifespan to macronutrient intake. Each 
graph shows the effects of two of macronutrients at the median point of the third macronutrient 
(shown in parenthesis below the X axis label). The response surfaces vary from red which is the most 
negative value to blue which is the most positive value. 
 
 
Figure 1.12. 3D GF response surfaces correlating median lifespan to macronutrient intake. Data 
previously published in (Solon-Biet et al. 2014). 
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Research Aims 
Nutrition has often been the subject of conjectures and ingenious hypotheses—but our actual 
knowledge is so insufficient that their only use is to try to satisfy our imagination. If we could 
arrive at some more exact facts they could well have applications in medicine.  
—François Magendie (1783–1855)  
 
Given the ability of diet to influence lifespan, the aims of this thesis are two-fold. First, to examine 
and build upon the analytical tools required to disentangle the effects of nutrition on health and 
ageing. In order to address this aim, this thesis will discuss the history, development and progress 
made in methods of applying the Geometric Framework to large and diverse data sets in Chapter 3. 
Second, the thesis aims to investigate the mechanisms that drive ageing, by looking at the roles of 
nutrient sensing pathways, their regulation as a result of diet, and their impact on longevity and age-
related outcomes. This aim was addressed primarily by studying tissue samples from a large dietary 
study of 858 mice, which has generated multiple publications previously (Solon-Biet et al. 2016; Le 
Couteur et al. 2014b; Solon-Biet et al. 2015c; Holmes et al. 2016; Gokarn et al. 2017; Gokarn et al. 
2018). This set of work consists of transcriptome analysis of hepatic and hypothalamic tissue to 
investigate the impact of diet on gene regulation (Chapter 4), and its impact on telomere length, 
mitochondrial function, and inflammation (Chapter 5).  
 
This thesis comprises of a novel set of work studying the regulation of nutrient sensing pathways and 
their impact on longevity and age-related end points through the paradigm of a dietary intervention. 
This study therefore represents a key step in understanding the mechanisms by which macronutrient 
intake influences the ageing process, and provides a basis for translational trials and guidelines to 
promote healthy ageing in humans. 
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Chapter 2: General Methods 
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Animals and husbandry 
858 three week old C57BL/6 male and female mice (Animal Resources Centre, WA, Australia) were 
housed three per cage in standard approved cages (Tecniplast, Varese, Italy) in the Molecular 
Physiology Unit of the ANZAC Medical Research Institute which is an SPF facility designed for 
housing transgenic mouse. A custom-designed 2-chamber Perspex insert, designed to collect food-
spillage, was placed beneath the food hopper of each cage to collect food waste for quantification. 
Mice were maintained at 24-26°C and 44-46% humidity under a 12h:12h light-dark photoperiod, with 
lights on at 0600. All protocols were approved by the Sydney Local Health District Animal Welfare 
Committee (Protocol No. 2009/003). 
 
30 experimental diet treatments were custom-designed and manufactured in dry, pelleted form by 
Specialty Feeds [Table 2.1]. The diet treatments addressed both nutritional quantity as well as quality. 
To manipulate diet quantity, indigestible cellulose was added to diet treatments, yielding 3 total energy 
(caloric) density regimes fixed at 8, 13 and 17 kJ g-1 (referred to as low, medium and high energy).  
 
Food intake was measured weekly for 6 months followed by monthly thereafter and corrected for 
spillage and water content. Mice were checked daily and body weight measurements were recorded to 
correspond with food intake measurements. Animals losing more than 20% body weight were culled 
and the corresponding diets discontinued.  
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Experimental diets 
30 experimental diet treatments were custom-designed and manufactured in dry, pelleted form by 
Gordon’s Specialty Feeds, Sydney, Australia. The diet treatments addressed both nutritional quantity 
as well as quality and represented a wide range of macronutrient ratios that systematically sampled a 
protein, carbohydrate and fat simplex. To manipulate diet quantity, indigestible cellulose was added to 
diet treatments, yielding 3 total energy (caloric) density regimes fixed at 8, 13 and 17 kJ g-1 (referred to 
as low, medium and high energy). After approximately 13 weeks of experimental feeding, an increased 
incidence of rectal prolapse was observed on some of the lowest protein diets, which has previously 
been attributed to dietary methionine deficiency (< 0.15% of diet) (Sun et al. 2009; Miller et al. 2005). 
Animals with severe rectal prolapse were culled and these diets also discontinued due to ethical 
concerns. In total, five diets were discontinued, leaving a total of 25 experimental diets for the 
remainder of the study.  
 
Table 2.1. Experimental diets. aDiets 2 (low energy) and 6 (medium energy) were discontinued within 
23 weeks. bDiets 3 (low energy), 3 (medium energy) and 6 (low energy) were discontinued within 10 
weeks of treatment. These diets were discontinued due to weight loss (≥ 20%), rectal prolapse or 
failure to thrive.  
Diet 1 2
a
 3
b
 4 5 6
a
 7 8 9 10 
%P 60 5 5 33 33 5 14 14 42 23 
%C 20 75 20 47 20 48 29 57 29 38 
%F 20 20 75 20 47 48 57 29 29 38 
Low energy 
(8 kJ g-1) 
P 5.03 0.42 0.42 2.77 2.77 0.42 1.17 1.17 3.52 1.93 
C 1.67 6.28 1.67 4.02 1.67 4.02 2.43 4.77 2.43 3.18 
F 1.67 1.67 6.28 1.67 4.02 4.02 4.77 2.43 2.43 3.18 
Medium 
energy  
(13 kJ g-1) 
P 7.54 0.63 0.63 4.15 4.15 0.63 1.76 1.76 5.28 2.89 
C 2.51 9.41 2.51 6.02 2.51 6.02 3.64 7.15 3.64 4.77 
F 2.51 2.51 9.41 2.51 6.02 6.02 7.15 3.64 3.64 4.77 
High 
energy  
(17 kJ g-1) 
P 10.06 0.84 0.84 5.53 5.53 0.84 2.35 2.35 7.04 3.86 
C 3.35 12.55 3.35 8.03 3.35 8.03 4.85 9.54 4.85 6.36 
F 3.35 3.35 12.55 3.35 8.03 8.03 9.54 4.85 4.85 6.36 
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Over their lifetime, mice were ad libitum-fed one of 25 diets varying in content of protein, 
carbohydrate and fat. Food intake was measured once per week for 6 months followed by once per 
month measurements thereafter and corrected for spillage and water content. Mice were checked daily 
and body weight measurements were recorded to correspond with food intake measurements.  
 
The % of protein (P), carbohydrate (C) and fat (F) (as a % of total energy) is shown in Table 2.1. 
Each diet was replicated at 8 kJ g-1 (low energy), 13 kJ g-1 (medium energy) and 17kJ g-1 (high energy). 
Diets varied in content of P (casein and methionine), C (sucrose, wheat-starch and dextrinised 
cornstarch) and F (soya bean oil). All other ingredients were kept similar. Other ingredients include 
cellulose, a mineral mix (Ca, P, Mg, Na, C, K, S, Fe, Cu, I, Mn, Co, Zn, Mo, Se, Cd, Cr, Li, B, Ni and 
V) and a vitamin mix (vitamin A, D3, E, K, C, B1, B2, Niacin, B6, pantothenic acid, biotin, folic acid, 
inositol, B12 and choline).  
 
Body Composition 
Body composition was assessed in 180 mice across all diets by dual-energy x-ray absorptiometry 
(DEXA) using the GE PIXImus2 Series Densitometer (GE Medical Systems Ultrasound and BMD, 
Bedford, United Kingdom) under general anaesthesia (intraperitoneal ketamine:xylazine) immediately 
prior to culling. 
 
Plasma insulin and leptin  
Plasma insulin levels were measured using the Ultrasensitive Mouse Insulin ELISA Kit (Alpco 
Diagnostics, Salem, NH). Plasma leptin levels were quantified using the Mouse Leptin ELISA Kit 
(Millipore, St. Charles, MO).  
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Plasma amino acids and fatty acids 
Amino acids were analysed at the Australian Proteome Analysis Facility, Macquarie University, using 
the Waters AccQTag Ultra chemistry (Waters Corp, Milford, MA). Plasma fatty acids were measured 
by gas chromatography-mass spectrometry (GCMS) at the Bio21 Institute, University of Melbourne. 
 
Blood lipids and biochemistry  
Blood cholesterol, triglycerides, HDLc, LDLc, liver function tests (alanine transaminase, aspartate 
aminotransferase, gamma-glutamyl transpeptidase) and creatinine were performed at the Concord 
Hospital Pathology Department.  
 
Extraction of Liver DNA, RNA, and protein 
Frozen liver tissue samples were sectioned into 10mg blocks 
and homogenised using a TissueLyser LT (Qiagen, Hilden, 
Germany). DNA, RNA, and protein were extracted as per the 
protocol listed in the Qiagen AllPrep DNA/RNA/Protein 
Mini Handbook. RNA was eluted into RNase-free water, 
quantified by spectrophotometry using a NanoDrop (Thermo 
Scientific, Waltham MA) at 230/260/280nm and stored at -
70°C. DNA concentration was also measured 
spectrophotometrically and stored at -20°C. Protein was 
pelleted and stored at -20°C.  
Figure 2.1. Procedure flowchart. Figure from Qiagen AllPrep 
DNA/RNA/Protein Mini Handbook. 
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Western blots for mTOR and phosphorylated-mTOR  
Protein pellets were resolubilised in SDS-PAGE buffer with protease inhibitor tablets (cOmplete, 
EDTA-free Protease Inhibitor Cocktail; Roche, Basel, Switzerland). Concentration of protein was 
quantified using bicinchoninic acid (BCA) assay (Thermo Scientific BCA Protein Assay Kit) and 
standard curves were developed with bovine serum albumin (BSA) controls. Samples were then 
diluted to a 2mg/mL concentration in 100uL volume of Laemmli buffer and 50 mM TCEP 
BondBreaker (Thermo Scientific). 20µg of protein was separated on 4-15% gradient mini-protean 
TGX gels (Bio-Rad). Gels were transferred onto nitrocellulose membranes at 25 V, 2.5 A for 10 min 
on a Trans-Blot Turbo transfer system (BioRad, Hercules, CA). Membranes were blocked for 1 h in a 
5% skim milk solution of Tris-buffered saline (TBS). Membranes were washed three times for ten min 
each, in wash buffer (TBS containing 0.1% Tween-20), and incubated overnight in primary antibody 
solution (5% BSA, TBS 0.1% Tween 20). Membranes were washed three times as before, and 
incubated for one hour in secondary antibody solution (5% skim milk solution of TBS 0.1% Tween, 
0.01% SDS). Membranes were washed three times as before, rinsed in water and analysed on a licor 
odyssey system. Densitometry was performed using licor software and results were exported using 
Prism (GraphPad) to excel sheets for further analysis. Antibodies used were total mTOR (Cell 
Signaling 4517 L27D4), phospho-Ser2448 mTOR (Cell Signaling 5536 D9C2) and α-tubulin (Sigma 
T6199, clone DM1A). 
 
Gene expression and microarray 
Frozen hypothalamus blocks from 24 mice (one male per group) and liver samples from 48 mice (one 
male and female per group, with low energy groups having less representation due to their 
proportional discontinuation as experimental diets as outlined above) were sectioned into 10mg 
segments. Total RNA was extracted using the Trizol method (Sigma) and quantified 
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spectrophotometrically using a NanoDrop (Thermo Scientific) at 230/260/280nm. RNA integrity 
from both hypothalamic and liver samples was verified using a Bioanalyzer (Agilent). 48 male liver 
samples (two per diet group) and 24 male hypothalamic samples (one per diet group) with an RIN>7 
were analyzed by Affymetrix Mouse Gene ST array. Liver microarray was performed at the Ramaciotti 
Centre for Genomics, University of New South Wales; GEO: GSE85998 – for publication in (Solon-
Biet et al. 2016).  Gene expression data was corrected by Bonferroni adjustment and normalised to 
actin. Liver samples that had undergone microarray assays were run on qPCR plates using the RT2 
profiler array using the Mouse Insulin Signaling Pathway kit (Qiagen – catalogue no.  PAMM-030Z). 
A pooled sample was serially diluted, and as a standard curve in the Fluidigm Biomark software for 
PCR analysis. 
 
Telomere length  
Average telomere length was measured from total genomic mouse DNA by using a real-time 
quantitative PCR method as described (Cawthon 2002). The results were normalised using the acidic 
ribosomal phosphoprotein PO (36B4) gene, which is well conserved and has been used for gene-
dosage studies. Primer sequences for 36B4 and telomeric repeats were as previously outlined (Callicott 
& Womack 2006). Forward and reverse telomeric primers were 5′ CGG TTT GTT TGG GTT TGG 
GTT TGG GTT TGG GTT TGG GTT 3′ and 5′ GGC TTG CCT TAC CCT TAC CCT TAC CCT 
TAC CCT TAC CCT 3′ respectively. Forward and reverse primers for the 36B4 gene were 5′ ACT 
GGT CTA GGA CCC GAG AAG 3′ and 5′ TCA ATG GTG CCT CTG GAG ATT 3′, respectively. 
Each reaction for the telomere portion of the assay included 12.5 µl Sybr Green PCR Master Mix 
(Sigma), 300 nM each of the forward and reverse primers and 20 ng genomic DNA. All PCRs were 
performed in duplicate. Master mix concentrations for the 36B4 portion contained 12.5 µl Sybr Green 
PCR Master Mix (Applied Bio- systems), 300 nM forward and reverse primers. A real time 
thermocycler (Roche LightCycler 480) was used with conditions as: 95 °C for 5 minutes followed by 
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45 cycles of 95°C for 10 s, with 60°C annealing for 15 seconds, followed by extension at 72 °C for 20 
seconds for the 36B4 gene, and 95°C for 5 minutes followed by 45 cycles of 95°C for 10 seconds, 
with 68°C annealing for 15 seconds, followed by extension at 72°C for 15 seconds for the telomere 
PCR. To serve as a reference for standard curve calculation, a pooled sample of mouse DNA from all 
183 samples was serially diluted over a 10-fold range, from 1 to 100 ng per well. Standard curves for 
36B4 and telomeric repeats were used for absolute quantification of samples using LightCycler 
software.  
 
 
Mitochondrial function 
Mitochondrial functions were assessed in liver tissue (n=170) using the Seahorse XF Extracellular 
Flux Analyzer which generates the key parameters of mitochondrial function using fresh isolated 
mitochondria from homogenised liver tissue: basal respiration, ATP production, proton leak, maximal 
respiration, glycolysis and spare respiratory capacity. Different conditions were used to measure the 
mitochondrial oxygen consumption e.g. by providing different combinations of substrates (pyruvate-
malate, glutamate-malate, succinate-rotenone, palmitoyl carnitine-malate) to the electron transport 
system. State III was monitored after injection of ADP and State IVo after injection of oligomycin. 
Respiratory Control Ratios (RCR) were calculated as State III/State IVo. Mitochondrial amount as 
well as substrate, ADP, and inhibitor concentrations were optimised prior to experiments. Hydrogen 
peroxide production was measured with an Amplex Red kit (Eugene, OR) using the same substrates 
as for mitochondrial respiration. Hydrogen peroxide production and enzymatic activities (3-
Hydroxyacyl Coenzyme A dehydrogenase, aspartate aminotransferase and citrate synthase) were 
measured spectrophotometrically on the same mitochondrial isolations. Citrate synthase activity was 
used to normalise the results, which are therefore expressed as mitochondrial function per 
mitochondrion. 
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Mitochondrial PCR 
Mitochondrial copy number was estimated from genomic mouse mtDNA by using a real-time 
quantitative PCR method previously described (Uddin et al. 2016). The results were normalised using 
the acidic ribosomal phosphoprotein PO (36B4) gene, which is well conserved and has been used for 
gene-dosage studies. Forward and reverse cytochrome b primers were 5′ 
CCCACCCCATATTAAACCCG 3′ and 5′ GAGGTATGAA GGAAAGGTATTAGGG 3’ 
respectively. Forward and reverse primers for the 36B4 gene were 5′ ACT GGT CTA GGA CCC 
GAG AAG 3′ and 5′ TCA ATG GTG CCT CTG GAG ATT 3′, respectively. All PCRs were done in 
triplicate. To serve as a reference for standard curve calculation, a pooled sample of mouse mtDNA 
from all 183 samples was serially diluted over a 10-fold range, from 1 to 100 ng per well. Standard 
curves for 36B4 and cytochrome b were used for absolute quantitation of samples using LightCycler 
software.  
 
Data analysis, visualisation and statistics 
All data analysis was based on macronutrient intake, primarily kilojoules per mouse per day 
(kJ/mouse/day), unless otherwise stated. Data was processed by fitting of GAMs with thin-plate 
splines to model responses relative to macronutrient intake in protein, carbohydrates, and fat. Full 
data analytic methods for evaluation of statistical significance and visualisation are described in 
Chapter 3.  
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Chapter 3: Methods – Developing analytical tools 
for the Geometric Framework 
 
For the better part of the last three decades, the Geometric Framework (GF) has been used to 
untangle the complex interactions between an animal and its nutritional environment (Raubenheimer 
& Simpson, 1993; Simpson & Raubenheimer, 1993). Since its conception, the application of the GF 
has evolved considerably, from a theoretical paradigm, to become an invaluable functional tool for the 
analysis and visualisation of data. This has allowed the GF to be used in a variety of experimental 
models, from being applied to behavioural dynamics in animal-environment interactions, to 
mechanistic studies in biological research. Given the complexity of the nutritional system, it has been 
difficult for reductionist models to analyse the effects of diet on ageing. The GF models a nutritional 
environment in a n-dimensional Cartesian space, whose dimensions correspond to variables such as 
macronutrient uptake (Raubenheimer et al. 2016). In this space, an animal’s interaction with its 
nutritional environment can be analysed, with outcome measures represented as a topographical 
response surface overlaying the n-dimensional nutrient space. 
 
Here, the evolution of the GF is reviewed, and the expansion of this model through this thesis is 
discussed, with specific reference to data handling techniques and integration of algorithms to 
improve visualisation and analysis of experimental data. Overall, a new iteration of the GF script is 
created in R, which can automate analytical methods for large data sets through an easily accessible 
interface that can be used for a wide array of scientific purposes, and lead to potential future 
applications such as its use in personalised nutrition in humans. While this application is not explored 
here, the methodological approach can be conceptualised through the use of personalised goal-
seeking optimisation tools that find local maxima and minima specific to the individual response 
surfaces of a subject.  
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This chapter will review concepts from nutritional ecology theory and R script coding functions, to 
explain the logic and workflow used by the Geometric Framework in its application to nutritional and 
ageing research. The algorithms and data handling methods discussed here were developed through 
multiple iterations. Novel analytical tools developed for the GF as part of this thesis include:  
1. Automation of the GF for large data sets 
2. 3-dimensional visualisation of response surfaces 
3. Correlation of data analysed through the GF, particularly for gene expression analysis 
 
Background 
In complex systems, the interplay between multiple elements makes reductionist or segmented studies 
difficult to interpret. For instance, manipulation of diet may lead to changes in the lifespan of an 
animal, but there may be a number of mechanisms underlying this change, each of which, if 
manipulated individually, may not produce the desired outcome [Figure 3.1]. While the GF was 
initially intended to study the role of nutrition, or other variable factors on sets of outcomes, major 
developments have taken place since its inception, which have bridged systemic and mechanistic 
approaches to analyse data. 
 
Figure 3.1. Mechanisms are often considered a black-box in ageing research due to the complexity in 
the interactions between the experimental inputs and response outcomes. 
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The most important of these was the fundamental paradigm shift away from the control versus 
treatment experimental model traditionally used in biological research, to analysis of systems as a 
whole. This is done by creating an n-dimensional Cartesian space, whose axes are represented by 
multiple variables of interest, where rather than comparing individual groups, a response surface is 
fitted by non-parametric regression modeling, effectively allowing comparison of all groups at once, 
thus substantially improving the predictive and explanatory power (Raubenheimer et al. 2016). This 
allows the effect of each variable axis on an outcome to be studied, both in isolation, as well as in 
combination with other axes. An example is illustrated in Figures 3.2 & 3.3, and Table 3.1 [data 
presented and discussed in Chapters 4 & 5]. Here, the 3-spatial axes represent macronutrient intake 
(Protein – P, Carbohydrates – C, Fat – F), and the topographical heatmap represents outcome.  
 
Figure 3.2. 2D GF plots for average liver telomere length ratio (ATLR).  
 
 
Figure 3.3. 2D GF plot for hepatic gene expression of Neuropeptide Y (NPY).  
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The GF plots above show two examples of how response surface fitting is beneficial to interpretation 
of the data. In Figure 3.2, there is a clear relationship to carbohydrates, as seen by the gradient lines 
being perpendicular to the carbohydrate axis, with response signal maximal at high C intake, and 
minimal with low C intake. Analysis of the Generalised Additive Models (GAMs) shows this to be a 
statistically significant result [Table 3.1].   
 
On the other hand, with Figure 3.3, there is a mixed response to the macronutrient axes, and it is 
difficult to know which dimensions are relevant to the response signal. While it may seem like protein 
and fat are the drivers of NPY gene expression here, given the perpendicular gradient lines to each, 
neither of these are statistically significant, and in fact it is the ratio of P:C eaten that is the significant 
factor for NPY expression [Table 3.1]. This example is used only to demonstrate the power of the 
GF, and further analysis of gene expression data is discussed in Chapter 4. 
 
Table 3.1. Statistical significance table, with p-values calculated from GAM surface fits for ATLR and 
NPY relative to the macronutrient axes, and macronutrient ratios. 
p-value P C F P:C P:F C:F 
ATLR 0.20 0.04 0.45 0.24 0.59 0.58 
NPY 0.36 0.59 0.39 0.41 0.01 0.44 
 
 
Taken together, this shows two things: 
1. The GF is able to be used on experiments with multiple continuous or disjointed data 
variables such as diet, exercise, temperature in the same analysis, through the creation of an 
n-dimensional variable environment that corresponds to the response being studied 
2. The GF is therefore able to examine the effect of input variables both in isolation, as well as 
in combinations with other variables, greatly increasing its power to analyse results 
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Evolution of the Geometric Framework 
The GF was initially designed to study local optima within a nutritional space, to examine appetite 
interactions on feeding behaviors and their correlation to physiology and health in various species. 
This was used to derive evidence for aspects such as the functional, ontogenic and evolutionary basis 
of innate homeostatic mechanisms that existed within species (Simpson & Raubenheimer 1993). An 
early example of this concept is Figure 3.4, where an early GF model was used to predict the 
phagostimulatory surface of locusts, which were fed diets varying in P:C content (Raubenheimer & 
Simpson 1997). Early models such as these were primarily based on behaviour, as the predicted 
response surfaces were based on intake targets and protein leverage, concepts which were relatively 
well established at the time (Simpson & Raubenheimer 1995). 
 
Figure 3.4. Predicted phagostimulatory surface for locusts fed diets varying in P:C ratio. Figure from 
(Raubenheimer & Simpson 1997). 
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As the model evolved, target points in the nutrient space encompassed both static points integrated 
over a period of time for cohort analysis, or dynamic paths over time for individual analysis (Simpson 
& Raubenheimer 1999). This helped expand the GF from solely analysing nutritional requirements, to 
also being able to compare amongst organisms, multivariate metrics such as metabolism, growth and 
lifespan, and their relationships to nutrition (Simpson et al. 2003). 
 
At this point, the GF was powerful enough to be able to revisit the question of which components of 
dietary restriction were most important, and answer the fundamental question ‘caloric restriction 
relative to what?’. Until this stage, the major barrier impeding the unraveling of the effects of CR was 
the lack of a conceptual framework from which to analyse experimental results. Since restriction 
implied a relative decrease, traditional approaches of control versus treatment models were inherently 
flawed, as they had to assume a control diet, and an arbitrary restriction relative to this. An example of 
this limitation is represented in Figure 3.5. Here, a study had seemingly showed that caloric restriction 
rather than protein restriction prolonged lifespan in rats (Davis et al. 1983). However, further analysis 
reveals another interpretation, that the relationship is not linear, but part of a more complex surface 
with a peak of 75kJ protein and 150kJ non-protein energy intake (Simpson & Raubenheimer 2007). 
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Figure 3.5. Analysing the findings of Davis et al 1983.  Figure from (Simpson & Raubenheimer 
2007). 
 
Figure 3.6. Parametric non-linear surface fitting of lifespan and lifetime egg product responses to 
diets varying in P:C ratio. Figure from (Lee et al. 2008). 
 
Convincingly separating CR versus nutrient specific effects was demonstrated for one of the first 
times in 2008, from data collected in Drosophila, through Lande-Arnold regression estimation of a 
parametric non-linear response surface (Lee et al. 2008). Responses were compared by using partial F 
tests based on pair fitness components. In the same paper however, non-parametric thin-plate splines 
were fitted for data visualization, as seen in Figure 3.6.  
 
Non-parametric regression allowed the shape and form of the predictor used to create the surface to 
not be confined, but rather derived from the data itself. At this stage however, the non-parametric R 
script techniques (‘fields’ package in R) used were not appropriate to run statistical analysis with, and 
so they were simply used for visualisation. Both methods used multiple regression analysis, which 
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allows computation of selection coefficients that have clear biological interpretations about forces of 
selection (Palacio et al. 2014). Generalised additive models (GAMs) with thin-plate splines using the 
‘mgcv’ package in R was the next major step in the evolution of the GF, because this was able to 
perform log-likelihood testing to compare nested models, allowing the response surface to be 
analysed for direct effects, two-way interactions and three-way interactions, as needed (Wood 2003; 
Wood 2006; Wood 2011). GAMs are statistical models where the relationship between predictors and 
response variables are not constrained by the assumption of a normal distribution, and are instead 
generalised to encompass linear, non-linear, and even additive models. The only drawback of this 
approach was that it required larger sample sizes compared to standard parametric regression models, 
because the data not only was used for analysis, but to identify the appropriate parameter, or predictor 
model itself. This development in statistical protocol, while not necessarily a pre-requisite for working 
on herbivorous insects; for which protein and carbohydrate are generally considered the two main 
energy-yielding axes; allowed much greater analytic power when using the third nutritional dimension 
of fat in the cases of omnivorous mammals. This propelled the GF from being applied primarily on 
insect models, to a wider range of organisms including humans (Raubenheimer et al. 2016). 
 
Finally, we arrive at the latest iteration of the GF, which has been used to publish multiple papers in 
recent years, including the breakthrough mammalian results from a large scale dietary study in mice, 
which showed that macronutrient ratios were more important than caloric intake in mediating the 
lifespan and health benefits of CR (Solon-Biet et al. 2014). An example is reproduced here in Figure 
3.7, with table of statistical significance attached. While it is possible to analyse this response surfaces 
relative to statistical analysis alone, the directionality of a correlation can be better understood through 
visualisation of colour (i.e. upregulation in red vs. downregulation in blue in the example below). 
Interpretation of these response surfaces depends largely on the relationship between the 
topographical gradient lines, or isoclines, and the macronutrient axes. 
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p-value P C F P:C P:F C:F 
mTOR 0.03 0.48 0.53 0.08 0.70 0.54 
Figure 3.7. 2D GF response surfaces correlating mTOR activation to macronutrient intake. Figure 
generated using custom GF script in R. Data previously published in (Solon-Biet et al. 2014). Full 
analysis of this result is presented and discussed in Chapter 4. 
 
One of the few drawbacks of this method was that each of the three slices that are used to visually 
represent the information are cut through the median of the third axis. For instance, in the left-most 
slice of Figure 3.7, the Protein vs. Carbohydrate plot, the slice is taken through the median of the Fat 
axis, indicated by the subtitle (Fat: 11). This means that while the statistical analysis may have been 
relatively sound, the visual representation may not present the full picture, since the visualisation is 
performed through slices at median points, which may have missed the key findings. In this chapter, 
the application of the GF is taken one step further, to a 3-dimensional visualisation (technically 4-
dimensional, as the overlaid topographical heatmap represents the response axis). This too is 
imperfect as the topographical map is highly dependent on the number of data points in the 3-
dimensional nutritional space, making the surface ‘bumpy’, and raising questions about what degree of 
mathematical smoothing is required to fit the data. An example of this visualisation is shown in Figure 
3.8, and is the 3-dimensional correlate of the 2-dimensional mTOR surfaces presented in Figure 3.7. 
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Figure 3.8. 3D GF response surfaces correlating mTOR activation to macronutrient intake. Figure 
generated using custom GF script in R. Here, peaks and valleys in the nutritional space represent 
dietary compositions, with colours at each point representing response output; in this case mTOR 
activation. The red areas represent highest mTOR activation, while the blue areas represent lowest 
mTOR activation. The 2D correlate of this plot is shown in Figure 3.7, as slices cut orthogonally to 
one dimension through its median point (Fat: 11, Carbohydrate: 13, Protein: 10). 
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New developments in statistical analysis of data through the GF 
The ‘mgcv’ package implementation of the GAM function fits thin-plate penalised regression splines 
to the data, using smooth functions designed to be optimal, in this case through a Laplace 
approximation to the Restricted Maximum Likelihood (REML) statistic (Wood 2011). This package is 
unique to other GAM packages in R, as it uses: 
1. Estimation of degree of smoothness is part of model fitting 
2. A Bayesian approach to variance estimation is used, improving confidence interval 
calculation 
3. Penalisation on the calculated parameters to prevent over fitting, and improve efficiency 
4. A highly customisable framework to allow different methods and models of fitting 
 
Here, an example set of data is used to demonstrate the full use of the current iteration of the GF, 
with detailed explanations of data handling methods, and use of R packages. All code, data 
visualization, and statistical modeling is handled through the R language, using R Studio as the 
graphical user interface (GUI).  
 
Numerous packages were used in this application of the GF, whose names, versions and associated 
packages are listed here using the ‘sessionInfo()’ function: 
> sessionInfo() 
R version 3.3.1 (2016-06-21) 
Platform: x86_64-apple-darwin13.4.0 (64-bit) 
Running under: OS X 10.11.6 (El Capitan) 
locale: 
[1] en_AU.UTF-8/en_AU.UTF-8/en_AU.UTF-8/C/en_AU.UTF-8/en_AU.UTF-8 
attached base packages: 
[1] grid      stats     graphics  grDevices utils     datasets  methods   base      
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other attached packages: 
[1] Hmisc_4.0-2     ggplot2_2.2.1   Formula_1.2-1   corrplot_0.77  fields_8.4-1    
maps_3.1.1      spam_1.4-0      akima_0.5-12    rgl_0.96.0      
[10] plot3D_1.1      survival_2.40-1 ellipse_0.3-8   lattice_0.20-34 sp_1.2-3        
mgcv_1.8-15     nlme_3.1-128    xtable_1.8-2    
loaded via a namespace (and not attached): 
[1] Rcpp_0.12.7         RColorBrewer_1.1-2  plyr_1.8.4          base64enc_0.1-3     
tools_3.3.1         rpart_4.1-10        digest_0.6.10       
[8] checkmate_1.8.2     htmlTable_1.9       jsonlite_1.1        tibble_1.2          
gtable_0.2.0        Matrix_1.2-7.1      shiny_0.14.1        
[15] gridExtra_2.2.1     stringr_1.1.0       cluster_2.0.5       knitr_1.14          
htmlwidgets_0.7     nnet_7.3-12         data.table_1.10.4   
[22] R6_2.2.0            foreign_0.8-67      latticeExtra_0.6-28 magrittr_1.5        
backports_1.0.5     scales_0.4.1        htmltools_0.3.5     
[29] splines_3.3.1       assertthat_0.1      misc3d_0.8-4        mime_0.5            
colorspace_1.2-7    httpuv_1.3.3        stringi_1.1.2      
 
 
In this R environment, after the appropriate packages have been loaded, data sets such as those 
collected during experimentation are loaded into data frames in R. In this example, the data collected 
is from the large-scale dietary study, and in particular contains values of circulating amino acids 
(AA’s), as well as the sum of the total branch chain amino acids (BCAA Sum) (Solon-Biet et al. 2014). 
Results of analysis are not discussed, as this chapter is focused on the coding methods used in the 
development of this thesis. This data set is set out as follows, with examples used in each line: 
eaten.P eaten.C eaten.F Sample ID Sex X1 X2 … Xn 
17.98 5.99 5.99 101 M 1 0.42 … 205.12 
14.75 4.91 4.91 142 F 2 0.81 … 586.34 
4.72 9.77 19.20 402 F 3 3.12 … 1094.91 
… … … … … … … … … 
Table 3.2. Example of a generic data set with outcome measures X1-n and input macronutrient 
intakes.   
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Data is first stored in comma separated value (.csv) format, and loaded into data frames as follows: 
> aveintake <-read.csv(paste(directory,filename,".csv",sep=""),1) 
 
Here, the directory and filename variables are assigned prior to loading of the data, in order to 
improve ease of access to files, and making bulk script uses (for multiple files/folders) much easier: 
> directory <- "/Users/Master/Dropbox/PhD Work/GF R SCRIPTS/Data/" 
> filename <- "aas"  # Name of the file - In this case aas.csv 
 
Automation of the script can be performed by the following function: 
> filelist <- list.files(directory,pattern=".csv") 
> for(y in 1:length(filelist)) 
> filename <- filelist[y] 
 
At the same time, the column in which the outcomes start is defined by the ‘starts’ variable: 
> starts <- 6 # Column at which the data starts at 
 
Additionally, analysis outputs can be saved automatically to a specified location, and the choice of 2D 
sliced GF plots, 3D GF plots and heatmap correlations between data columns can be saved as pdfs. 
The save location directory is also created at this point, and choice is carried out by an ‘if’ logical: 
> saveloc <- paste("/Users/Master/Dropbox/PhD Work/GF SCRIPTS/GF/",filename,"/",sep="")  
> dir.create(saveloc) 
> pdfs <- "on" # pdfs of GF plots ("on" or "off") 
> pdf3d <- "on"   # pdf of 3D GF plot ("on" or "off") 
> heatmap <- "on"  # pdf of heatmap correlations ("on" or "off") 
> if(pdfs=="on"){ 
> if(pdfs=="on"){ 
> if(heatmap=="on"){  
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Once the data is loaded, it will appear as follows: only columns 1-7 displayed here): 
> head(aveintake[,1:7]) 
    eaten.P   eaten.C   eaten.F Sample.ID Sex Body.weight..g. Alanine..A. 
1 17.983838  5.985079  5.985079       101   M           24.22      12.394 
2 14.745112  4.907220  4.907220       102   F           22.02      20.813 
3  4.724988  9.767927 19.197779       103   M           23.67      53.983 
4  7.776437 12.826281 12.826281       104   M           23.97      35.197 
5  9.526251 13.834762  5.765345       105   F           23.15      34.806 
6 11.030679  6.675834 16.019608       106   F           24.06      41.357 
 
 
Next, the topographical colour map used in the response surface is formatted with variables that will 
be passed onto the plotting algorithms later on in the code: 
> rgb.palette<-colorRampPalette(c("blue","cyan","yellow","red"), 
+ space="Lab",interpolate="linear") 
> no.cols<-256 
> no.cols3d<-15889 
> gr<-101 
> rg<-15889 
 
 
Two custom functions are now created, one to handle the response surface data frame to match the 
required topographical colour map, and one to correlate the correlation matrix:  
#+++++++++++++++++++++++++ 
# Computing the topographical response surface 
#+++++++++++++++++++++++++ 
# x : input variable of x-axis as data array 
# y: input variable of y-axis data array 
# rgnames: regulated names as data array 
 
> findConvex<-function(x,y,rgnames){ 
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+   hull<-cbind(x,y)[chull(cbind(x,y)),] 
+   px<-pretty(x) 
+   py<-pretty(y) 
+   x.new<-seq(min(px),max(px),len=gr) 
+   y.new<-seq(min(py),max(py),len=gr) 
+   ingrid<-as.data.frame(expand.grid(x.new,y.new))                                                               
+   Fgrid<-ingrid 
+   Fgrid[(point.in.polygon(ingrid[,1], ingrid[,2], hull[,1],hull[,2])==0),]<-NA 
+   names(Fgrid)<-rgnames 
+   return(Fgrid) 
+ } 
 
 
This first function takes the x-axis and y-axis input variables and sequences the topographical map in 
a segmented fashion, creating a data matrix that can be passed to the graphical algorithms used later. 
Next, the correlation matrix function is called. The code is a customised adaptation of:  
> source("http://www.sthda.com/upload/rquery_cormat.r") 
 
After these pre-processes are complete, the data are able to start being processed. The first step to do 
this, is to call the custom ‘findConvex’ function, to compute the required data frames (df2) from the 
three macronutrient axes in the data set; “eaten.P”, “eaten.C”, and “eaten.F”: 
> df2<-list() 
> df2[[1]]<-findConvex(aveintake$eaten.P, aveintake$eaten.C,c("eaten.P","eaten.C")) 
> df2[[1]]$eaten.F<-median(aveintake$eaten.F) 
> df2[[2]]<-findConvex(aveintake$eaten.P, aveintake$eaten.F,c("eaten.P","eaten.F")) 
> df2[[2]]$eaten.C<-median(aveintake$eaten.C) 
> df2[[3]]<-findConvex(aveintake$eaten.C, aveintake$eaten.F,c("eaten.C","eaten.F")) 
> df2[[3]]$eaten.P<-median(aveintake$eaten.P) 
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Computation of the GAMs can now begin, by creation of a 4-dimensional matrix, where the first 
three columns as the macronutrient inputs, and the fourth dimension is the response variable, which 
in this data frame is selected as a variable column ‘h’:  
> for(h in starts:ncol(aveintake)){ # Run the process for all data columns 
> aveintake2 <- aveintake[,c(1,2,3,h)] # Macronutrients + response variable columns 
> aveintake2 <- na.omit(aveintake2) #Omit missing values from the data matrix 
 
 
Here, the variable column h will travel between the values of ‘starts’, which is the first column we 
assigned earlier, and the total number of columns in the data set, calculated by the ‘ncol’ function. 
This was a significant development in the automation of the data processing capability of the GF 
script, as iterative loops allow processing of extremely large sets of data such as microarrays, as done 
in Chapter 4. 
 
Next, the actual GAM is calculated using the ‘gam’ function in the mgcv package: 
# rowN : the name of the response variable to be passed to the gam function 
# bs: basis of smooth, in this case we use “tp”, or thin-plate spline regression 
# rgnames: regulated names as data array 
# method: REML used here 
> rowN <- colnames(aveintake2)[4] 
> colnames(aveintake2)[4] <- "col1" 
> gam1<-gam(col1~s(eaten.P,bs="tp")+s(eaten.C,bs="tp")+s(eaten.F,bs="tp") 
+s(eaten.P,eaten.C,bs="tp") +s(eaten.P,eaten.F,bs="tp") 
+s(eaten.C,eaten.F,bs="tp"),method="REML",data=aveintake2,select=TRUE) 
 
The GAM data are now stored in the variable ‘gam1’, whose summary looks like: 
 
> summary(gam1) # Function used to give GAM output 
Family: gaussian  
Link function: identity  
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Formula: 
col1 ~ s(eaten.P, bs = "tp") + s(eaten.C, bs = "tp") + s(eaten.F, bs = "tp") + 
s(eaten.P, eaten.C, bs = "tp") + s(eaten.P, eaten.F, bs = "tp") + s(eaten.C, eaten.F, 
bs = "tp") 
 
Parametric coefficients: 
            Estimate Std. Error t value Pr(>|t|)     
(Intercept)  42.5719     0.9561   44.52   <2e-16 *** 
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Approximate significance of smooth terms: 
                         edf Ref.df     F  p-value     
s(eaten.P)         2.101e+00      8 1.762 0.000282 *** 
s(eaten.C)         1.255e-03      8 0.000 0.382803     
s(eaten.F)         6.702e-01      8 0.254 0.079892 .   
s(eaten.P,eaten.C) 1.418e-01      3 0.051 0.288857     
s(eaten.P,eaten.F) 6.501e-05      3 0.000 0.850069     
s(eaten.C,eaten.F) 1.438e-04      3 0.000 0.781072     
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
R-sq.(adj) =  0.136   Deviance explained = 15.4% 
-REML = 548.62  Scale est. = 129.81    n = 142 
 
In this example, the GAM was calculated on one the last column of the data, which was the BCAA 
sum data. The output of the GAM is used to determine the statistical significance of the response 
surface to each of the variable axes, in isolation, and in combination, as represented by the 
significance of the smooth terms above. Next, a function is used to capture these outputs in a stored 
data frame, which will be collated across all the response variables and saved as a text file. Here, the p-
values from the current response are stored in ‘pvalH’, and the entire table is stored in ‘pval’:  
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> pvalH <- as.numeric(summary(gam1)$s.pv) # Store the p-values as numerics 
> pvalH[7] <- rowN # The column name is the name of the response variable 
> pval <- rbind(pval,pvalH) # Add the new p-values to the existing data frame 
 
Smooth terms are created through the use of penalised regression splines whose parameters are 
selected by a Laplace approximation to REML, and an important aspect to discuss here is the way in 
which the p-values for smooth terms are derived. This is done based on an extension of Nychka’s 
analysis of the frequentist properties of Bayesian confidence intervals for smoothing parameters 
(Marra & Wood 2012). What is therefore computed is a variant of the Bayesian, where the 
components of the test statistic are weighted by the iterative fitting weights, based on a likelihood 
ratio statistic (Wood 2011; Wood 2013). These p-values identify statistical significance to each 
macronutrient in isolation, and in combination.  
 
The resulting table can be extracted from the gam data frame using the summary function, and can be 
tabulated as follows: 
 
> summary(gam1)$s.pv 
[1] 0.0002823811 0.3828032777 0.0798922369 0.2888569293 0.8500685076 0.7810717985 
 
 
Table 3.3. GAM p-value outputs to macronutrient axes and ratios. 
p-value P C F P:C P:F C:F 
BCAA.Sum 0.000282381 0.382803278 0.079892237 0.288856929 0.850068508 0.781071798 
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2D visualisation of data through the Geometric Framework 
Next, the data is passed from ‘gam1’ to the topographical map, by linking it to the ‘df2’ data frames 
that had been computed earlier, and now that the 2D graphs/slices are ready to be plotted, variables 
such as font sizes are allocated: 
> fit1<-list() # Set up the data frame as a list 
> for(j in 1:3){ 
+ fit1[[j]]<-predict(gam1,newdata=df2[[j]])} # Link the data to the GAM 
> fit2 <- predict(gam1,newdata=aveintake2) 
> contourFontSize <- 0.4 # Contour label font size 
> par(cex=1.0, cex.axis=1.5,cex.lab=1.2, cex.main=1.5, cex.sub=1) # Plot label sizes 
> mains1<-c(rowN,rowN,rowN) # Labels for each slice are the response column label 
> opr<-par(mfrow=c(1,3)) # All 3 slices are plotted on the same frame 
> map<-rgb.palette(no.cols) # The colour gradient is set 
 
Next, the medians of each axis are calculated and rounded to the nearest integer for display purposes. 
The max and min values are also calculated to create evenly distributed notches in the axes: 
> sub1<-c(paste("(Fat: ",round(unique(df2[[1]]$eaten.F),0),")",sep=""), 
+         paste("(Carbohydrate: ",round(unique(df2[[2]]$eaten.C),0),")",sep=""),  
+         paste("(Protein: ",round(unique(df2[[3]]$eaten.P),0),")",sep="")) 
> mn<-min(c(unlist(fit1[[1]]),unlist(fit1[[2]]),unlist(fit1[[3]])),na.rm=TRUE) 
> mx<-max(c(unlist(fit1[[1]]),unlist(fit1[[2]]),unlist(fit1[[3]])),na.rm=TRUE) 
 
The plots are finally created. This section of code is slightly inelegant, and could be improved through 
recursive loops, however the code runs relatively efficiently, so loops would only make the code look 
more presentable rather than necessarily functionally improving it: 
> # 1st slice 
> locs<-(range(unlist(fit1[[1]]),na.rm=TRUE)-mn)/(mx-mn)*no.cols 
> surf<-matrix(fit1[[1]],nrow=sqrt(dim(df2[[1]])[1])) 
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> px<-pretty(aveintake$eaten.P) 
> py<-pretty(aveintake$eaten.C) 
> x.new<-seq(min(px),max(px),len=gr) 
> y.new<-seq(min(py),max(py),len=gr) 
> image(x.new,y.new,surf,col=map[locs[1]:locs[2]],xlab=labs1[1],ylab=labs1[2],  
+ main=mains1[1],sub=sub1[1],axes=FALSE) 
> axis(1) 
> axis(2) 
> contour(x.new,y.new,surf,add=TRUE,levels=pretty(range(mn,mx),nlev), 
+ labcex=contourFontSize) 
 
This is repeated three times, with changes to the appropriate variables where required for each slice. 
Thus the topographical response map is overlaid onto the nutritional surface, to create a 4-
dimensional output, which is captured by slicing through the medians to produce 2-dimensional plots 
with the response variable represented by colour. 
The resulting output is the response surface plot: 
 
Figure 3.9. 2D GF response surfaces correlating total circulating BCAA’s to macronutrient intake. 
The GAM output can also be automatically captured in full as in a text file: 
> txt1 <- file(paste(saveloc,q,s1[q],"/",rowN,".txt", sep="")) 
> writeLines(capture.output(summary(gam1)),txt1) 
> close(txt1) 
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Once the script has run through each response column, the total output of the p-value table is saved 
in two methods. The first is the table in full, with all p-values; and the second is the table with only 
statistically significant values (p-value < 0.05) displayed: 
> write.table(pval, paste(saveloc,filename,"-pval.csv", sep=""), row.names = FALSE,  
+ col.names = FALSE, sep=",") # Full p-value table 
> pvalsig <- pval # Passes the table to a new data frame 
> pvalsig[pvalsig>0.05] <- "" # Removes all non-significant values 
> pvalsig[1,] <- head(pval,1) # Ensures the row titles are the same 
> pvalsig[,1] <- pval[,1] # Ensures the column titles are the same 
> write.table(pvalsig, paste(saveloc,filename,"-pvalsig.csv", sep=""), row.names = F,  
+ col.names = F, sep=",") # Writes the statistically significant p-value table 
 
3D visualisation of data through the Geometric Framework 
Next, the 4-dimensional output data is used to create a 3-dimensional plot with the response variable 
represented by colour. While 2D slices through medians of the 3rd axis, by being incomplete, have the 
potential to be visually misleading, the 3D plot produced in this section was developed to show the 
complete picture, which could be manipulated and moved around as an interactive plot. This section 
primarily uses the ‘rgl’ package, which is a 3D real-time rendering system for R, and the ‘akima’ 
package, which contains methods for interpolation of gridded splines to form the topographical map 
that is overlaid onto the 3D nutrient surface.  
  
First, the data is passed to individual data matrices, which correspond to the macronutrient axes: 
> aveintake2<- data.matrix(aveintake2) # Data has to be in matrix format 
> x1<- data.matrix(aveintake2[,1])  
> y1<- data.matrix(aveintake2[,2]) 
> z1<- data.matrix(aveintake2[,3]) 
> s<- interp(x1,y1,z1) # Implements bivariate interpolation onto a grid 
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The ‘interp’ algorithm from the ‘akima’ package, implements bivariate interpolation of the irregularly 
spaced response surface data onto a grid, which can then be used as a topographical map for the 
nutritional surface (Akima 1978; Renka 1996). The data matrix ‘s’ therefore contains the information 
needed for correlation with the pre-specified colour matrix. The colour matrix is now calculated, as 
before, however it now uses the ‘interp’ function rather than the ‘findConvex’ function: 
> px<-pretty(x1) 
> py<-pretty(y1) 
> x.new<-data.matrix(seq(min(px),max(px),len=gr)) 
> y.new<-data.matrix(seq(min(py),max(py),len=gr)) 
> z.new<-data.matrix(seq(min(fit2),max(fit2),len=gr)) 
> surf<-data.matrix(fit2) # Data has to be in matrix format 
> c1 <- interp(x1,y1,surf) # interpolation data to match to the colour palette 
 
> map<-rgb.palette(no.cols3d) # The 3D colour palette used 
> cols <- heat.colors(no.cols3d) 
> cuts <- with(c1, cut(z, breaks=no.cols3d)) # Creates the 3D contour matrix 
 
 
The ‘persp3d’ function in the ‘rgl’ package is now used to plot the surface in a 3-dimensional space. 
This line of code integrates all aspects of the data collected so far, including the: 
- Nutrient space 
- Topographical 3-dimensional response surface 
- Colour map with gradient matched to the responses 
> with(s,persp3d(x,y,z,color=map[cuts],xlab="",ylab="",zlab="", main=NULL, box=F, 
axes=T)) 
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Figure 3.10. 3D response surface produced using the GF. Here, peaks and valleys in the nutritional 
space represent dietary compositions, with colours at each point representing response output. The 
red areas represent high response output, while the blue areas represent low response output. This has 
overlaid with the corresponding 2D slice through the median fat axis for illustration of how to read 
the 3D plot. In this case, the 2D plot shows that the isoclines are perpendicular to the carbohydrate 
axis, indicating that this response is driven primarily by carbohydrate intake. 
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Since the plot is angled arbitrarily, the viewpoint must be shifted by rotation. This can either be done 
manually, or by a preset value. Here, the optimal viewpoint was found by manual rotation, and the 
output was saved for future reference using the ‘par3d’ function: 
> par3d()$userMatrix 
           [,1]       [,2]        [,3] [,4] 
[1,] -0.7052403  0.7044325 -0.08006757    0 
[2,] -0.4247192 -0.3293558  0.84328991    0 
[3,]  0.5676702  0.6287286  0.53146100    0 
[4,]  0.0000000  0.0000000  0.00000000    1 
 
This viewpoint however is only optimal for the current nutritional surface, and almost certainly 
require adjustment for optimization in other data sets. This is recalled using the ‘view3d’ function 
whose inputs ‘pp’ are the viewpoint matrix listed above: 
> view3d(userMatrix=pp,zoom=zoom) 
 
This raises two important considerations: 
 
1. Determining the optimal viewpoint for any given surface:  
The inherent draw back of a 3-dimensional visualisation is that it is not possible to view the entirety 
of the surface at one time. This is because optimizing one view is not possible without impacting the 
view of another part of the surface. Additionally, this method does not show the slice, or volume of 
the nutrient space, as it only provides a topographical view. For this reason, there isn’t necessarily an 
optimal viewpoint from which to view the plot, thus reducing its publication value as a static image. 
On the other hand, through the method listed above, the plot generated by the rgl package in R is an 
interactive tool, allowing rotation and manipulation of the plot as required. Therefore, while the 3D 
plot may not be ideal for publication for all experimental frameworks, it is an extremely useful tool for 
interrogation of complex nutritional spaces in conjunction with statistics and 2D plots. 
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2. The degree of smoothing of the 3D surface required to appropriately interpret results: 
Given that the plot is a topographical response surface overlaid onto the nutrient surface, the more 
complex the nutrient space, the more difficult it is to interpret the 3D plot. While the benefit of this 
visualisation is that it is able to show local maxima and minima to a much greater extent than 2D 
plots, the drawback is, as mentioned in consideration 1, that it does not display the interior volume of 
the nutritional space. This is akin to being able to visualise the surface of a pyramid, but not its 
interior. Therefore, as the number of non-surface data points in the experimental framework increase, 
the more difficult this visualisation becomes to interpret. While this problem is partially solved by 
analysing data in conjunction with statistics and 2D plots, it is certainly a critical limiting factor to 3D 
visualisation.  
 
In addition, since the mgcv package in R predicts optimal degree of smoothing as part of the fitting, 
choosing appropriate smoothing parameters of the surface can also become an issue in some cases, 
and can lead to problems in calculation of p-values. Smoothing optimisation here is based on a trade-
off between over- and under-fitting of the data set, which is computed through the estimation of 
smoothing parameters. Given that the p-values are calculated without considering uncertainty in the 
smoothing parameter estimates, high uncertainty in these estimates can cause artificially low p-values 
(Wood 2013). This especially occurs with nested smooths or with high concurvity in the model, where 
model parameter estimates and smoothing parameter estimates do not converge (Wood 2011). For 
this reason, the p-value calculations that are produced through the 3D interpolation are considered 
less accurate than those calculated through the 2D GAM, and the surfaces therefore must be 
considered in conjunction, making the 3D model unable to act as a stand alone analytical tool in most 
cases. 
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Specific add-ons to the GF script for analysis of data during this thesis 
Gene expression analysis  
Microarray data was processed using the ‘affy’, ‘oligo’, and ‘limma’ R packages from Bioconductor, 
and annotation, matching, clustering, and correction was performed using the ‘pd.mogene.2.0.st’, 
‘annotate’, and ‘mogene21sttranscriptcluster.db’ database R packages from Bioconductor. Data was 
parsed into csv files, and processed through the GF script as described earlier. Once significance of 
smooth terms was calculated for each gene to macronutrient intakes and ratios, the data were analysed 
using a custom volcano plot script developed using the ‘calibrate’ package in R to find unbiased genes 
of interest. Unbiased genes of interest, and selected genes known to be involved in nutrient sensing 
pathways are identified and analysed in detail in Chapter 4. Since there are multiple variable-responses 
present for each macronutrient axis, a unidirectional volcano plot is formed for p-value versus fold 
change plots. For Pearson’s correlations, a bivariate volcano plot is formed. Full volcano plot script 
details are provided below. 
 
The ‘calibrate’ package was used for this script, as shown by the ‘sessionInfo()’ function: 
> sessionInfo() 
R version 3.3.1 (2016-06-21) 
Platform: x86_64-apple-darwin13.4.0 (64-bit) 
Running under: OS X 10.11.6 (El Capitan) 
locale: 
[1] en_AU.UTF-8/en_AU.UTF-8/en_AU.UTF-8/C/en_AU.UTF-8/en_AU.UTF-8 
 
attached base packages: 
[1] stats     graphics  grDevices utils     datasets  methods   base      
 
other attached packages: 
[1] calibrate_1.7.2 MASS_7.3-45     
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loaded via a namespace (and not attached): 
[1] tools_3.3.1 
 
Data is called from the comma separated value file, and loaded into data frames as follows: 
> aveintake <-read.csv(paste(directory,filename,".csv",sep=""),1) 
 
In this R environment, the data set used was the microarray data parsed into a comma separated value 
file as described above. Table 3.4 shows this with the first 4 genes. FC – fold change; log2fc – log 
base 2 of fold change; pval(x) – p-value calculated using the GF for each macronutrient, and ratio. 
 
Table 3.4. Gene expression and statistical significance data set from microarray analysis. 
Gene FC log2fc pvalp pvalc pvalf pvalpc pvalpf pvalcf 
Serpinb3c 391.92 8.61 0.97 0.27 0.27 0.69 0.39 0.04 
Gm8693 55.01 5.78 0.01 0.09 1.00 0.33 0.82 0.39 
Zfp874b 51.25 5.68 0.68 0.56 0.06 0.66 0.38 0.68 
Scgb2b12 37.67 5.24 0.01 0.36 0.39 0.75 0.42 0.21 
 
 
 
The percentile cut off for fold change is set to find unbiased genes of interest (GOI). This value can 
be varied depending on the list of genes that are captured by the volcano plot.  
> fcstat <- 0.99 # Fold change cut-off value for volcano plot 
 
 
Data can now be plotted using the standard ‘plot’ function in R, and labeling of genes is performed 
using the ‘textxy’ function in the ‘calibrate’ package. The statistical threshold for p-values was chosen 
at p<0.05. Log2(fold change) was chosen for the x-axis as per volcano plot convention, while log10(p-
value) was chosen for the y-axis to limit axis size. 
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The resulting output is a unidirectional volcano plot, with genes of interest labeled by colour, as 
shown in Figure 3.10 below. 
 
Figure 3.10. Example unidirectional volcano plot for unbiased genes of interest from a microarray. 
Outputs can be seen in Table 3.5 
 
 
The output of this volcano plot can be tabulated to contain the fold change and p-values for genes of 
interest sorted by macronutrient to which they are significantly correlated [Table 3.5]. 
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Table 3.5. Example output table for unbiased genes of interest, sorted by macronutrient correlation. 
Gene Fold Change log2fc pval BY 
Gm8693 55.00524782 5.781497362 0.007088124 P 
Scgb2b12 37.66513381 5.23515775 0.008008181 P 
Olfr1195 31.26318164 4.966392703 0.002319759 P 
Olfr315 21.82934031 4.448196627 0.016244258 P 
Ugt2b37 20.17806289 4.334715776 0.021455283 P 
Slc22a27 8.764625436 3.131692438 0.003507577 C 
Bcl2a1a 9.134831758 3.191378158 0.030501294 P:F 
Apol7c 12.6910257 3.665736768 0.039717287 C:F 
 
 
Correlation of data  
Another additional tool developed to complement the GF script is a correlation matrix, used to 
compare various data sets. Here, the method of correlation can be varied depending on the data set 
used. For many data sets, the Pearson product-moment correlation coefficient can be used, when the 
responses are predicted to be linearly correlated with macronutrient intake. Additional correlations 
such as Spearman and Kendall rank correlations can be substituted if the correlations are not 
predicted to be linear, or there is significant skew in the data set. First, we can check the distribution 
of the example data sets, and their approximate correlation plots as follows: 
> testset <- aveintake[,31:34] # Example test set containing last 4 columns 
> hist(testset) # Creates histogram of the set 
> plot(testset) # Creates x-y plot of set 
> bagplot(testset) # Creates bagplot of set (only bagplot of BCAA shown below) 
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Figure 3.11. Data plots of an example data set as (a) histograms, (b) dotplots, (c) bagplots. 
 
As we can see, the distributions are relatively normal, and the correlations can in some case be linear, 
as seen in Figure 3.11. The bagplot is a bivariate generalization of a boxplot, and is used to 
demonstrate the distribution of the data points. Here we see that Pearson’s correlations would work 
best for the data set, as they are predicted to be linearly correlated.  
 
The application of this method to data sets that are significantly correlated to a specific nutrient or 
ratio allows directionality to be quickly identified. The custom ‘rquery.cormat’ function (as described 
earlier in this chapter) can now be called to create a clustered correlation matrix – in this case, with 
non-significant correlations left blank. This can only be done with the subset of responses that we 
already know are correlated with a particular macronutrient intake or ratio, as a correlation between 
two unrelated response surfaces would not provide any data that can be appropriately interpreted: 
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> a2 <- aveintake[,starts:ncol(aveintake)] # ‘a2’ contains all the response data  
> ps <- pvalsig[c(1,ux),] # ‘ps’ contains significant p-vals to a chosen axis ‘ux’ 
> a3 <- data.frame(a2[,is.na(match(colnames(a2),ps[1,]))==0]) # Significant subset  
> rquery.cormat(a2, labcex=0.5) # Creates the correlation matrix 
 
 
 
 
Figure 3.12. Correlation matrix of response variables that were significantly correlated to P:F ratio. 
Here we can see that almost all the responses are in the same direction with P:F ratio, with only body 
weight being correlated in the opposite direction to any amino acid result. 
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This matrix can now be used to check the correlations and directionality of the response variables. 
For instance, in this case, we can see that Ornithine is positively correlated with Lysine, but negatively 
correlated with body weight. Inspection of the 2D GF plots confirm this relationship, as shown in 
Figure 3.13, where the maxima and minima in Lysine and Ornithine localise to the same space, while 
the relationship is opposite between Ornithine and body weight. 
 
Figure 3.13. 2D GF surfaces correlating Lysine, Ornithine, and body weight to macronutrient intake. 
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General comments 
The evolution of the geometric framework since the early 90’s has allowed integration of evolutionary 
and mechanistic approaches to ageing research, by creating a unifying framework in which to analyse 
the seemingly disparate data (Raubenheimer et al. 2016). Despite this, wider application of the GF 
across other scientific fields has been limited, due to a lack in accessibility, particularly of a user-
friendly functional interface, until the last decade with the use of R scripts. This has allowed complex 
response surface fitting and data visualisation methods to be applied on a large scale, allowing the GF 
to be propelled into the public sphere through its application in a variety of publications (Hew et al. 
2016; Speakman et al. 2016; Wahl et al. 2016; Solon-Biet et al. 2016; Simpson et al. 2017a).  
 
Here, we reviewed the progressive iterations of the GF since its inception, and have outlined 
developments made to the GF script as part of this thesis through example data sets. The problem in 
application of the GF to large data sets is addressed through automation using iterative loop scripts, 
and the discord between analysis and visualisation in 2D planes is aided by the creation of a 3D 
visualisation tool. Finally, additional tools used to analyse data such as gene regulation are outlined, 
and methods of data correlation are discussed.  
 
Future work on this area should include methods to optimise the coding structures used to improve 
efficiency and computation. Additionally, a new algorithm could be developed which is able to analyse 
the local maxima and minima of multiple response surfaces to create a goal-seeking optimisation tool 
that could be used to answer questions such as “What is the optimal diet to maximise cardiovascular 
health, while minimizing liver fibrosis?” This would no doubt be an invaluable research tool, and 
could help broaden the horizons of the GF beyond nutritional and ageing research, to a much more 
widely encompassing experimental paradigm.  
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Chapter 4: The Impact of Diet on Nutrient 
Sensing Pathways 
 
Excerpts from this chapter related to the liver have been published in (Gokarn et al. 2018); 
excerpts related to the hypothalamus are in review for submission; data related to mTOR 
activation have been published in (Solon-Biet et al. 2014). 
 
Background 
While caloric restriction (CR) has been shown to have the potential to extend lifespan, there is still 
uncertainty about the mechanisms for its effects. Debate also exists as to whether it is reduction of 
calories, or macronutrients that primarily mediates the effects of CR on ageing (Levine et al. 2014; 
Brown-Borg & Buffenstein 2016; Speakman et al. 2016; Le Couteur et al. 2015). Regardless of which 
of these is true, a common mechanism by which nutritional interventions influence ageing is related 
to the modulation of several nutrient sensing cellular growth pathways (Vijg & Campisi 2008; Le 
Couteur, McLachlan, et al. 2012b; López-Otín et al. 2016). Experimental modulation of these 
pathways; mTOR, AMPK, IIS and sirtuins; have been shown to influence lifespan and health in a 
variety of taxa, through their effects on cellular processes such as metabolism, mitochondrial 
biogenesis, autophagy, gene expression, growth, replication, and other pleiotropic signaling effects 
[Figure 4.1] (Houtkooper et al. 2012; Hofmann et al. 2015; Baur et al. 2006; Longo et al. 2015; Junnila 
et al. 2013; Zoncu et al. 2010; Finkel 2015; Pazoki-Toroudi et al. 2016).  
 
In humans however, the evidence for CR is not as robust as in other model organisms, partly due to 
the difficulty in implementing long-standing dietary regimens and subsequently measuring their 
impact on lifespan. To circumvent these issues of 1) CR vs. macronutrients, and 2) the difficulty of 
implementing long-term nutritional strategies in humans, modulation of these nutrient sensing 
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pathways, which are largely evolutionarily conserved, seem to be a robust method to investigate 
translatable therapeutics (Longo et al. 2015; da Costa et al. 2016; Partridge 2012). This can be 
achieved through either ad libitum diets varying in macronutrient and caloric ratio, or with 
pharmaceutical agents and gene mutations directly targeting the nutrient sensing pathways. 
 
Figure 4.1. The four major nutrient sensing pathways (Sirtuins, AMPK, mTOR, and IIS) and their 
relationship with age-related end points. Figure adapted from (Bonkowski & Sinclair 2016). 
 
As yet, there have not been any reports of the effects of low protein, high carbohydrate diets on gene 
expression, nor the long-term effects of dietary macronutrients on gene expression. The liver is the 
primary organ that responds to nutrition, and regulates systemic metabolic responses to diet. 
Therefore hepatic gene expression is a strong candidate to be responsive to dietary perturbations, and 
it is hypothesised that protein will be the key driver of gene expression. There have been many, 
mostly short-term studies of the effects of diet on the hepatic transcriptome that have identified a 
wide range of genes and pathways that are influenced by nutrition and these are mostly involved with 
the regulation of the metabolism of nutrients and energy (Osada 2013; Schmucker 1998; Dhahbi et al. 
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2005; Schwarz et al. 2012). There has also been increasing interest in discovering which genes and 
pathways mediate this response, partly because this can provide a platform for the discovery of 
pharmacological agents for delaying aging (Benayoun et al. 2015; Le Couteur et al. 2012b). Key 
nutrient sensing pathways that are thought to influence aging include mTOR, SIRT1, insulin/IGF-1 
and AMPK, and more recently FGF21 (Bishop & Guarente 2007; Solon-Biet et al. 2015b; Solon-Biet 
et al. 2016). The effects of caloric restriction on mammalian gene expression has also been undertaken 
to provide data-driven insights into pathways and genes that influence healthy aging (Swindell 2009; 
Plank et al. 2012). In one meta-analysis of over 50 animal studies, it was found that caloric restriction 
is associated with overexpression of 101 genes and underexpression of another 73 genes in the liver. 
Pathways affected by caloric restriction included growth hormone signaling, lipid metabolism and 
immune responses (Plank et al. 2012). Another similar meta-analysis identified genes associated with 
oxidative stress, inflammation and tumorigenesis in 22 different tissue types in mice (Swindell 2009).  
 
The hypothalamus also plays a key role in mediating the effects of diet on the body, since it is not 
only involved in food intake, but also in the neuroendocrine interactions that mediate functions such 
as growth, reproduction and metabolism (Waterson & Horvath 2015). By virtue of its location, the 
hypothalamic arcuate nucleus is able to use fenestrated capillaries that make up the blood brain barrier 
to sense nutrient and hormonal signals, and coordinate responses through orexigenic neuropeptide Y 
(NPY) and agouti-related peptide (AgRP) and anorexigenic pro-opiomelanocortin (POMC) neuronal 
feedback loops (Timper & Brüning 2017). In addition, mutations in the POMC, brain-derived 
neurotrophic factor (BDNF) and melanocortin-4-receptor (MC4R) genes have been shown to result 
in increased appetite and obesity in both humans and rodents (Krude et al. 1998; Yeo & Heisler 
2012). Both CR and intermittent fasting, have also been shown to cause behavioural fluctuations in 
mice, with significant changes to gene expression in the central nervous system (CNS), varying across 
the prefrontal cortex, amygdala and hypothalamus (Yamamoto et al. 2009). It is therefore 
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hypothesised that energy intake will be a key driver of gene expression in the hypothalamus. Several 
meta-analyses on genome-wide association studies (GWAS) have also shown multiple single 
nucleotide polymorphisms (SNPs) in hypothalamic genes which are associated with high BMI and 
obesity (Speliotes et al. 2010; Xu & Xie 2016). While GWAS and quantitative trail loci (QTL) 
mapping are the most common methods used to investigate the genetic basis for energy and 
macronutrient intake, so far almost no genetic associations have been found that correspond to 
longevity (Broer & van Duijn 2015; Yashin et al. 2015; Collaku et al. 2004). This limits the translation 
of findings from animal model GWAS, since even though dietary studies can be performed in a much 
more accurate manner in animal laboratory conditions, results do not necessarily have an immediate 
correlate to humans. On the other hand, more targeted molecular techniques such as microarray, 
polymerase chain reactions (PCR) and western blotting have been used to good effect in determining 
common genes and pathways that are relevant to humans (Bonkowski & Sinclair 2016; Han & Hickey 
2005; Razi et al. 2017; Dhahbi et al. 2005). Given the multitude of roles of the liver and hypothalamus 
on ageing, food intake, metabolism and health, investigations were undertaken here to examine the 
effects of protein, carbohydrate and fat on hepatic and hypothalamic gene expression in ageing mice 
maintained on lifelong ad libitum diets varying in the ratios of these macronutrients. To analyse the 
impact of both individual macronutrients and ratios, the Geometric Framework (GF) was applied to 
this experimental design, as previously described (Simpson et al. 2015; Simpson & Raubenheimer 
2007). Here, the GF was used to study the effects of varying dietary composition on these nutrient 
sensing pathways using tissue collected from a large-scale dietary study in mice. This was primarily 
performed through interrogation of genetic expression of the pathways and their downstream targets, 
through the use of microarray and PCR assays on hepatic and hypothalamic tissue. In addition, direct 
measures were performed to validate the gene expression data through measures of circulating protein 
and western blot analyses. These sets of data were then correlated with each other, and lifespan data 
collected from the same cohort, to determine their correlation with the ageing process.  
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Methods 
Chapters 2 and 3 describe the details of the methods used in this chapter. The work done in this 
thesis primarily focused on extraction of DNA, RNA and protein from tissue samples, performing 
assays (microarray, PCR, western blots), development of data analysis tools (R scripts and 
frameworks) and data analysis. Briefly, three-week-old male and female mice (C57Bl6/J, n=858) were 
ad libitum-fed one of 25 experimental diets varying in protein, carbohydrate, fat and energy content. 
Energy manipulations were achieved by addition of cellulose generating low, medium and high energy 
density diets (8, 13, and 17 kJ/g) [Table 4.1]. At 15 months of age, one cohort of mice (n=183) 
spanning the diets was euthanised and tissues collected, while the remaining mice were maintained for 
lifespan analysis.  
 
Frozen liver (n=183) and hypothalamic (n=24) tissue samples from mice at 15 months of age were 
sectioned into 10mg blocks, and DNA, RNA, and protein were extracted using the Qiagen AllPrep 
Mini Kit. Isolated RNA (n=24 male/n=22 female from the liver, n=24 male from the hypothalamus 
[See Table 4.1]) was analysed using Affymetrix Mouse Gene ST arrays at the Ramaciotti Centre for 
Genomics, University of New South Wales; GEO: GSE85998 (Solon-Biet et al. 2016). Gene 
expression data were normalised to actin expression. Liver samples that had undergone microarray 
assays were run on qPCR plates using the RT2 profiler array using the Mouse Insulin Signaling 
Pathway kit (Qiagen). A pooled sample was serially diluted, and as a standard curve in the Fluidigm 
Biomark software for PCR analysis. Protein pellets were resolubilised and used to run western blots 
for mTOR and phosphorylated-mTOR.  
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A flowchart of the methods performed in this chapter are outlined below: 
 
 
 
Data analyses were based on macronutrient intake (kJ/mouse/day). The relationship between 
macronutrients and gene expression was determined using two methods. First, the correlation 
between the intake of each macronutrient and the expression of each gene was calculated using a 
Pearson’s correlation coefficient. Second, the Geometric Framework approach was used where the 
statistical significance of the relationships between each gene and macronutrients and the interactions 
between macronutrients was calculated with Generalised Additive Models (GAMs). In addition to the 
GAM statistics (GAMS), graphical representation of the relationship between macronutrients and 
gene expression was assessed for some genes of interest using the GF as described in Chapter 3.  
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Genes of interest were determined from the P values returned by each of these methods and 
application of Benjamini Hochberg correction with a FDR of 0.05. Heatmaps were performed in R 
using gplots package. Gene enrichment analysis was performed in Enrichr to determine gene 
pathways based on the KEGG database and biological pathways based on the GO Biological 
Processes 2017 (Kuleshov et al. 2016). Only pathways and processes with more than two genes 
represented and an adjusted P value <0.05 were considered to be potentially significant. Once 
significance of smooth terms was calculated for each gene to macronutrient intakes and ratios, the 
data was analysed using a custom volcano plot script developed using the ‘calibrate’ package in R to 
find unbiased genes of interest (GOI). Unbiased genes of interest, and selected genes known to be 
involved in nutrient sensing pathways were identified and analysed in more detail using the GF script.  
 
Table 4.1. Sex, diets and dietary intakes of mice included in transcriptome analysis of liver. 
Sex Protein  eaten 
Carbohydrates 
eaten 
Fat  
eaten 
Energy 
density 
Protein/Carbohydrate 
/Fat ratio 
M 25.82 8.59 8.59 High 60/20/20 
F 22.04 7.33 7.33 High 60/20/20 
M 2.44 36.49 9.73 High 5/75/20 
F 2.02 30.19 8.05 High 5/75/20 
M 2.13 8.5 31.89 High 5/20/75 
F 2.75 10.98 41.18 High 5/20/75 
M 16.19 23.51 9.79 High 33/48/20 
F 2.45 23.49 23.49 High 5/48/48 
F 6.72 13.9 27.32 High 14/29/57 
F 5.51 22.39 11.39 High 14/57/29 
M 12.48 20.59 20.59 High 23/38/38 
M 2.21 33.06 8.82 High 5/75/20 
F 13.01 7.87 18.89 High 33/20/48 
F 6.11 12.64 24.84 High 14/29/57 
M 25.77 8.58 8.58 High 60/20/20 
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M 15.67 22.76 9.48 High 33/48/20 
F 11.8 7.14 17.14 High 33/20/48 
M 2.05 19.61 19.61 High 5/48/48 
M 8.19 16.94 33.3 High 14/29/57 
M 6.53 13.51 26.56 High 14/29/57 
M 9.58 15.81 15.81 High 23/38/38 
F 7.46 12.31 12.31 High 23/38/38 
M 1.92 28.8 7.68 High 5/75/20 
M 2.3 22.03 22.03 High 5/48/48 
F 2.34 22.44 22.44 High 5/48/48 
M 5.95 24.17 12.3 High 14/57/29 
M 14.85 10.23 10.23 High 42/29/29 
M 7.78 12.83 12.83 Low 23/38/38 
M 16.61 5.53 5.53 Low 60/20/20 
F 15.15 5.04 5.04 Low 60/20/20 
F 7.24 11.95 11.95 Low 23/38/38 
F 13.8 9.51 9.51 Low 42/29/29 
M 6.48 13.41 26.35 Medium 14/29/57 
F 4.7 19.13 9.73 Medium 14/57/29 
F 14.14 9.74 9.74 Medium 42/29/29 
F 7.11 11.73 11.73 Medium 23/38/38 
M 13.81 8.35 20.05 Medium 33/20/48 
F 13.5 9.3 9.3 Medium 42/29/29 
F 8.04 13.26 13.26 Medium 23/38/38 
F 13.48 9.29 9.29 Medium 42/29/29 
M 11.29 16.4 6.83 Medium 33/48/20 
M 5.39 21.93 11.16 Medium 14/57/29 
F 10.33 15 6.25 Medium 33/48/20 
M 12.01 7.27 17.45 Medium 33/20/48 
F 11.35 6.87 16.48 Medium 33/20/48 
M 8.13 13.42 13.42 Medium 23/38/38 
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Results 
The effects of macronutrients on overall liver gene expression 
Global transcriptome analysis of the liver was performed using Affymetrix Mouse Gene ST arrays 
representing 21,798 hepatic genes. To form an unbiased assessment of these genes, fold change and 
p-values, calculated through the Geometric Framework, were passed to a volcano plot script in R, to 
identify the genes with maximum fold change that were significantly correlated with diet [Figure 4.2]. 
The most highly expressed gene was Alb (albumin) and there was about a 100-fold difference in the 
expression of the highest versus the lowest expressed genes within each liver. Of the three 
macronutrients, dietary protein was associated with changes in the expression of the highest number 
of genes using either correlation analysis (n=1279 genes, 648 positive correlation, 631 negative 
correlation) or GAMS (n=2933 genes). This compared to only 8 genes by correlation analysis and 72 
genes by GAMS for dietary carbohydrates; and only 3 genes by correlation analysis and 19 genes by 
GAMS for dietary fat (Figure 4.3 A-B). For dietary protein, there were 980 genes (77% of genes from 
correlation analysis) in common using either GAMS or correlation analysis, while for dietary 
carbohydrates there were 4 genes (50% of genes from correlation analysis) in common using both 
types of analysis, indicating that both types of analysis are identifying similar overall trends. 
 
Heatmap analysis [See Figure 4.4] revealed a very strong inverse relationship between gene expression 
that correlated with protein intake compared with intake of fat or carbohydrates, such that genes that 
were positively correlated with the intake of dietary protein were negatively correlated with the intake 
of either fat or carbohydrates, and vice versa. Although the inverse relationships between the 
macronutrients on the heatmaps are very distinct, it should be noted that only a few genes were 
statistically significantly associated with the intakes of carbohydrates or fats. 
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Figure 4.2. Volcano plot showing genes of interest identified through an unbiased analysis of the 
hepatic microarray. Genes are colour coded based on correlation to macronutrient axis or ratio. 
Genes of interest (GOI’s) were selected based on both fold change, as well as having a p-value greater 
than p=0.05.  
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Figure 4.3. Venn diagrams showing the effects of macronutrient intake on gene expression in the 
liver. 4.3A shows the results determined using Pearson’s correlation coefficient (black positive 
correlation, red negative correlation). 4.3B shows the results determined using GAMS (PxC 
interactive term between carbohydrates and protein). 
 
 
Figure 4.4 Heatmaps comparing the overall pattern of expression of genes in the liver. The values are 
Pearson’s correlation coefficients ranked from most positive correlation in red to the most negative 
correlation in blue. The most positive 1000 genes and the most negative 1000 genes are included. The 
genes have been ranked according to significance of the correlation with protein (A), carbohydrates 
(B) and fat (C). 
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The genes with the most statistically significant association with macronutrient intake are shown in 
Table 4.2. Four representative surfaces using the Geometric Framework approach are shown in 
Figure 4.5. These genes are shown because they were highly significantly associated with 
macronutrient intake and demonstrate characteristic responses to macronutrients that can be easily 
visualised by the Geometric Framework method [Table 4.3]. Nicotinamide N-methyltransferase 
(Nnmt) was positively associated with protein intake (Figure 4.5A), while Insulin-like growth factor 2 
mRNA-binding protein 2 (Igf2bp2) was negatively associated with protein intake (Figure 4.5B). 
Glucosylceramidase beta 2 (Gba2) was positively associated with carbohydrate intake (Figure 4.5C), 
while Solute carrier family 15 member 5 (Slc15a5) was positively associated with both protein and 
carbohydrate intake (Figure 4.5D). 
 
Table 4.2. Gene expression with the highest statistical association with macronutrient intake in the 
liver determined using either GAMS or correlation analysis. For correlation analysis, genes are divided 
into those with positive and negative correlation. Benjamini Hochberg correction with a FDR of 0.05 
has been performed for the P values. Genes in the top twenty for both GAMS and correlation 
analysis are bolded. 
 
Protein  p  Carbohydrates p Fat p 
Top genes by GAMS analysis 
Igf2bp2 7.34E-21 Slc15a5 5.83E-07 Sag 2.9E-11 
Adgrg2 6.31E-12 Reg1 3.11E-06 Gm5424 9.18E-09 
Orm1 1.71E-10 Sox13 0.00072 Hsd3b1 2.58E-07 
Nnmt 1.57E-10 Alb 0.00073 Cps1 1.99E-05 
Igsf23 6.3E-10 Lrrc16a 0.00108 Cfap54 0.00054 
Spink5 6.72E-10 Fam131c 0.00168 Mir192 0.00150 
Gm5424 6.24E-09 Cyp4a12a 0.00220 Gpc1 0.00288 
Corin 1.63E-08 Hsd17b6 0.00358 X1700012C14Rik 0.00759 
Itga6 9.14E-08 Rnf128 0.00610 Zfp449 0.01249 
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Impa2 1.83E-07 Gba2 0.00927 Fam19a5 0.01529 
Gpi1 2.41E-07 Rtn4 0.01255 Pcdh18 0.02078 
Slc15a5 2.57E-07 Elovl3 0.01706 Gfod2 0.02631 
Fgf21 3.06E-07 X1700012C14Rik 0.01613 Sema5b 0.02444 
Vtcn1 2.95E-07 Wasf3 0.01623 Sult1e1 0.02970 
Psat1 3.09E-07 Pdilt 0.01556 Rnf133 0.03283 
Arhgef2 9.22E-07 Adgrg7 0.01509 Trpc3 0.03193 
Hsd17b6 1.05E-06 Derl3 0.01469 Slc39a12 0.03276 
Slc13a2 1.09E-06 Pard3b 0.01428 Sel1l3 0.03158 
Cps1 1.16E-06 Cyp2u1 0.01425 Cidec 0.03688 
Soat2 5.73E-06 Hsd3b5 0.01567   
Top genes by correlation analysis, positive correlation with intake 
Cth 1.92E-05 Slc17a8 0.00711 Gpc1 0.038492 
Lrtm1 2.64E-05 Pard3b 0.01925   
Slc13a2 2.36E-05 Gba2 0.02124   
Gpx6 6.05E-05 Tubg1 0.02399   
Acmsd 9.08E-05 A230050P20Rik 0.02411   
Sdhb 0.00022 Fam131c 0.02692   
Nnmt 0.00021 Unc13b 0.02818   
Acadsb 0.00022 Ergic1 0.03640   
Gm5424 0.00025     
Slc43a1 0.00037     
Top genes by correlation analysis, negative correlation with intake 
Adgrg2 4.78E-06   Cps1 0.00722 
Impa2 2.72E-05   Gm5424 0.01158 
Igf2bp2 4.72E-05     
Slc9a7 4.76E-05     
Unc13b 5.69E-05     
Lhx6 6.77E-05     
Slc17a8 0.00025     
App 0.00028     
Slc7a7 0.00030     
Gpi1 0.00032     
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Figure 4.5. Two dimensional response surfaces created using the GF. The relationships between the 
macronutrients and four hepatic genes (A Nnmt, B Igf2bp2, C Gba2, D Slc15a5) are demonstrated. 
Each graph shows the effects of two of macronutrients at the median point of the third 
macronutrient (shown in parenthesis below the X axis label). The response surfaces vary from red 
which is the most negative value to blue which is the most positive value. The GAM statistics are 
shown in Table 4.3. 
 
A 
B 
C 
D 
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Table 4.3. Statistics for the Geometric Framework figures in Figure 4.5. GAMS data for hepatic 
expression of Slc15a5, Nnmt, Igf2bp2 and Gba2. 
 edf df F P 
Nnmt 
Protein 3.602e+00 8 11.861 3.08e-14 
Fat 9.190e-01 8 1.417 0.000488 
Carbohydrates 1.266e-05 8 0.000 0.603552 
P x F 7.364e-06 3 0.000 1.000000 
P x C 1.879e-05 3 0.000 0.334256 
F x C 1.291e+00 3 1.346 0.048472 
Slc15a5 
Protein 9.824e-01 8 6.962 1.48e-10 
Fat 8.469e-01 8 0.691 0.0138 
Carbohydrates 9.842e-01 8 7.781 2.79e-11 
P x F 3.323e-06 3 0.000 0.7224 
P x C 5.495e-05 3 0.000 0.4078 
F x C 1.487e-06 3 0.000 0.9572 
Igf2bp2 
Protein 4.066e+00 8 22.398 <2e-16 
Fat 9.167e-02 8 0.013 0.299 
Carbohydrates 1.573e-05 8 0.000 0.481 
P x F 4.107e-06 3 0.000 0.503 
P x C 4.094e-06 3 0.000 0.678 
F x C 1.762e-06 3 0.000 0.985 
Gba2 
Protein 8.442e-01 8 0.168 0.1930 
Fat 8.244e-01 8 0.587 0.0108 
Carbohydrates 9.536e-01 8 2.568 4.4e-06 
P x F 2.580e-06 3 0.000 0.5303 
P x C 4.501e-06 3 0.000 0.3722 
F x C 4.107e-01 3 0.168 0.2799 
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The effects of macronutrients on hepatic gene pathways 
Gene pathway analysis based on correlation coefficients was able to be analysed according to whether 
the genes had a positive or a negative correlation with macronutrient intake [See Table 4.4, Figure 
4.6A]. Pathways enriched by genes whose expression was positively correlated with protein intake 
included oxidative phosphorylation and multiple pathways associated with amino acid metabolism, as 
well as a pathways associated with neurodegenerative diseases. Pathways enriched by genes whose 
expression was negatively correlated with protein intake include several key metabolic signaling 
pathways, PI3k-Akt, mTOR, AMPK and insulin signaling as well as pathways associated with various 
cancers. Gene pathway analysis based on GAMS only found five pathways associated with protein 
intake all of which were also present in the pathways found using correlation analysis. There were few 
if any significant or relevant pathways linked to carbohydrate or fat intake with either analytical 
approach. 
 
The effects of macronutrients on biological processes in the liver 
Biological processes associated with genes whose expression was positively correlated with protein 
intake included a very large number of processes associated with mitochondria as well as amino acid 
metabolism [See Table 4.5, Figure 4.6B]. Biological processes associated with genes whose expression 
was negatively correlated with protein intake included transcription, protein metabolism and cell 
differentiation and maturation. There were no pathways associated with fat intake and only two with 
carbohydrate intake, and none identified using GAMS analysis. 
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Figure 4.6. (A) Gene pathways and (B) Biological processes associated with protein intake, where the 
association between protein intake and hepatic gene expression has been determined using Pearson’s 
correlation coefficient. Pathways analysis was performed using Enrichr. Full datasets are in Tables 4.4 
and 4.5. 
 
 
  
A 
B 
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Table 4.4. Gene pathway analysis based on KEGG database in Enrichr. The genes of interest in the 
liver were determined using either Pearson’s correlation coefficient or GAMS to evaluate the 
relationship between each macronutrient and gene expression, and a FDR of 0.05. There were no 
pathways that were significant for carbohydrates, fat or the interactions between macronutrients. 
Gene pathway analysis using Enrichr and KEGG database 
 overlap -log(p) p adj p 
Pathways associated with genes posi t ive ly  correlated with protein intake using Pearson’s 
coefficient 
Oxidative phosphorylation  46/133 34.7474 0.0000 0.0000 
Parkinson's disease  47/142 34.4844 0.0000 0.0000 
Metabolic pathways  127/1239 32.5861 0.0000 0.0000 
Alzheimer's disease  44/168 27.4649 0.0000 0.0000 
Huntington's disease  46/193 26.7592 0.0000 0.0000 
Non-alcoholic fatty liver disease  38/151 23.0914 0.0000 0.0000 
Valine, leucine and isoleucine degradation  18/48 14.6411 0.0000 0.0000 
Arginine biosynthesis  8/20 7.0726 0.0000 0.0000 
Cardiac muscle contraction  14/78 6.8751 0.0000 0.0000 
Propanoate metabolism  9/32 6.3681 0.0000 0.0000 
Biosynthesis of amino acids  13/74 6.3146 0.0000 0.0000 
Alanine, aspartate and glutamate metabolism  9/35 6.0039 0.0000 0.0000 
Tryptophan metabolism  9/40 5.4771 0.0000 0.0000 
Glycine, serine and threonine metabolism  9/40 5.4771 0.0000 0.0000 
Carbon metabolism  14/113 4.8876 0.0000 0.0002 
Cysteine and methionine metabolism  8/45 4.1418 0.0001 0.0008 
Glyoxylate and dicarboxylate metabolism  6/28 3.6980 0.0002 0.0022 
Peroxisome  10/83 3.5550 0.0003 0.0028 
beta-Alanine metabolism  6/31 3.4419 0.0004 0.0035 
Histidine metabolism  5/24 3.0999 0.0008 0.0073 
Arginine and proline metabolism  7/50 3.0339 0.0009 0.0081 
Pentose and glucuronate interconversions  5/36 2.2871 0.0052 0.0394 
Lysine degradation  6/52 2.2427 0.0057 0.0419 
Pathways associated with genes negat ive ly  correlated with protein intake using Pearson’s 
coefficient 
PI3K-Akt signaling pathway  38/341 10.4612 0.0000 0.0000 
Focal adhesion  25/202 8.0027 0.0000 0.0000 
AGE-RAGE signaling pathway  16/101 6.8180 0.0000 0.0000 
Pathways in cancer  34/397 6.5509 0.0000 0.0000 
ECM-receptor interaction  14/82 6.4542 0.0000 0.0000 
Small cell lung cancer  12/86 4.6848 0.0000 0.0007 
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mTOR signaling pathway  10/60 4.6824 0.0000 0.0007 
Amoebiasis  12/100 4.0266 0.0001 0.0026 
Choline metabolism in cancer  12/101 3.9844 0.0001 0.0026 
Proteoglycans in cancer  18/203 3.9423 0.0001 0.0026 
Toxoplasmosis  13/118 3.9275 0.0001 0.0026 
Colorectal cancer  9/62 3.7883 0.0002 0.0033 
Pancreatic cancer  9/66 3.5770 0.0003 0.0049 
Progesterone-mediated oocyte maturation  11/98 3.4813 0.0003 0.0057 
Thyroid hormone signaling pathway  12/118 3.3460 0.0005 0.0071 
Acute myeloid leukemia  8/57 3.3248 0.0005 0.0071 
Rap1 signaling pathway  17/211 3.2686 0.0005 0.0076 
Protein digestion and absorption  10/90 3.1798 0.0007 0.0088 
AMPK signaling pathway  12/124 3.1512 0.0007 0.0089 
Insulin resistance  11/109 3.0855 0.0008 0.0092 
Phospholipase D signaling pathway  13/144 3.0799 0.0008 0.0092 
Fc gamma R-mediated phagocytosis  10/93 3.0674 0.0009 0.0092 
TNF signaling pathway  11/110 3.0524 0.0009 0.0092 
Hepatitis B  13/146 3.0240 0.0009 0.0092 
N-Glycan biosynthesis  7/49 3.0201 0.0010 0.0092 
Renal cell carcinoma  8/66 2.8944 0.0013 0.0118 
Central carbon metabolism in cancer  8/67 2.8514 0.0014 0.0125 
Dorso-ventral axis formation  5/27 2.8041 0.0016 0.0135 
MAPK signaling pathway  18/255 2.7630 0.0017 0.0143 
HTLV-I infection  18/258 2.7072 0.0020 0.0157 
Thyroid cancer  5/29 2.6597 0.0022 0.0169 
Arrhythmogenic right ventricular cardiomyopathy  8/74 2.5733 0.0027 0.0200 
Ras signaling pathway  16/227 2.5114 0.0031 0.0224 
Osteoclast differentiation  11/132 2.4192 0.0038 0.0269 
Jak-STAT signaling pathway  12/158 2.2649 0.0054 0.0373 
Endometrial cancer   6/52 2.1877 0.0065 0.0433 
Cell cycle  10/124 2.1481 0.0071 0.0450 
Viral carcinogenesis  14/205 2.1471 0.0071 0.0450 
Pathways associated with genes linked to protein intake by GAMS 
Non-alcoholic fatty liver disease (NAFLD)  45/151 5.8505 0.0000 0.0004 
Oxidative phosphorylation  35/133 3.5035 0.0003 0.0320 
Focal adhesion  48/202 3.4093 0.0004 0.0320 
Huntington's disease  46/193 3.3239 0.0005 0.0320 
Parkinson's disease  36/142 3.2516 0.0006 0.0320 
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Table 4.5. Biological pathways analysis based on Gene Ontology Biological Process 2017 database in 
Enrichr. The genes of interest in the liver were determined using either GAMS or Pearson’s 
correlation coefficient to evaluate the relationship between each macronutrient and gene expression, 
and a FDR of 0.05. There were no processes detected using GAMS or for fat. 
 
Biological processes using Enrichr and GO Biological processes 2017 database 
 overlap -log(p) p adj p 
Biological processes associated with genes posi t ive ly  correlated with protein intake using 
Pearson's coefficient 
mitochondrial electron transport, NADH to 
ubiquinone  
22/46 20.5891 0.0000 0.0000 
mitochondrial respiratory chain complex I assembly  22/62 17.1563 0.0000 0.0000 
mitochondrial electron transport, ubiquinol to 
cytochrome c 
7/14 10.2933 0.0000 0.0000 
branched-chain amino acid catabolic process 9/16 10.1865 0.0000 0.0000 
cristae formation 9/27 7.0838 0.0000 0.0000 
mitochondrial electron transport, cytochrome c to 
oxygen 
7/20 5.7876 0.0000 0.0002 
mitochondrial ATP synthesis coupled proton 
transport 
7/21 5.6234 0.0000 0.0002 
tryptophan catabolic process 5/9 5.4572 0.0000 0.0003 
urea cycle 5/10 5.1676 0.0000 0.0005 
mitochondrial ATP synthesis coupled electron 
transport 
4/6 4.8540 0.0000 0.0010 
lysine catabolic process 5/12 4.6931 0.0000 0.0013 
cellular nitrogen compound metabolic process 6/23 4.2116 0.0001 0.0037 
mitochondrial translational termination 11/87 4.0461 0.0001 0.0046 
mitochondrial translational elongation 11/87 4.0461 0.0001 0.0046 
ATP biosynthetic process 6/25 3.9908 0.0001 0.0049 
oxidative phosphorylation 4/10 3.7518 0.0002 0.0079 
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L-phenylalanine catabolic process 4/11 3.5665 0.0003 0.0114 
cellular amino acid biosynthetic process 5/25 3.0143 0.0010 0.0346 
aerobic respiration 5/25 3.0143 0.0010 0.0346 
mitochondrial respiratory chain complex III 
assembly 
3/8 2.8084 0.0016 0.0484 
Biological processes associated with genes negat ive ly  correlated with protein intake using 
Pearson's coefficient 
extracellular matrix organisation 18/142 6.0919 0.0000 0.0011 
platelet activation 12/94 4.2924 0.0001 0.0244 
positive regulation of transcription of nuclear large 
rRNA transcript from RNA polymerase I promoter 
4/8 4.1619 0.0001 0.0244 
positive regulation of protein phosphorylation 13/113 4.1215 0.0001 0.0244 
phosphate-containing compound metabolic process 5/16 3.9428 0.0001 0.0244 
cell maturation 4/9 3.9179 0.0001 0.0244 
cellular protein metabolic process 17/186 3.9158 0.0001 0.0244 
endodermal cell differentiation 6/26 3.8254 0.0001 0.0263 
positive regulation of gene expression 18/214 3.6549 0.0002 0.0346 
regulation of small GTPase mediated signal 
transduction 
13/129 3.5387 0.0003 0.0407 
receptor-mediated virion attachment to host cell 3/5 3.4916 0.0003 0.0412 
cellular response to hypoxia 8/55 3.4328 0.0004 0.0432 
Ras protein signal transduction 8/56 3.3782 0.0004 0.0453 
cell migration 13/136 3.3153 0.0005 0.0486 
Biological processes associated with genes correlated with carbohydrate intake using 
Pearson's coefficient 
synaptic vesicle priming 6/17 2.6202 0.0024 0.0102 
bile acid metabolic process 6/17 2.6202 0.0024 0.0102 
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The effect of macronutrients on longevity regulating pathways in the liver  
The KEGG ‘longevity regulating pathways, multiple species’ gene set (ko0413, 
http://www.genome.jp/dbget-bin/www_bget?pathway+ko04213) includes 59 genes of which 50 
were present in this microarray data set, some with two variants. Using GAMS analysis there were 
only seven genes in common with these longevity regulating genes (Atg5, Mtor, Pik3r2, Igf1r, Prkab2, 
Hsap1b, Adcy3) and three using correlation analysis (Atg4, Mtor, Pik3r2). The correlation coefficients 
between each of these genes and macronutrients were plotted on a heatmap [Figure 4.7] to determine 
the overall pattern of the relationship between macronutrient intake and expression of genes 
associated with the regulation of aging. There were many more genes whose expression were 
negatively correlated with protein intake than positively correlated with protein intake. Genes 
associated with carbohydrate intake had the opposite pattern. Consequently, there was a clear inverse 
pattern between genes associated with protein intake versus those associated with carbohydrate intake 
(and a similar, but less marked pattern when comparing protein intake and fat intake).  
 
The Geometric Framework was used to evaluate five nutrient sensing genes that are considered to 
link nutrition with aging: Mtor, Igf1, Sirt1, Prkab2 (a subunit of AMPK) and Ffg21 [See Figure 4.8, 
Table 4.6]. Surprisingly the expression of Mtor, which is one of the key signaling pathways stimulated 
by protein, was upregulated with lower protein intake. The effects of macronutrients on mTOR 
protein phosphorylation in these mice has been previously published (Solon-Biet et al. 2014), and 
comparison of these data with Mtor gene expression showed that there was no correlation (r=-0.052, 
p=0.7). Low protein intake was associated with reduced expression of Igf1 and increased expression of 
Prkab2 and Fgf21. The expression of Sirt1 was not significantly influenced by diet by dietary 
macronutrients. The genes influenced by protein intake were compared to those reported to be 
influenced by caloric restriction. A meta-analysis identified 174 genes where expression is influenced 
by caloric restriction (Plank et al. 2012) of which only 30 were in common with those genes 
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influenced by protein intake determined by GAMS, and only 11 in common with those genes 
influenced by protein intake determined by correlation [Table 4.7]. 
 
Figure 4.7. Heatmap showing the relationship between longevity regulating genes in the liver 
according to KEGG, and the correlation coefficients that link each of these genes with protein, 
carbohydrates, fat and total energy intake. Positive correlation coefficients are shown in red and 
negative coefficients in blue. 
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Figure 4.8. Three dimensional response surfaces created using the GF. The relationships between the 
macronutrients and four nutrient sensing hepatic genes (A Mtor, B Igf1, C Pkrab2, D Fgf21) are 
demonstrated. Each graph shows the effects of two of macronutrients at the median point of the 
third macronutrient (shown in parenthesis below the X axis label). The response surfaces vary from 
red, which is the most negative value to blue which is the most positive value. The GAM statistics are 
shown in Table 4.6. 
 
A 
B 
C 
D 
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Table 4.6. Statistics for the Geometric Framework figures in Figure 4.8. GAMS data for hepatic 
expression of Mtor, Igf1, Prkab2 and Ffg21. 
 edf df F P 
Mtor 
Protein 2.170e+00 8 3.016 1.45e-05 
Fat 2.873e-05 8 0.000 0.507 
Carbohydrates 1.795e-05 8 0.000 0.765 
P x F 2.350e-01 3 0.085 0.286 
P x C 1.122e-05 3 0.000 0.364 
F x C 2.588e-01 3 0.099 0.291 
Igf1 
Protein 8.092e-01 8 0.53 0.0193 
Fat 9.036e-06 8 0.00 0.3452 
Carbohydrates 5.297e-07 8 0.00 0.5722 
P x F 7.436e-01 3 0.47 0.1522 
P x C 2.033e-07 3 0.00 1.0000 
F x C 2.067e-07 3 0.00 0.6170 
Prkab2 
Protein 1.276e+00 8 1.082 0.0031 
Fat 1.790e-05 8 0.000 0.7183 
Carbohydrates 1.067e-05 8 0.000 0.8009 
P x F 1.653e+00 3 2.840 0.0076 
P x C 8.471e-07 3 0.000 0.6440 
F x C 6.838e-06 3 0.000 0.6708 
Fgf21 
Protein 4.313e+00 8 8.913 1.91e-10 
Fat 8.544e-05 8 0.000 0.361 
Carbohydrates 6.244e-06 8 0.000 1.000 
P x F 5.098e-06 3 0.000 0.648 
P x C 1.639e-05 3 0.000 1.000 
F x C 5.026e-06 3 0.000 0.670 
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Table 4.7. Genes in common between those influenced by protein intake from this study and 
compared with those influenced by caloric restriction as published by (Plank et al. 2012) where there 
were 101 genes upregulated by caloric restriction and 73 downregulated. Genes of interest were 
determined using either a correlation analysis or GAMS with a FDR of 0.05 for their association with 
protein intake. 
 
Upregulated in caloric restriction Downregulated in caloric restriction 
Altered expression with protein intake determined by GAMS 
Klf10 C9 
Rgs16 Col15a1 
Cyp2j6 Hsd3b2 
Zbtb16 Slc10a2 
Cyp2b13 Extl1 
BC089597 Cyp2f2 
Sds Hipk2 
Mt2 R3hdm2 
Lpin1 Col3a1 
Per1 Stac3 
Angptl4  
Plin4  
St3gal5  
Fmo3  
Rhobtb1  
Cbr1  
Nat8  
Cpt1a  
Arrdc2  
Por  
Altered expression with protein intake determined by correlation analysis 
Cyp2j6 C9 
Sds Cyp2f2 
Sult1d1 Col15a1 
Fam195a  
Plin4  
Zbtb16  
Klf10  
Rgs16  
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PCR confirmation of hepatic microarray analysis 
In order to validate the results of the transcriptome analysis, quantitative RT-PCR was performed on 
a set of 84 genes associated with nutrient sensing pathways. Gene expression values from the 
microarray and PCR were correlated using a Q-Q plot to determine distribution of gene expression 
(Warnat et al. 2005). The expression of the majority of genes from the microarray were closely 
correlated with their PCR counterparts [Figure 4.9, Table 4.8].  
 
 
 
Figure 4.9. Correlation between Affymetrix microarray gene expression data and PCR data for 84 
genes listed in Table 4.8. 
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Table 4.8. List of genes on Qiagen Insulin Signalling Pathway RT2 Profiler PCR Array  
Insulin Receptor-Associated Proteins 
Insulin & Receptors: Ins1, Insl3, Irs1, Irs2, Sorbs1. 
Insulin-Like Growth Factors & Receptors: Grb10, Igf1r, Igfbp1. 
SH3 / SH2 Adaptor Proteins: Cbl, Grb10, Grb2. 
Other Insulin Receptor-Associated Proteins: Dok1, Dok2, Dok3, Eif4ebp1, Frs2, Frs3, Gab1, 
Nck1, Ppp1ca, Ptpn1 (PTP1B), Ptprf, Shc1. 
PI3 Kinase Signaling 
Genes: Akt1, Akt2, Akt3, Eif2b1, Mtor, Pdpk1, Pik3ca (p110alpha), Pik3cb, Pik3r1 (p85alpha), 
Pik3r2 (p85beta), Prkcg, Prkci, Prkcz. 
PI3 Kinase Signaling Target Genes: Adra1d, Bcl2l1 (Bcl-XL), Dusp14, G6pc, G6pc2, Hk2, Igfbp1, 
Pck2, Serpine1 (PAI-1), Srebf1, Ucp1, Vegfa. 
MAP Kinase Signaling 
Genes: Araf, Braf, Dok2, Dok3, Gab1, Grb2, Hras, Kras, Map2k1 (Mek1), Mapk1 (Erk2), Raf1, 
Rps6ka1, Rras, Rras2, Shc1, Sos1. 
MAP Kinase Signaling Target Genes: Bcl2l1 (Bcl-XL), Ercc1, Fos, Nos2 (iNOS), Klf10 (Tieg1), 
Ucp1. 
Primary Insulin Signaling Target Genes: Cebpb, Fos, Jun, Lep (Leptin), Prl. 
Secondary Insulin Signaling Effector Target Genes: Npy, Pck2, Tg. 
PPAR Targets 
Acox1, Cfd (Adn), Cap1, Cebpb, Gpd1, Pck2, Pparg, Retn, Slc27a4. 
SREBP1 Targets 
Acaca, Fbp1, G6pc, Gck, Pck2, Pklr. 
Carbohydrate Metabolism 
Glucose Metabolism: Fbp1, G6pc, Gck, Gpd1, Hk2, Ins1, Lep (Leptin), Pck2, Pklr. 
Glycogen Metabolism: G6pc, Ppp1ca. 
Carbohydrate Transport: Ins1, Slc2a1, Sorbs1. 
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Lipid Metabolism 
Cholesterol Metabolism: Ldlr, Lep (Leptin), Srebf1. 
Fatty Acid Metabolism: Acox1, Slc27a4. 
Lipid Transport: Ldlr, Slc27a4, Sorbs1. 
Other Lipid Metabolism Genes: Araf, Prkcg, Prkci, Prkcz, Raf1, Shc1. 
Protein Metabolism 
Protein Phosphatases: Dusp14, Ppp1ca, Ptpn1 (PTP1B), Ptprf. 
Protein Kinases: Akt1, Akt2, Akt3, Araf, Gsk3b, Igf1r, Map2k1 (Mek1), Mapk1 (Erk2), Pdpk1, 
Pik3ca (p110alpha), Pik3r1(p85alpha), Prkcg, Prkci, Prkcz, Raf1,Rps6ka1. 
Protein Biosynthesis: Eif2b1, Eif4ebp1, Ppp1ca. 
Protein Transport: Gsk3b, Hras, Prkci, Rras2. 
Other Protein Metabolism Genes: Bcl2l1 (Bcl-XL), Cebpa, Cebpb, Dok3, Frs2, Gab1, Gck, Grb10, 
Grb2, Jun, Ldlr, Lep(Leptin), Nck1, Nos2 (iNOS), Pik3r2 (p85beta), Serpine1 (PAI-1), Shc1, 
Sorbs1, Sos1, Ucp1. 
Transcription Factors & Regulators: Aebp1, Cebpa, Cebpb, Fos, Jun, Pparg, Srebf1, Klf10 (Tieg1). 
Cell Growth & Differentiation 
Cell Cycle: Gsk3b, Hras, Igf2, Jun, Kras, Mapk1 (Erk2), Vegfa. 
Cell Proliferation: Gsk3b, Igf2, Irs2, Lep (Leptin), Nos2 (iNOS), Shc1, Vegfa. 
Growth Factors & Receptors: Frs2, Igf1r, Igf2, Igfbp1, Lep (Leptin), Shc1, Vegfa. 
Cell Differentiation: Cebpa, Cebpb, Gsk3b, Jun, Map2k1 (Mek1), Pik3r1 (p85alpha), Pparg. 
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The effects of macronutrients on overall hypothalamic gene expression 
Across the 10,908 genes probed by the hypothalamic microarray [Figure 4.10], diet caused changes in 
the expression of 157 genes when analysed using correlation statistics (123 up-regulated, 34 down-
regulated). The majority of these genes were influenced fat intake (52 up-regulated, 3 down-regulated) 
and total energy intake (44 up-regulated, 6 down-regulated) [Figure 4.11A]. 140 genes had over 5-fold 
differences in expression between the highest and lowest groups, while 25 genes had greater than 10-
fold changes in expression.  
 
GF analysis allowed ratios to be examined in addition to individual macronutrients, with a total of 934 
genes having changes in their regulation as a result of varying macronutrient composition [See Figure 
4.11B]. Interestingly, the GF analysis showed similar results to the correlation method, with fat once 
again playing the most significant role in regulating hypothalamic gene expression (n=205 genes), 
although the protein-to-carbohydrate (P:C) ratio, or the non-fat (fat intake vs non-fat intake) ratio was 
also picked up as a key regulator of gene expression (n=469 genes). Volcano plot analysis was used to 
identify genes of interest [Figure 4.10], with the top ten genes by macronutrient intake outlined in 
Table 4.9, both by GF and correlation analysis. 
 
Representative surfaces for each macronutrient (protein, carbohydrates, fat) are shown in Figure 4.12 
with their corresponding GAM statistics shown in Table 4.10. These genes were chosen because they 
are each in the top 10 most significantly altered expression levels based on GF analysis [Table 4.9], as 
well as demonstrate characteristic responses that are easily identified visually. Spindle assembly 
abnormal protein 6 (Sass6) is negatively correlated with protein intake, as seen in Figure 4.12A, where 
lower expression (blue colour) is associated with high protein, while high expression (red colour) is 
associated with low protein in the diet. Ubiquinol-cytochrome c reductase (Uqcr) is positively 
associated with carbohydrate intake [See Figure 4.12B], and B cell leukemia/lymphoma 2 related 
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protein A1b (Bcl2a1b) was positively associated with fat intake [See Figure 4.12C]. Of the genes 
significantly influenced by each macronutrient and ratio, several were involved in cellular growth and 
metabolism. As shown in Figure 4.11, the protein-to-carbohydrate ratio was the key driver of changes 
in gene expression. Key genes of interest here were: carbohydrate intake significantly influenced 
expression of Slc6a3, Igf1 and Sirt2; protein intake significantly influenced Npy, Akt3, Sirt1; and P:C 
ratio significantly influenced Sirt5, Rps6a4/5, Igf2r, Igf1r and Sirt3.  
 
 
 
 
 
Figure 4.10. Unidirectional volcano plot of the 10908 genes in the hypothalamic microarray based on 
fold change versus p-value as derived from the GF. Genes are colour coded based on correlation to 
macronutrient intake (P, C, F) or ratio (PxC, PxF, CxF) as outlined in the legend.  
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Figure 4.11. Venn diagrams showing the effects of macronutrient intake on hypothalamic gene 
expression. In addition to macronutrients, total energy is also shown in Figure 4.11A, with results 
determined using Pearson’s correlation coefficient (black positive correlation, red negative 
correlation).  Figure 4.11B uses GF analysis, with macronutrient ratio results also shown (PxC, PxF, 
CxF interactive terms between protein, carbohydrates and fat). 
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Table 4.9. Gene expression with the highest statistical association with macronutrient intake 
determined using either GF or correlation analysis in the hypothalamus. Benjamini Hochberg 
correction with a FDR of 0.05 has been performed for the p-values. Expression is broken down into 
up- or down-regulation.  
Protein 
GF Correlation 
Gene p-value Gene Expression p-value 
Hgs 9.25E-07 Spg21 Up 2.51E-04 
Sass6 1.02E-06 D630014A15Rik Down 2.95E-04 
Tmem87a 8.56E-06 BC031181 Up 7.23E-04 
LOC100046457 8.90E-06 Arl3 Down 9.52E-04 
Psat1 9.00E-06 Asah3l Down 1.24E-03 
Ivns1abp.2 1.37E-05 Trpm6 Up 1.38E-03 
Atp1b1 1.78E-05 LOC100045680 Down 1.48E-03 
Psma7.1 2.66E-05 LOC381420 Down 2.01E-03 
X4933426M11Rik 3.76E-05 Gtpbp6 Up 2.45E-03 
LOC329416 4.12E-05 Sec22c Down 2.50E-03 
 
Carbohydrates 
GF Correlation 
Gene p-value Gene Expression p-value 
A730094H17Rik 1.31E-11 4930538K18Rik Down 2.79E-05 
LOC386330 8.12E-11 Pik3ip1 Down 1.41E-04 
X2810403A07Rik 1.81E-10 Txnrd3 Down 1.96E-04 
Ptprs 2.43E-10 Odf2 Down 2.03E-04 
X9530053J19Rik 7.60E-10 Aloxe3 Down 2.26E-04 
X4933439J20Rik 9.58E-10 6330444G18Rik Up 2.65E-04 
Kcnq2.1 1.30E-09 Setd1a Down 2.70E-04 
Adrbk2 1.84E-09 Man1b1 Down 2.94E-04 
Uqcr 1.90E-09 Eng Up 2.95E-04 
X9430091F09Rik 3.07E-09 Zfp704 Down 3.13E-04 
 
Fat 
GAMS Correlation 
Gene p-value Gene Expression p-value 
X4933421H10Rik 2.77E-09 Tmed9 Up 3.73E-05 
E030007H10Rik 1.36E-08 Zfr Up 5.16E-05 
Csnk1g2 3.15E-08 BC005537 Up 1.16E-04 
Loxl1 2.23E-07 LOC100039786 Up 1.59E-04 
Pgcp 2.95E-07 Pbrm1 Up 1.71E-04 
Vamp8 3.44E-07 Sui1-rs1 Up 1.74E-04 
Bcl2a1b 4.30E-07 2400001E08Rik Up 1.77E-04 
Supt16h.1 6.00E-07 Tmem176b Up 1.92E-04 
Unk 1.14E-06 LOC268700 Up 2.18E-04 
Hspg2 1.26E-06 Tmed2 Up 2.60E-04 
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Figure 4.12. Representative three dimensional response surfaces created using the GF. The 
relationships between the macronutrients and the hypothalamic genes are demonstrated using the 
colour maps, with red being the most positive response, and blue being the most negative response. 
Slices are taken through the median of each of the axes (shown in parenthesis below the x-axis label). 
Figure 4.12A is a representative surface for correlation with protein intake on the Sass6 gene. Figure 
4.12B is a representative surface for correlation with carbohydrate intake on the Uqcr gene, and Figure 
4.12C is a representative surface for correlation with fat intake on the Bcl2a1b gene. GAM statistics are 
provided in Table 4.10. 
 
 
 
 
  
A 
B 
C 
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Table 4.10. Statistics for the Geometric Framework figures in Figure 4.12. GAMS data for 
hypothalamic expression of Sass6, Uqcr, and Bcl2a1b. 
 
 edf df F p-value 
Sass6 
Protein 9.73E-01 8 12.497 1.02E-06 
Carbohydrates 7.46E-01 8 2.781 2.89E-02 
Fat 4.69E-01 8 0.641 1.17E-01 
P x C 1.42E+00 3 0.000 1.22E-02 
P x F 7.74E-01 3 0.000 1.18E-01 
C x F 1.22E+00 3 0.000 2.66E-02 
Uqcr 
Protein 9.02E-01 8 0.646 3.18E-03 
Carbohydrates 1.93E+00 8 4.567 1.90E-09 
Fat 1.40E-05 8 1.150 6.62E-01 
P x C 1.78E+00 3 0.000 2.09E-07 
P x F 1.78E+00 3 0.000 1.09E-06 
C x F 1.28E+00 3 0.000 2.43E-03 
Bcl2a1b 
Protein 3.32E-05 8 0.000 9.38E-01 
Carbohydrates 5.89E-01 8 4.089 9.69E-02 
Fat 9.75E-01 8 15.509 4.30E-07 
P x C 5.75E-01 3 0.000 2.15E-01 
P x F 1.63E-05 3 0.000 7.77E-01 
C x F 1.60E+00 3 0.000 1.05E-02 
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Similar to the results from hepatic gene expression in the same cohort of animals, heatmap analysis 
[See Figure 4.13] showed a strong inverse relationship between gene expressions correlating to protein 
intake compared with fat intake.  
 
 
 
 
 
 
 
Figure 4.13. Heatmaps comparing the effects of protein, carbohydrates and fat on overall gene 
expression patterns in the hypothalamus. Here, the values are Pearson’s correlation coefficients 
ranked from most positive correlation in red to the most negative correlation in blue. The most 
positive 1000 genes and the most negative 1000 genes are included. The genes have been ranked 
according to significance of the correlation with protein (Figure 4A), carbohydrates (Figure 4B) and 
fat (Figure 4C). 
 
 
 
 
  
  144 
The effects of macronutrients on hypothalamic genes related to biological processes 
Enrichr gene pathway analysis performed using the KEGG and GO biological process databases is 
outlined in Tables 4.11 and 4.12. Gene pathway analysis here is based on significant correlation alone, 
and does not differentiate between positive and negative correlations. Protein was found to be 
involved with several pathways associated with metabolism and biosynthesis of macronutrients, as 
well as inflammation, in particular the regulation of NF-kB. Carbohydrate intake was associated with 
pathways involved in mineralocorticoid and fluid homeostasis, as well as activity of ion transport 
channels. Fat on the other hand, which affected the most number of genes, was associated primarily 
with protein transport and formation pathways, including multiple processes related to the 
endoplasmic reticulum, and Golgi apparatus. The protein-to-carbohydrate ratio had multiple 
correlations to disease pathways, particularly neurodegenerative diseases, as well as protein translation, 
transportation and localisation through SRP-mediated protein targeting [See Table 4.13]. 
 
The effect of macronutrients on longevity regulating pathways in the hypothalamus 
43 of the 59 genes that are described in the KEGG ‘longevity regulating pathways, multiple species’ 
gene set (ko0413, http://www.genome.jp/dbget-bin/www_bget?pathway+ko04213) were present in 
this microarray data set, some with two variants. GF analysis revealed that 28 of these genes had their 
expression significantly influenced by macronutrient intake [Table 4.14]. Of these, 13 were correlated 
with P:C ratio, and 12 to carbohydrate intake, with protein and fat influencing 6 genes each. 
Correlation coefficients of these genes have been plotted on a heatmap to each of the macronutrients, 
as well as total energy [See Figure 4.14]. Once again, protein and fat seemed to have inverse effects on 
gene regulation.  
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Table 4.11. Gene pathway analysis based on the KEGG database in Enrichr. The hypothalamic 
genes of interest were determined using either Pearson’s correlation coefficient or GAMS to 
evaluate the relationship between each macronutrient and gene expression, and a FDR of 0.05.  
 
Protein 
Pathway p-value 
Carbon metabolism 8.83E-03 
Aldosterone-regulated sodium reabsorption 9.40E-03 
Carbohydrate digestion and absorption 1.24E-02 
Biosynthesis of amino acids 3.15E-02 
Proximal tubule bicarbonate reclamation 8.28E-02 
Biosynthesis of unsaturated fatty acids 8.28E-02 
Circadian rhythm 1.07E-01 
Herpes simplex infection 1.53E-01 
cAMP signaling pathway 1.71E-01 
Viral carcinogenesis 1.79E-01 
  
Carbohydrates 
Pathway p-value 
Chemokine signaling pathway 7.54E-03 
Proximal tubule bicarbonate reclamation 4.83E-02 
Aldosterone-regulated sodium reabsorption 8.06E-02 
Vasopressin-regulated water reabsorption 9.04E-02 
Carbohydrate digestion and absorption 9.24E-02 
Endocrine and other factor-regulated calcium reabsorption 9.63E-02 
N-Glycan biosynthesis 1.00E-01 
Mineral absorption 1.04E-01 
Endocytosis 1.07E-01 
Arachidonic acid metabolism 1.25E-01 
  
Fat 
Pathway p-value 
Protein export 2.30E-02 
Systemic lupus erythematosus 5.04E-02 
Ubiquitin mediated proteolysis 5.27E-02 
Viral carcinogenesis 6.03E-02 
Glycine, serine and threonine metabolism 6.33E-02 
Endocrine and other factor-regulated calcium reabsorption 8.37E-02 
Hedgehog signaling pathway 9.30E-02 
Alzheimer's disease 9.47E-02 
Protein processing in endoplasmic reticulum 9.62E-02 
Alcoholism 1.12E-01 
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Table 4.12. Gene pathway analysis based on the GO Biological process database in Enrichr. The 
hypothalamic genes of interest were determined using either Pearson’s correlation coefficient or 
GAMS to evaluate the relationship between each macronutrient and gene expression, and a FDR of 
0.05.  
Protein 
GO Biological Process p-value 
Central nervous system myelination 4.92E-03 
Negative regulation of co-receptor activity involved in epidermal growth factor 
receptor signaling pathway 6.01E-03 
Extra-ocular skeletal muscle development 7.20E-03 
Cardiac muscle cell contraction 8.05E-03 
Negative regulation of NF-kappaB import into nucleus 1.19E-02 
Positive regulation of receptor internalisation 1.24E-02 
Negative regulation of epidermal growth factor-activated receptor activity 1.46E-02 
Cytoplasmic sequestering of NF-kappaB 1.69E-02 
Regulation of neuron migration 1.81E-02 
Positive regulation of cytokine production involved in inflammatory response 2.41E-02 
Carbohydrates 
GO Biological Process p-value 
positive regulation of voltage-gated potassium channel activity 1.25E-04 
positive regulation of calcium:sodium antiporter activity 1.25E-04 
positive regulation of large conductance calcium-activated potassium channel activity 2.01E-04 
atrial cardiac muscle cell to AV node cell communication by electrical coupling 4.04E-04 
membrane repolarisation during SA node cell action potential 4.66E-04 
SA node cell to atrial cardiac muscle cell communication by electrical coupling 4.66E-04 
membrane repolarisation during atrial cardiac muscle cell action potential 7.54E-04 
regulation of cardiac muscle contraction by regulation of the release of sequestered 
calcium ion 9.24E-04 
positive regulation of potassium ion transmembrane transporter activity 1.11E-03 
membrane repolarisation during ventricular cardiac muscle cell action potential 1.11E-03 
Fat 
GO Biological Process p-value 
Endoplasmic reticulum tubular network formation 3.59E-03 
Endoplasmic reticulum tubular network maintenance 2.12E-03 
Positive regulation of PERK-mediated unfolded protein response 3.59E-03 
Endoplasmic reticulum tubular network membrane organisation 4.46E-03 
PERK-mediated unfolded protein response 6.45E-03 
Negative regulation of protein localisation to plasma membrane 6.45E-03 
Negative regulation of Golgi to plasma membrane protein transport 7.57E-03 
Positive regulation of actin filament bundle assembly 8.77E-03 
Negative regulation of cytoplasmic translational initiation 1.29E-02 
Protein autoubiquitination 1.57E-02 
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Table 4.13. Gene pathway analysis based on the KEGG and GO biological process databases in 
Enrichr for the protein-to-carbohydrate ratio. The hypothalamic genes of interest were determined 
using either Pearson’s correlation coefficient or GAMS to evaluate the relationship between each 
macronutrient and gene expression, and a FDR of 0.05.  
 
Protein-to-Carbohydrate ratio (P x C) 
KEGG Pathway p-value 
SRP-dependent co-translational protein targeting to membrane, translocation 1.02E-05 
Cytoplasmic translation 8.71E-05 
SRP-dependent cotranslational protein targeting to membrane, docking 4.02E-05 
Maintenance of translational fidelity 2.52E-04 
Plastid translation 2.52E-04 
N-terminal peptidyl-proline demethylation involved in translation 2.68E-04 
SRP-dependent cotranslational protein targeting to membrane, signal sequence 
recognition 1.42E-04 
Nuclear-transcribed mRNA catabolic process, nonsense-mediated decay 1.76E-04 
Translational termination 3.82E-04 
Translational elongation 4.52E-04 
 
GO Biological Process p-value 
SRP-dependent cotranslational protein targeting to membrane, translocation 1.02E-05 
Cytoplasmic translation 8.71E-05 
SRP-dependent cotranslational protein targeting to membrane, docking 4.02E-05 
Maintenance of translational fidelity 2.52E-04 
Plastid translation 2.52E-04 
N-terminal peptidyl-proline dimethylation involved in translation 2.68E-04 
SRP-dependent cotranslational protein targeting to membrane, signal sequence 
recognition 1.42E-04 
Nuclear-transcribed mRNA catabolic process, nonsense-mediated decay 1.76E-04 
Translational termination 3.82E-04 
Translational elongation 4.52E-04 
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Figure 4.14. Heatmap showing the relationship between longevity regulating genes in the 
hypothalamus according to KEGG, and the correlation coefficients that link each of these genes with 
protein, carbohydrates, fat and total energy intake. Positive correlation coefficients are shown in red 
and negative coefficients in blue. Full results are provided in Table 4.14. 
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Table 4.14. Pearson correlations and GF analysis for hypothalamic genes identified in KEGG 
‘longevity regulating pathways, multiple species’ gene set (ko0413, http://www.genome.jp/dbget-
bin/www_bget?pathway+ko04213).  Pearson correlations are denoted as cor(X), where X refers to 
either protein (P), carbohydrate (C), fat (F), or energy (E). GF p-values are denoted as pval(X), with X 
referring to the same nomenclature as above. Non-significant values are left blank. 
 
Gene cor(P) cor(C) cor(F) cor(E) pval(P) pval(C) pval(F) pval(PxC) pval(PxF) pval(CxF) 
Hspe1 -0.257 0.191 0.481 0.452   1.02E-04   1.02E-02 
Rps6kb1 -0.519 0.309 0.404 0.301 3.43E-02   9.57E-04 2.34E-03 1.10E-03 
Sirt1 -0.461 -0.019 0.328 -0.078 2.42E-02   2.80E-02   
Raptor -0.292 0.131 0.322 0.212   3.46E-02 3.30E-02   
Sod2 -0.231 0.314 0.313 0.449    6.23E-04   
Atg5 -0.461 0.174 0.308 0.111 4.09E-02   6.56E-03   
Adcy2 -0.104 -0.072 0.297 0.117    5.05E-03   
Akt3 -0.407 0.058 0.270 -0.007       
Pik3ca -0.192 0.295 0.248 0.398       
Adcy9 -0.214 0.243 0.232 0.310       
Adcy4 0.124 0.321 0.162 0.594  1.44E-03     
Igf1r -0.373 0.252 0.137 0.106 1.34E-02      
Foxo1 -0.289 -0.018 0.125 -0.130 5.35E-03  9.09E-03    
Pnck 0.065 -0.216 0.114 -0.077       
Adcy1 -0.094 0.177 0.109 0.219       
Nras 0.267 -0.055 0.099 0.242    5.99E-03   
Prkab1 0.222 -0.146 0.067 0.080   1.82E-02    
Hspa1a -0.050 0.232 0.066 0.273      4.36E-02 
Adcy8 0.037 0.338 0.048 0.438  2.04E-03     
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Prkaa1 -0.003 -0.087 0.034 -0.065       
Adcy6 0.064 -0.225 -0.002 -0.194   1.37E-02    
Adcy7 -0.126 0.307 -0.010 0.223   4.62E-02 2.86E-03   
Kat2b 0.127 -0.074 -0.032 -0.010       
Akt1s1 0.148 -0.111 -0.044 -0.044    4.02E-02  9.90E-03 
Pik3r1 -0.157 0.271 -0.095 0.081  5.07E-03  1.06E-02   
Sirt2 0.196 0.191 -0.098 0.270  4.25E-02     
Kras 0.135 -0.222 -0.111 -0.236       
Eif4ebp2 0.021 0.091 -0.119 0.003       
Irs2 -0.159 0.057 -0.127 -0.181  7.34E-03     
Irs2 -0.159 0.057 -0.127 -0.181  7.34E-03     
Gpr1 0.229 -0.353 -0.163 -0.352       
Igf1 -0.069 0.407 -0.175 0.223  2.87E-02     
Cryab 0.076 0.507 -0.191 0.430  3.67E-06  3.16E-02   
Prkag1 -0.028 0.450 -0.199 0.278  9.55E-03     
Hdac11 0.256 -0.087 -0.220 -0.097       
Adcy3 -0.081 0.075 -0.226 -0.193       
Itpka 0.210 0.062 -0.248 0.001       
Clpb 0.123 -0.050 -0.248 -0.189       
Insig2 0.323 0.128 -0.250 0.160  4.07E-03     
E4f1 0.284 -0.110 -0.312 -0.185       
Frap1 0.432 0.058 -0.357 0.071  5.59E-03   4.58E-02  
Sod1 0.101 0.033 -0.388 -0.246    8.66E-03   
Hras1 0.228 0.232 -0.449 0.012 1.90E-02 1.15E-03  2.54E-02 4.48E-03 7.85E-04 
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mTOR activation in the liver 
Given that the majority of the genes in the liver that were significantly altered by diet were primarily 
influenced by protein intake, mTOR was further analysed, as its activation is known to be regulated by 
circulating amino acids, through its role as a dietary protein sensor. As mTOR gene expression was 
assayed through both microarray and PCR, a western blot was performed to look at the ratio of 
phosphorylated mTOR to total mTOR, to study the dynamics of mTOR activation.  Here, it was 
shown that protein intake had a significant effect (p=0.0281) on mTOR activation, with mTOR 
positively correlated to protein intake [See Figure 4.15].  
 
While protein is shown to be the key driver of mTOR, high protein diets were the ones with the 
highest P:C ratio. Similarly with the lifespan data shown in Figure 4.16, the statistically significant 
driver is carbohydrate intake (p=0.0132), however the diets highest in carbohydrate are those low in 
P:C ratio [Table 4.15]. Therefore, while there isn’t direct alignment of mTOR activation and lifespan 
along a single macronutrient axis, the ratio of protein to carbohydrates plays an important role in both 
these responses in opposite directions. The diet group with the highest lifespan was aligned with a 
local minimum in the mTOR activation response surface. The highest median lifespan was actually 
seen in a relatively high P:C ratio group, however when looking at the trend across groups, increasing 
P:C ratio was negatively correlated with both median and maximum lifespan. Given that mTOR is 
generally considered as a pro-ageing growth pathway, these findings are in line with the literature. 
 
Interestingly, mTOR activation was not significantly correlated with mTOR gene expression (r=-
0.052, p=0.74 [Figure 4.17]. This raises the perennial question as to whether gene expression should 
be interpreted as a separate entity to protein activation. It should be noted that both mTOR activation 
and gene expression, are significantly correlated to protein intake, but in different directions, as shown 
in the GF plots in the next section.  
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p-value P C F P:C P:F C:F 
mTOR 2.8E-02 0.48 0.53 0.08 0.70 0.54 
 
Figure 4.15. GF response surfaces correlating hepatic mTOR activation to macronutrient intake.  
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p-value P C F P:C P:F C:F 
Median Lifespan 0.50 1.3E-02 1 0.99 0.97 0.62 
Figure 4.16. GF response surfaces correlating median lifespan to macronutrient intake. Data 
presented in Table 4.15. 
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Table 4.15. Median and maximum lifespan in weeks. Maximum lifespan was determined as the 
average of the longest lived 10% (n=2-3) of each cohort. Table from (Solon-Biet et al. 2014). 
 
Energy 
Density  
Protein 
(%) 
Carb 
(%) 
Fat 
(%) 
Protein: Carb 
ratio 
Median 
lifespan 
Maximum 
lifespan 
Medium  5 75 20 0.07 121.86 157.43 
High  5 20 75 0.25 106.43 154.21 
High  5 75 20 0.07 119.43 151.79 
Medium  14 57 29 0.25 123 151.57 
High  42 29 29 1.45 138.86 151.14 
Medium  42 29 29 1.45 122.57 148 
Medium  14 29 57 0.48 113.86 147.36 
High  5 48 48 0.1 124.43 146.21 
Medium  33 48 20 0.69 122.57 145.71 
Medium  23 38 38 0.61 123.86 143.07 
High  33 48 20 0.69 98.29 141 
High  14 57 29 0.25 117.43 140.07 
High  33 20 48 1.65 107.14 136.86 
Low  33 48 20 0.69 126.57 134.14 
Medium  33 20 48 1.65 106.57 133.79 
High  14 29 57 0.48 108 133.71 
Medium  60 20 20 3 108 129.5 
High  60 20 20 3 99.57 127.57 
High  23 38 38 0.61 100 124.57 
Low  14 57 29 0.25 98.57 119.43 
Low  33 20 48 1.65 78.57 116.36 
Low  14 29 57 0.48 88.71 115.07 
Low  42 29 29 1.45 85.85 104 
Low  60 20 20 3 84.29 102.86 
Low  23 38 38 0.61 89.29 100.36 
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The relationships between nutrient sensing pathways and phenotype in the liver 
Based on published literature, there are several canonical pathways that link diet and ageing. These 
include the sirtuin pathways, mTOR, AMPK, IIS and FGF21 (Solon-Biet et al. 2015b). This study 
measured parameters related to several of these pathways at 15 months of age. It was not possible to 
correlate these pathways directly with life expectancy in the same animals, however, it was possible to 
perform indirect correlations via diet, i.e. the measures of the pathways measured at 15 months in 
mice on a particular diet was correlated with the lifespan of mice maintained on the same diet. 
Collating all the information collected on growth pathways in these animals, it is apparent that the 
majority of pathways which are significantly responsive to diet are affected by protein intake [See 
Table 4.16]. These results support the hypothesis that macronutrient intake, particularly protein, is 
responsible for modulating nutrient sensing intracellular growth pathways, whose downstream effects 
could impact ageing and health.  
 
Here, insulin, IGF-1 and FGF21 were measured in plasma from blood samples, and median lifespan 
was correlated from animals in the same dietary groups. The remainder of the assays; PCR, microarray 
and western blots; were performed from liver samples to ensure consistency of the sample tissue. 
These results were also compared to median lifespan in the same cohort of animals, however, since 
the lifespan data is from different animals, the results are only correlated via diet, limiting the 
conclusions that can be drawn. While mTOR and IIS pathways are inversely correlated with SIRT, 
FGF21 and AMPK pathways as expected, interestingly, only energy intake and FGF21 were 
significantly correlated with median lifespan [See Figure 4.17]. However it is important to note that 
this analysis was performed by simple Pearson correlations, and therefore less meaningful given the 
multidimensional nature of this nutritional study compared to the GF plots, shown in Figure 4.18. 
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Figure 4.17. Nutrient sensing  pathway correlations to each other and to median lifespan (liver gene 
expression and blood levels). Blank results indicate non-significant correlations (p>0.05). The 
correlations show that SIRT/FGF21/AMPK expression is opposite to mTOR/IIS, in line with the 
literature given that the latter set are considered pro-ageing, while the former set are considered pro-
longevity (Solon-Biet et al. 2015b).  
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Table 4.16. Nutrient sensing pathway in liver analysis associated with macronutrient intake using 
GAMs. The surfaces are shown in Figure 4.18. 
 
Pathway Assay P C F P:C P:F C:F 
FGF21 Plasma (protein) 1.41E-29 0.24 0.81 0.41 0.60 0.44 
FGF21 PCR (gene) 1.91E-10 0.36 1 1 0.648 0.67 
IGF1 Plasma (protein) 2.76E-04 3.91E-02 0.08 0.08 0.48 1.00 
IGF1 PCR (gene) 1.93E-02 0.35 0.57 1 0.15 0.62 
Insulin Plasma 7.74E-04 6.66E-05 0.06 0.16 0.17 0.28 
Median 
lifespan 
Correlated 
measure 0.50 1.30E-02 1 0.99 0.97 0.62 
mTOR 
Western blot 
(protein) 2.81E-02 0.48 0.53 0.08 0.70 0.54 
mTOR PCR (gene) 1.45E-05 0.51 0.77 0.36 0.29 0.29 
Prkaa1 
PCR (AMPK  
α-subunit 1) 0.82 0.50 1.00 0.73 0.71 0.68 
Prkaa2 
PCR (AMPK  
α-subunit 2) 0.55 0.61 0.54 1.05E-03 0.32 0.08 
SIRT1 PCR 0.66 0.68 0.69 0.77 0.79 0.71 
SIRT2 PCR 7.74E-03 0.59 0.66 0.34 0.40 0.40 
SIRT3 PCR 0.20 0.21 1.00 0.06 0.72 0.91 
SIRT4 PCR 0.53 0.98 0.46 0.91 0.97 0.22 
SIRT5 PCR 0.78 0.09 0.39 0.41 0.22 0.35 
SIRT6 PCR 0.10 0.97 0.68 1.28E-02 0.56 0.69 
SIRT7 PCR 2.19E-03 0.47 0.73 0.80 0.53 0.81 
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Figure 4.18. 2D GF plots for hepatic nutrient sensing pathway assays, including circulating and tissue 
protein levels, and gene expression in the liver (statistical analysis provided in Table 4.16).  
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Discussion 
Nutrient sensing pathways have been widely studied in ageing research studies, with a variety of 
results, largely depending on experimental paradigm (DR versus CR versus macronutrient restriction 
versus pharmacological intervention), species studied, tissue type used, and sex of the animal (Garratt 
et al. 2016). Research over the past few decades has shown that protein in particular is an important 
regulator of these effects on lifespan, however given the aforementioned variation, the debate remains 
ongoing (Nakagawa et al. 2012). 
 
Transcriptional modulation by diet and age have been studied through the use of microarrays in the 
past, however the majority of these have focused on single interventions, for example ad libitum 
versus CR (Wanders et al. 2014). Here, the GF was harnessed to disentangle the effects of diet on 
transcriptional responses by evaluating relationships with specific macronutrient intakes and ratios. 
Genome wide changes were assessed both by unbiased methods, as well as through specific 
interrogation of nutrient sensing pathways, and other intracellular pathways thought to be involved 
with ageing. These results were then validated using quantitative real-time PCR, and correlated various 
other assays performed on the same cohort of mice. Together, these form a set of pathways, which 
can be correlated to lifespan in the same cohort of animals, to provide insights into the mechanisms 
underlying ageing. 
 
Impacts of diet on the hepatic gene regulation and mTOR activation 
In a review of 172 publications on the effects of nutrients on the hepatic transcriptome, (Osada 2013) 
reported that (1) protein intake influenced genes involved with lipogenesis, fatty acid uptake, oxidative 
stress and DNA methylation; (2) carbohydrate intake influenced genes involved with oxidative stress, 
cell proliferation, ammonium and as well as Pparga and Fxr; and (3) fat intake influenced 
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inflammation, beta-oxidation and several genes including A2m, Slc13a5, Nrep, Cyp3a and Scd1. The 
studies in the review were mostly short-term over days and weeks and used heterogeneous dietary 
interventions. By contrast, the long-term study examining the effects of 25 different diets varying in 
macronutrients over 15 months showed that protein intake was the most powerful driver of gene 
expression, while the intake of carbohydrates and fat had very limited effects which were in the 
opposite direction to changes seen with protein intake. It appears that either aging and/or very long-
term dietary exposure, only protein intake remains a potent regulator of hepatic gene expression, 
which presumably reflects a greater biological imperative to regulate long-term protein metabolism. 
 
There have been a few other studies that have examined the effects of differing amounts of 
macronutrients on hepatic gene expression over longer-term periods, and these reported similar 
effects to those observed with dietary protein. Diaz-Rua and colleagues (Díaz-Rúa et al. 2017) fed rats 
two diets differing in protein content (protein:carbohydrate:fat 20:70:10 vs 45:45:10) and determined 
effects on hepatic transcriptome after four months. They identified 30 genes that were the most 
relevant genes affected by a high protein diet in the liver, of which 14 were also identified in this study 
(Slc7a2, Slc43a1, Agxt, Got1, Gpt, Hpd, Sds, Asl, Cps1, Nnmt, Slc4a2, Kcnma1, Pgam2, Dgat1). By 
comparison, Schwarz et al (Schwarz et al. 2012) fed mice one of three diets (protein:carbohydrate:fat 
15:75:10, 15:50:35 or 50:15:35) for 12 weeks and then measured hepatic gene expression. They 
identified 154 genes where expression was increased by dietary protein, and these were involved with 
amino acid and nitrogen metabolism or energy and oxidative metabolism and included 12 of these 
same genes listed above.  
 
Gene pathway analysis of these genes (using Enrichr and the KEGG database) shows that they are 
involved with the biosynthesis of amino acids and the metabolism of alanine, aspartate and glutamate, 
while a biological process analysis (using Enrichr and the GO Biological Process 2017) shows that 
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they are involved with the urea cycle and amino acid biosynthetic processes. These pathways and 
biological processes have obvious implications for the metabolism of dietary protein. It should be 
noted that the quality (i.e. source) of dietary protein has also been reported to influence hepatic 
transcriptome (Endo et al. 2002; Song et al. 2016). It was also shown that LPHC diets are associated 
with longer lifespan in ad libitum-fed mice, a finding which is supported by numerous insect studies 
(Solon-Biet et al. 2014, Le Couteur et al. 2016). Most previous studies on nutrition and aging have 
shown that caloric restriction reduces aging and increases lifespan (Mercken et al. 2012; Ingram & de 
Cabo 2017), and there have been many studies investigating the effects of caloric restriction on gene 
expression (Swindell 2008; Plank et al. 2012).  
 
Therefore gene expression results from this study were compared with published data on genes whose 
expression is influenced by aging or caloric restriction. When compared to the KEGG longevity 
regulating pathways only seven out of 59 genes were found to be common (Atg5, Mtor, Pik3r2, Igf1r, 
Prkab2, Hsap1b, Adcy3) which suggests that low protein, high carbohydrate diets might influence 
lifespan by alternative pathways. However, it should be noted that these seven genes include pathways 
that are critical to the response of aging to nutrients including autophagy, mTOR, IGF-1 and AMPK. 
Gene expression in this study was also compared with published data on caloric restriction from a 
meta-analysis (Plank et al. 2012)  and only found a few genes in common (6-17% depending upon 
analytic method). Again this lack of overlap suggests that low protein, high carbohydrate diets 
influence aging via different pathways.  
 
Therefore this study interrogated the data for pathways that are generally believed to be crucial for 
mediating the effects of nutrition on aging: mTOR, AMPK, SIRT1, IGF-1 and FGF21 [See Table 
4.16]. Low protein intake was associated with increased Ffg21 and Prkab2 expression and reduced Igf-1 
expression, which reflect the direction of change seen with caloric restriction. However, surprisingly 
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Mtor expression was increased with low protein intake, despite the observation that mTOR 
phosphorylation was decreased with low protein, high carbohydrate diets [See Figure 4.18].  
 
No significant correlation was found between mTOR phosphorylation and Mtor gene expression so 
this disparity probably reflects the differences between transcription, translation and activation [Figure 
4.17]. Overall, it appears that the effects of macronutrients on gene expression in the liver do not 
substantially overlap with effects that have previously been found to be associated with caloric 
restriction or regulation of longevity, however there are some key pathways that are concordant 
including IGF-1, AMPK and FGF21. It should be noted that a high protein ad libitum-fed diet will 
lead to reduced energy intake through protein leverage and vice versa (Simpson and Raubenheimer 
2005), therefore a high protein intake may induce changes in gene expression similar to those seen in 
caloric restriction because of concomitant reduction in calorie intake. 
 
Interestingly, Pearson correlation between these pathways and median lifespan only showed a 
significant result for circulating FGF21 and energy intake. There are two potential explanations for 
this; first, direct correlations are likely inadequate given the complex nature of intake-response 
dynamics in many of these pathways (as highlighted by the use of the GF above), and second, the 
median lifespan values used here were correlations within diet groups, not actual lifespan in the mice 
undergoing the phenotype/genotype assays. These results are well aligned with the literature, with 
protein restriction, particularly BCAA restriction, being implicated partly with the effects of DR on 
ageing (Wanders et al. 2014; Park & Prolla 2005; Solon-Biet et al. 2014; Solon-Biet et al. 2016). 
Further investigation of individual subcomplexes of mTOR (mTORC1, mTORC2) would be the next 
important step in understanding the modulation of mTOR through diet, and its effects on ageing. 
Many individual genes of interest were found due to their statistical association with macronutrients 
and their involvement metabolic responses and aging, and some of these are discussed below. For 
  166 
example, Velazquez-Villegas et al found that high ratios of dietary protein to carbohydrates (P:C:F of 
50:33:17 vs 20:63:17 vs 5:77:18) fed to mice over 8 days increased the hepatic expression of 
glutaminase 2 (Gls2) (Velázquez-Villegas et al. 2016).  
 
 
 
Figure 4.19. Three dimensional response surfaces created using the GF. The relationship between the 
macronutrients and hepatic genes (A Gls2, B Acaca) are demonstrated. Each graph shows the effects 
of two of macronutrients at the median point of the third macronutrient (shown in parenthesis below 
the X axis label). The response surfaces vary from red, which is the most negative value to blue which 
is the most positive value. The GAM statistics are shown in Table 4.17. 
 
 
Likewise Schwarz et al found that high protein diets increased expression of Gls2 in mice after 1 and 
12 weeks (Schwarz et al. 2012). Gls2 is the main glutaminase expressed in the liver and increases 
protein catabolism via the urea cycle. Gls2 has been reported to be upregulated in response to high 
protein diets, inflammation and diabetes (Velázquez-Villegas et al. 2016). In this study, Gls2 was also 
positively correlated with protein intake according to both GAMS and correlation analysis, and was 
amongst the top twenty genes influenced by protein intake [Figure 4.19, Table 4.17]. Analysis by the 
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GF showed that Gls2 expression was mostly influenced by protein intake, with a small effect of fat 
intake, and no effect of carbohydrate intake. Of course it is not unexpected for a gene to be involved 
in protein catabolism to be upregulated in response to high dietary protein intake, and the data shows 
that this response is maintained long-term and into old age.  
 
 
 
Table 4.17. Statistics for the Geometric Framework figures in Figure 4.19. GAMS data for hepatic 
Gls2 and Acaca expression. 
 
  Edf  df  F  P  
Gls2  
Protein  2.88E+00 8 4.756 2.74E-07 
Fat  8.96E-01 8 1.074 0.003 
Carbohydrates  1.85E-01 8 0.028 0.26 
PxF  2.96E-06 3 0 0.71 
PxC  2.39E-06 3 0 0.957 
FxC  6.17E-06 3 0 0.998 
Acaca  
Protein  1.42E+00 8 1.379 0.001 
Fat  4.04E-05 8 0 0.469 
Carbohydrates  2.86E-05 8 0 0.462 
PxF  2.41E-05 3 0 0.345 
PxC  2.52E-01 3 0.098 0.25 
FxC  1.61E+00 3 3.913 0.001 
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Garcia-Caraballo et al. studied the effects of seven diets varying in macronutrients (protein 11-58%, 
carbohydrates 0-81%, fat 8-42%) over 3 weeks on hepatic gene expression (Garcia Caraballo et al. 
2017). They found that high-protein, low-carbohydrate diets reduced Fgf21 and Pparg expression 
whereas using the GF, it was shown that these were only reduced by protein intake and not 
influenced by the other macronutrients. They also found that Acaca (acetyl-CoA carboxylase 1) was 
influenced by the ratio of carbohydrates to fat. On GF analysis it was also found that the interactive 
term between carbohydrates and fat was associated with Acaca expression as well as protein (Figure 
4.19B, Table 4.17). The overlapping results between the two studies indicate that macronutrients 
individually and interactively can influence the expression of genes involved in fatty acid and glucose 
metabolism, as well as the key metabolic hormone, FGF21. Unlike Garcia-Carabello, this study did 
not find any changes in the expression of two other key metabolic regulators, Pck1 or Fasn. 
 
Pathways analysis revealed an association between protein intake and several neurodegenerative 
disorders including Alzheimer’s disease, while biological processes included some involved with 
neuronal projections, dendrite morphogenesis and axon guidance. Protein intake was shown to be 
negatively associated with the expression of App. Polymorphisms in App are associated with 
Alzheimer’s disease, while APP has crucial functions during the development of the brain, and in 
neuronal plasticity, memory and neuroprotection in the aging brain (Müller & Deller 2017). This 
might provide a mechanism linking diet to cognitive impairment, noting that many of the diets 
associated with better cognitive function are low in protein and animal-based protein (van de Rest et 
al. 2015). In this study, macronutrients did not influence the expression of the other important 
dementia gene, Apoe. High protein intake was associated with increased expression in Nnmt (Figure 
4.5A), which might be of interest with another neurodegenerative disease, Parkinson’s disease. 
Pathways analysis showed an association between protein intake and pathways linked to Parkinson’s 
disease. Higher levels of NNMT have been detected in the cerebrospinal fluid of patients of patients 
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with Parkinson’s disease (Aoyama et al. 2001), and low protein, high carbohydrate diets are associated 
with delayed onset of signs in a Drosophila model of Parkinson’s disease (Bajracharya & Ballard 
2016). 
 
There are limitations to this study. Only a subset of 46 mice of the total of 183 euthanised at 15 
months of age were used for gene expression studies, although they did span the full range of diets. 
Only a single tissue and single strain of mouse were analysed, and the data were not robust enough to 
study the effects of sex. There is not any established statistical method to evaluate gene expression 
across a large range of diets, so this study used two methods: correlation analysis with intake of each 
macronutrient, and a GAMS analysis where all the macronutrients and their interactions are assessed 
within a single statistical model. The advantage of correlation analysis is that the direction of change is 
immediately apparent. However the use of GAMS and GF is preferable because it allows interactive 
terms to be assessed. Encouragingly both methods generated similar conclusions in terms of the 
predominant effect of protein on gene expression, and the pathways, processes and genes that were 
identified. This adds additional robustness to the conclusions drawn here.  
 
In summary, protein was the strongest driver of gene expression in the livers of old mice. Protein 
intake was associated with pathways involved with energy and amino acid metabolism. Although there 
was only some overlap with genes known to be associated with regulation of longevity and caloric 
restriction, protein intake was associated with changes in several key nutrient sensing pathways that 
influence aging including AMPK, mTOR, IGF-1 and FGF21.  
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Impacts of diet on the hypothalamic gene regulation  
While multiple studies have looked at the effects of caloric restriction and intermittent fasting on the 
central nervous system, the impact of individual macronutrients, and intake ratios have not been 
thoroughly studied (Moretto et al. 2017). In this study, the GF was used to evaluate the effects of diet 
on hypothalamic gene expression. Similar to the results in the hepatic transcriptome in the same 
cohort of animals, as well as the overall hypothalamic gene expression changes, the longevity 
regulating pathways were affected in opposite directions by fat and protein. This may be due to the 
fact that since fat and P:C ratio had the greatest overall effects on overall gene expression, it may be 
the fat vs non-fat component that regulates gene expression in the hypothalamus, with protein being 
the main driver of the non-fat component, as shown above, and seen in previous studies (Solon-Biet 
et al. 2014; Solon-Biet et al. 2015b). 
 
In both correlation and GF analysis, fat was the macronutrient that was most influential on gene 
expression, consistent with previous studies on the hypothalamic transcriptome (Jang et al. 2017; 
Yamamoto et al. 2009). Expression of Npy, Pomc and Agrp have been demonstrated to respond to 
short-term dietary changes in mice, particularly with changes in composition of dietary fat and caloric 
intake (Jang et al. 2017). While fat and energy were the primary drivers of gene expression changes in 
this study, Npy was most strongly correlated with carbohydrate intake (7x fold change, -0.3248 
Pearson’s correlation coefficient, p=0.0068), while Pomc and Agrp expression was not captured in the 
microarray [Figure 4.20A, Table 4.18].  
 
On the other hand, NF-kB regulation, which has previously been described as being important in the 
control of systemic ageing (G. Zhang et al. 2013), was identified as one of the key pathways linked 
with protein intake through the gene ontology biological process. Given that protein intake was 
correlated with NF-kB import into the nucleus and sequestration of NF-kB, this points to a potential 
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mechanistic link between protein and ageing. Nfkbia gene expression was negatively correlated with 
protein (3.5x fold change, -0.366 Pearson’s correlation coefficient, p= 3.34E-04) [See Figure 4.20B, 
Table 4.18].  
 
 
 
Figure 4.20. Representative three dimensional response surfaces created using the GF. The 
relationships between the macronutrients and the hypothalamic genes are demonstrated using the 
colour maps, with red being the most positive response, and blue being the most negative response. 
Slices are taken through the median of each of the axes (shown in parenthesis below the x-axis label). 
Figure 4.20A is the surface for the Npy gene. Figure 4.20B is the surface for the Nkfbia gene, and 
Figure 4.20C is the surface for the Vip gene. GAM statistics are provided in Table 4.18. 
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Table 4.18. Statistics for the Geometric Framework figures in Figure 3. GAMS data for 
hypothatlamic expression of Npy, Nfkbia, and Vip. 
 edf df F p-value 
Npy 
Protein 8.03E-01 8 2.990 2.79E-02 
Carbohydrates 1.39E+00 8 3.789 1.68E-02 
Fat 9.93E-05 8 0.000 3.14E-01 
P x C 1.40E+00 3 0.000 4.52E-02 
P x F 7.54E-06 3 0.000 8.26E-01 
C x F 7.57E-06 3 0.000 1.00E+00 
Nfkbia 
Protein 9.35E-01 8 5.295 3.34E-04 
Carbohydrates 8.81E-01 8 5.063 4.23E-03 
Fat 5.69E-05 8 0.000 5.65E-01 
P x C 1.01E+00 3 0.000 1.02E-01 
P x F 1.09E+00 3 0.000 1.29E-01 
C x F 2.80E-05 3 0.000 3.64E-01 
Vip 
Protein 6.26E-01 8 0.380 1.98E-01 
Carbohydrates 6.65E-01 8 0.000 8.46E-01 
Fat 4.15E-01 8 1.982 3.62E-02 
P x C 1.44E+00 3 0.000 2.06E-02 
P x F 1.59E-05 3 0.000 4.89E-01 
C x F 4.82E-05 3 0.000 8.16E-01 
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A review by Satoh et al. identified multiple key genes involved with lifespan extension in C57BL/6 
mice, including Ucp2, Irs2, Igf1r, Ikbk, Sirt1, as well as Vip, which while not involved in lifespan 
extension, were shown to be altered in ageing (Satoh et al. 2017). In the present study, Vip was the 
19th most highly affected gene by fold change, and was most significantly influenced by fat (9.89x fold 
change, 0.375 Pearson’s correlation coefficient, p=0.0206) [See Figure 4.20C, Table 4.18]. The 
longevity data from the same cohort of mice showed that LPHC diets were the most effective in 
extending lifespan in mice, and interestingly, these same diets corresponded the most significantly to 
the KEGG longevity regulating pathways, with 13 of the 43 genes being influenced by the P:C ratio in 
the diet, 12 genes being influenced by carbohydrate intake, and 6 genes being influenced by protein 
intake [Figure 4.14, Table 4.14].  
 
Despite the interesting correlations found in this study that supports previous work in the field, it 
should be noted that only 1 animal per diet group was used for this microarray analysis so this is 
considered a pilot study. While this did cover all groups in the study, the use of only male mice limited 
the ability to correlate gene expression results to phenotypic results. In addition, sex is known to 
inherently alter gene regulation, and have variable effects in relation to metabolism, dietary 
macronutrients and longevity pathways (Satoh et al. 2017; Michán et al. 2010). Another limitation to 
the study was the use of analytical tools. As there is no established statistical methodology to correlate 
gene expression results over multiple diets, this study used a combination of correlation analysis and 
GF analysis, as previously described. The fact that both methods revealed similar patterns of change 
with relation to macronutrients provides some support for the validity of the results, however a larger 
trial with great numbers would increase the statistical power of such a study.  
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General remarks 
Overall, this set of work provides analysis of the effects of dietary macronutrients and their 
interactions on nutrient sensing pathways, and on gene expression globally. Nutrient sensing pathways 
in both the liver and the hypothalamus were heavily influenced by diet, albeit in different ways, with 
hepatic gene expression being most strongly modulated by protein intake, and hypothalamic gene 
expression being most strongly modulated by fat and total energy intake. While many studies have 
previously outlined similar findings, this is the first study of its kind to systematically analyse the 
impact of an array of macronutrient intake ratios on gene expression, and anlyse the results through a 
multidimensional geometric framework. In particular, the inverse relationship between macronutrients 
and gene expression (protein vs non-protein in the liver, and fat vs non-fat in the hypothalamus) are 
novel findings, and highlight critical differences between the roles of the same pathways in different 
tissues. Further research samples collected from various organ types could reveal more detailed 
insights as to modulation of tissue specific pathways. Broadly, this study has shown that dietary 
macronutrients play an important role in transcription in both the liver and hypothalamus, with many 
of the genetic pathways being significantly altered by macronutrient intake. Given the interplay 
between protein and carbohydrates, and their documented effects on lifespan, this study provides 
evidence that modulation of these nutrient-sensing pathways are a likely mechanism linking diet and 
ageing.  
 
Mechanistically, it can be argued that the impact of total energy intake on longevity-related gene 
expression in the hypothalamus supports previous work suggesting that caloric restriction itself, 
regardless of macronutrient balance, may be a key driver for longevity. However, while longevity-
related genes in the hypothalamus were largely driven by fat and total energy intake, these results did 
not correlate with an increase in lifespan in the same cohorts of mice. Given that the hypothamlus is 
known to be involved in multiple physiological feedback loops, the role of fat and energy intake on 
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hypothalamic gene expression must be interpreted in the context of the impact of these same diets on 
both other tissue types, as well as on wider outcomes such as health and lifespan. On the other hand, 
protein restriction, which was shown to increase lifespan in the cohort studied here, is mechanistically 
tied to modulation of gene expression in nutrient sensing pathways related with metabolism in the 
liver. Therefore, these results support the hypothesis that caloric restriction and protein restriction, 
while both important influencers of health and lifespan, may have distinct, albeit somewhat 
overlapping mechanisms of action. Tissue-specific activation of nutrient sensing pathways, 
complexities in measuring intake and energy derived from different macronutrient sources, and 
compensatory feeding responses such as protein leverage, may also contribute to the differences in 
pathway activation between the liver and hypothalamus; a topic which is discussed in greater detail in 
Chapter 6. While a comprehensive analysis from gene to protein was performed for mTOR, further 
work should be done in the other nutrient sensing pathways to determine the relationship between 
transcription and protein activation. Furthermore, the data shows differential activation of these 
pathways between the brain and liver, suggesting that there is likely tissue specific variation. Given 
that other tissue types such as brown adipose tissue (BAT), white adipose tissue (WAT), and skeletal 
muscle, also play important roles in metabolism and energy storage, further studies using similar 
experimental methods could be performed in these tissues to better understand their roles in the 
ageing process.  
 
Finally, it was also shown that the GF is a useful analytical paradigm for complex, multifactorial data, 
especially when used in combination with simple correlation methods, such as Pearson product-
moment coefficients. The generation of analytical tools through R scripts is therefore an important 
step in improving data processing, and providing outputs, which can be easily interpreted through 
visualisation. 
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Chapter 5: The Impact of Diet on Age-Related 
End Points 
 
 
To date, nutritional interventions such as caloric restriction (CR) and intermittent fasting have been 
the most robust non-genetic interventions to delay the onset of age-related disease and increase 
lifespan (Longo et al. 2015; Finkel 2015; Kowald & Kirkwood 2016). The benefits of CR and 
intermittent fasting have been demonstrated in a variety of species ranging from yeast to non-human 
primates thus indicating that diet is a critical and conserved intervention for increasing health span 
and lifespan (Heilbronn & Ravussin 2003; Fontana & Partridge 2015).  
 
Recently it was demonstrated in a large dietary study, that a low-protein, high-carbohydrate (LPHC) 
ad libitum-fed diet was also beneficial in extending healthspan and lifespan (Solon-Biet et al. 2014). 
This result has now been demonstrated in a variety of species, however the mechanisms which 
mediate the effects of a LPHC diet on longevity and health remain unclear (Mirzaei et al. 2014; 
Nakagawa et al. 2012; Grandison et al. 2009; Soultoukis & Partridge 2016; Le Couteur et al. 2015).  
 
In Chapter 4, the effects of macronutrients on the nutrient sensing pathways that underpin ageing are 
presented, and it was shown that macronutrients and macronutrient balance have significant impacts 
on gene regulation, and activity of these pathways, particularly in the liver. Given that augmentation 
of these pathways has been shown to link nutrition with ageing, the next step is to study the 
downstream effects on age-related phenotypic end points. These so called ‘Hallmarks of Ageing’ 
(Chapter 1), encapsulate many cellular processes influenced by ageing and most, if not all of these 
processes are influenced in some way by nutrient sensing pathways (López-Otín et al. 2016).  
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Therefore, in this Chapter, the effects of nutrition and nutrient sensing pathways are examined on 
three age-related endpoints:  
1) Telomere length – Chapter 5.1 
2) Mitochondrial number and function – Chapter 5.2 
3) Inflammation – Chapter 5.3 
 
 
Figure 5.0. Proposed end points to by studied in this chapter. 
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Chapter 5.1: The relationship between dietary macronutrients and hepatic 
telomere length 
 
A version of this chapter has been published in (Gokarn et al. 2017). 
 
Background 
Aging can be delayed by a variety of nutritional interventions, of which caloric restriction has been the 
most extensively studied (Mercken et al. 2012; Lee & Longo 2011). Studies utilising the principles of 
nutritional geometry have found that dietary macronutrients also influence lifespan, with most studies 
in insects and mice reporting that LPHC diets maximise lifespan in ad libitum feeding paradigms (Lee 
et al. 2008; Raubenheimer et al. 2016; Le Couteur et al. 2015; Solon-Biet et al. 2014). In a recent study, 
mice maintained on diets with a protein to carbohydrate ratio of nearly 1:10 had the longest lifespan 
and best late-life health despite increased fat mass (Solon-Biet et al. 2014). These diets were associated 
with optimisation of various nutrient sensing pathways that influence aging including mTOR, insulin, 
FGF21 and IGF-1 (Solon-Biet et al. 2014; Solon-Biet et al. 2016). 
 
A large number of biological processes underlie aging and some of these have been termed the 
‘hallmarks of aging’ (López-Otín et al. 2013): amongst these processes is telomere attrition. Telomeres 
form the ends of eukaryotic chromosomes and comprise repetitive stretches of DNA (TTAGGG) 
bound to specific proteins. Telomeres play a critical role in longevity due to their role in protecting 
the ends of chromosomes and prevention of chromosome fusion. A key enzyme, telomerase, is 
critical in the maintenance of telomere length, and this enzyme has been shown to be attenuated by 
the same nutrient sensing pathways affected by dietary intervention (Blasco 2005).  It has been 
suggested that the “molecular clock” – the shortening of telomeres throughout an organism’s life, 
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might eventually signal growth arrest, leading to replicative senescence (McLean & Le Couteur 2004).  
This phenomenon has been observed both in cultured non-immortalised cells (Endo et al. 2002; Song 
et al. 2016), as well as in live animal studies (Rudolph et al. 1999). Although the results are variable, a 
number of epidemiological studies have suggested that leukocyte telomere length (LTL) decreases 
with age in humans (Vidaček et al. 2017; Mons et al. 2017). Thus, telomere length has been proposed 
to be a biomarker of aging, with short telomeres contributing to aging by causing cellular senescence 
(Coppé et al. 2010; Blasco 2005; Vidaček et al. 2017). 
 
In addition, mouse models of certain age-related diseases such as Werner syndrome and ataxia 
telangiectasia have also been used to study telomere length. Interestingly, these models only 
phenotypically manifest common pathologies when there is premature telomere shortening, thus 
highlighting the critical role of telomere integrity in attenuation of disease manifestation (Sahin & 
DePinho 2012). Taken together, these results suggest that telomeres are a critical factor in the 
maintenance of healthspan and improved lifespan in both wild-type organisms and models of disease.  
Given that a LPHC diet was effective in promoting healthspan and extending lifespan in a large 
cohort of mice, even more so than 20% calorie restriction by dilution (Solon-Biet et al. 2014), this 
study aimed to investigate the effect of these dietary regimes on telomere length. The relationship 
between telomere length and various markers of nutrition (nutrient sensing pathways, circulating 
amino acids and fatty acids) and mitochondrial function were also explored as potential mechanistic 
links between nutrition, telomeres and aging.   
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Methods 
Methods on animal husbandry and diet are outlined in full in Chapter 2. The lifespan, metabolomics 
and signaling pathway data from this mouse study have been published previously (Solon-Biet et al. 
2014; Solon-Biet et al. 2016).  
 
Briefly, liver tissue (n=183) was harvested for evaluation of telomere length. Blood levels of insulin, 
FGF21 and IGF-1 were measured by ELISA, hepatic mitochondrial function using Seahorse XF 
Extracellular Flux Analyzer, hepatic mTOR and p-mTOR by western blotting. In 22 of the samples, 
genomic DNA quality did not pass QC thresholds, and were excluded from the analysis. Average 
telomere length was measured from total genomic mouse liver DNA by using a real-time quantitative 
PCR method (Cawthon 2002). Normalisation was done using the acidic ribosomal phosphoprotein 
PO (36B4) gene. Standard curves for 36B4 and telomeric repeats were used for absolute quantitation. 
Telomere concentrations were normalised to the 36B4 control gene concentration of the same 
sample.  
 
Data obtained in this manner from replicates is considered to be the average telomere length ratio 
(ATLR), as previously described (Callicott & Womack 2006). Data were analysed using Pearson’s 
correlation coefficient. The Geometric Framework (GF) was used to visualise the relationship 
between macronutrients and ATLR as described in detail in Chapter 3. P-values less than 0.05 were 
considered statistically significant and a Bonferroni correction was applied for multiple comparisons. 
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Results 
Telomere length was able to be determined in DNA extracted from 161 livers collected from 183 
mice. The average ATLR was 6.8 ± 18.2, the median 2.0, and the majority of the values were between 
1-4 [Figure 5.1.1A]. There was no difference between females (n=85, 7.1 ± 16.6) and males (n=76, 6.4 
± 14.5) so they were pooled. The telomere length in kbp was estimated from the ATLR using an 
empiric formula derived in C57Bl/6 mice previously published (Callicott & Womack 2006). Using this 
estimation, the telomere length across all diets averaged 16.6 ± 23.3 kbp and the distribution of 
telomere length was skewed to the right [Figure 5.1.1A-B]. 
 
  
 
Figure 5.1.1. The distribution of telomere lengths in DNA extracted from mouse livers, determined 
by ATLR (A) and converted to kbp (B) according to the empiric equation of (Callicott & Womack 
2006). The Y-axis refers to the number of mice. 
 
 
There was a significant positive correlation between carbohydrate intake and ATLR (r=0.18, P=0.02) 
and a significant negative correlation with protein intake (r=-0.16, P=0.04). There were no 
correlations between ATLR and fat intake or total energy intake [Figure 5.1.2A-D].  
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Analysis of the full, 3-macronutrient response surface using GF and GAMS revealed that 
carbohydrate intake was the main driver of ATLR (P=0.04), with the longest telomeres occurring in 
mice on the low protein, high carbohydrate diets. The pattern of distribution of ATLR across the 
dietary surfaces matched the changes previously reported for lifespan, such that the longest telomeres 
and lifespan were seen in mice maintained on low protein high, carbohydrate ad libitum-fed diets 
[Figure 5.1.3A-B, Table 5.1.1]. Direct comparison between ATLR and lifespan was not possible in the 
same animals because ATLR was measured in animals sacrificed at 15 months of age. 
 
Figure 5.1.2. The relationship between the intake of dietary macronutrients and energy with ATLR 
(average telomere length ratio) in DNA from livers of mice aged 15 months. There were significant 
correlations with protein (5.1.2A, r=-0.16, P=0.04) and carbohydrates (5.1.2B, r-=0.18, P=0.02) but 
not fat (C) or total energy (D). 
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Figure 5.1.3. Representation of the relationship between macronutrients and ATLR (A) and median 
lifespan (B) using the Geometric Framework. Three 2D slices are given to show all three nutrient 
dimensions (protein, carbohydrate, fat). For each 2D slice, the third factor is at its median (shown 
below the x-axis in parentheses). In all surfaces, red indicates the highest value, while blue indicates 
the lowest value with the colors standardised across the three slices. The diet with the longest 
telomere length and lifespan is demonstrated with the red line, and this was a low protein, high 
carbohydrate diet in both cases. There is a very similar response of both ATLR and median lifespan 
to dietary macronutrients. For 3D representation, see Figure 5.1.5. 
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Table 5.1.1. GAM statistics related to Figure 5.1.3 and Figure 5.1.5. The results for median lifespan 
are from Solon-Biet et al (2014). 
 
 Edf df F P 
ATLR 
Protein (P) 0.30 8 0.05 0.20 
Carbohydrate (C) 0.69 8 0.28 0.04 
Fat (F) 0.00 8 0.00 0.45 
P × C 0.43 3 0.18 0.24 
P × F 0.00 3 0.00 0.59 
C × F 0.00 3 0.00 0.58 
P × C × F 0.00 7 0.00 0.48 
Median lifespan 
Protein (P) 0.00 4 0.00 0.50 
Carbohydrate (C) 1.12 4 1.68 0.01 
Fat (F) 0.00 4 0.00 1.00 
P × C 0.00 2 0.00 0.10 
P × F 0.00 2 0.00 0.10 
C × F 0.00 2 0.00 0.62 
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The correlations between ATLR, circulating amino acids (n=120) and fatty acids (n=128) were 
assessed. There were significant positive correlations between ATLR and asparagine (P=0.01), 
glutamate (P=0.0006) and taurine (P=0.008) [Figure 5.1.4A-D], but not with other amino acids or 
fatty acids. Only glutamate remained significant after Bonferroni correction for analysis of 26 amino 
acids [Table 5.1.2]. There was a weak association with one fatty acid C21.0 (P=0.04). 
 
 
 
  
Figure 5.1.4. The relationship between circulating amino acids and ATLR. There were significant 
correlations with asparagine (3A, r=0.23, P=0.01), glutamate (3B, r=0.31, P=0.0006), taurine (3C, 
r=0.24, P=0.008) and a weak correlation with total amino acids (3D, r=0.18, P=0.05) but not with the 
other amino acids. 
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There were no statistically significant correlations between ATLR and hepatic pmTOR/mTOR, 
measures of hepatic mitochondrial function determined by Seahorse, or circulating levels of FGF21, 
insulin or IGF-1 [Table 5.1.2]. 
 
 
 
Table 5.1.2. Pearson’s correlation coefficient and P value for the relationship between ATLR and 
amino acids, fatty acids, hepatic mitochondrial function and nutrient sensing pathways (*FGF21 was 
insignificant when 1 outlier was removed from analysis). The bold font identifies statistically 
significant values prior to Bonferroni correction.  
 
Parameter r P Parameter r P 
Amino acids 
Alanine 0.06 0.49 Isoleucine 0.00 0.97 
alpha Aminoadipic acid 0.01 0.95 Leucine -0.04 0.64 
alpha Aminobutyric acid 0.10 0.28 Lysine 0.07 0.43 
Arginine 0.18 0.05 Methionine 0.10 0.27 
Asparagine 0.23 0.01 Ornithine 0.07 0.43 
Aspartic acid 0.12 0.20 Phenylalanine 0.09 0.35 
Citrulline 0.17 0.07 Proline 0.13 0.16 
Cysteine 0.02 0.84 Serine 0.13 0.16 
Glutamate 0.31 0.0006 Taurine 0.24 0.008 
Glutamine 0.17 0.07 Threonine 0.12 0.21 
Glutathione 0.07 0.43 Tryptophan 0.09 0.31 
Glycine 0.02 0.80 Tyrosine 0.15 0.11 
Histidine 0.09 0.34 Valine -0.05 0.57 
Fatty acids 
C9.0 0.03 0.77 C18.2 0.08 0.40 
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C10.0 -0.15 0.09 C18.1.cis 0.07 0.41 
C11.0 -0.06 0.52 C18.3 0.03 0.74 
C12.0 -0.14 0.11 C18.1.trans 0.06 0.50 
C13.0 0.01 0.92 C18.0 0.04 0.66 
C14.0 0.01 0.95 C19.0 -0.10 0.26 
C15.0 -0.05 0.57 C20.4 0.06 0.51 
C16.1 0.10 0.26 C20.0 -0.03 0.72 
C16.0 0.03 0.74 C21.0 -0.18 0.04 
C17.0 0.04 0.67 C22.1 -0.17 0.06 
   C22.0 -0.07 0.42 
Hepatic mitochondrial function 
beta-hydroxyacyl-CoA 
dehydrogenase -0.02 0.74 H2O2 glutamate 0.03 0.70 
aspartate aminotransferase -0.01 0.87 State III palmitoyl  -0.01 0.92 
State III pyruvate -0.03 0.71 State IV palmitoyl  -0.01 0.87 
State IV pyruvate -0.02 0.77 H2O2 palmitoyl  -0.03 0.77 
H2O2 pyruvate -0.03 0.72 RCR pyruvate 0.09 0.26 
State III succinate -0.03 0.68 RCR succinate 0.00 0.96 
State IV succinate -0.03 0.74 RCR glutamate 0.04 0.61 
H2O2 succinate -0.03 0.69 RCR palmitoyl carnitine 0.02 0.82 
State III glutamate -0.03 0.70 Citrate synthase -0.08 0.33 
State IV glutamate -0.03 0.69    
Signaling and nutrient sensing pathways 
Insulin -0.07 0.43 IGF-1 -0.12 0.17 
FGF21* 0.12 0.22 pmTOR/mTOR 0.02 0.83 
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Figure 5.1.5 3D Representation of the relationship between macronutrients and ATLR and median 
lifespan using the Geometric Framework from Figure 5.1.3, Table 5.1.1. Differences in shape reflect 
differences in specific nutritional intake points between the two sets of mice. 
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Discussion 
Many observational studies in human populations have found an association between various diet 
constituents and leukocyte telomere length (LTL). Consumption of anti-oxidant rich, plant-derived 
foods and the Mediterranean diet are linked with longer LTL, while shorter LTL have been associated 
with dietary fats, refined cereals, meat products and sugar-sweetened beverages (Vidaček et al. 2017; 
Freitas-Simoes et al. 2016; Rafie et al. 2016). In a prospective study of young humans, change in 
telomere length over time was inversely associated with total energy intake as well as that of each 
macronutrient (Kark et al. 2012). A number of environmental and lifestyle factors including diet 
appear to influence telomere length, which may provide a mechanism for their effects on aging and 
age-related health (Vidaček et al. 2017; Freitas-Simoes et al. 2016). 
 
There have been fewer studies of nutrition and telomeres in mice and rats. Telomeres are longer and 
shorten more rapidly with ageing in rodents than in humans (Vera et al. 2012; Tanrikulu-Kucuk & 
Ademoglu 2012). Caloric restriction in mice was associated with longer LTL at 15 months (Vera et al. 
2013) while 40% protein restriction maintained telomere length in livers of rats aged 16 months, 
compared with a decrease in telomere length in those rats on standard chow (Tanrikulu-Kucuk & 
Ademoglu 2012). In this study, in which mice had ad libitum access to food, telomere length assessed 
by ATLR was positively correlated with carbohydrate intake, and negatively correlated with protein 
intake, while fat and total energy intake had no effect. Analysis using the Geometric Framework 
showed that ATLR positively correlated with carbohydrate intake, and highest ATLR was achieved in 
mice maintained on low protein, high carbohydrate, low fat diets that were ad libitum-fed over a 
lifetime. The surface generated by Geometric Framework analysis reveals that ATLR doubled from 
approximately 6 in mice on high protein, low carbohydrate diets to about 13 in those on low protein 
high, carbohydrate diets. These values are approximately equivalent to 16 and 27 kbp (using an 
empiric conversion equation (Callicott & Womack 2006)), which are similar to values of 19 and 23 
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kbp seen in the livers of 16 month old rats maintained on standard chow or protein restriction 
respectively (Tanrikulu-Kucuk & Ademoglu 2012). In the mouse caloric restriction study (Vera et al. 
2013), liver telomere length was not reported, however, caloric restriction was associated with longer 
telomeres in kidney (94 kbp vs 62 kbp), lung (55 vs 21 kbp) and muscle (14 vs 11 kbp) at 15 months 
of age. Together, the data in humans and rodents are consistent with a robust effect of nutrition on 
telomere length in older age, thereby providing a plausible mechanistic link for the effects of nutrition 
on ageing and age-related health. 
 
Telomere length provides a biomarker and a mechanism for aging. The ability of telomere length to 
predict aging and lifespan has been reported both in aged mice (Vera et al. 2012; Cherif et al. 2003; 
Ludlow et al. 2012) and humans (Mons et al. 2017; Cawthon et al. 2003). This relationship has mostly 
been studied using LTL (Blasco 2005). However one study in humans found that telomere length in 
the liver was 12.9 kbp in newborns compared to 8.3 kbp in a centenarian (Takubo et al. 2000), while 
there is a reduction in the percentage of longer telomeres in livers of rats by 15 months of age (Cherif 
et al. 2003).  
 
In the present study, it was not possible to directly compare telomere length and lifespan in the same 
mice, because the telomeres were evaluated in the livers of mice sacrificed at 15 months of age. 
However, responses of both ATLR and median lifespan to macronutrients in mice could be 
compared to corresponding data from the same experimental cohort. As shown in Figure 5.1.3 and 
Figure 5.1.5, the surfaces demonstrating the relationship between macronutrients and median lifespan 
versus ATLR are almost identical. Mice maintained on low protein, high carbohydrate diets had the 
longest median lifespan and the longest ATLR. The results provide indirect evidence that is consistent 
with the concept that long telomere length is associated with longer lifespan. In addition, the rankings 
by diet of the median lifespan were compared to the telomere length, and there was a significant 
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positive relationship, such that diets associated with longest median lifespan were also associated with 
longest telomeres [Figure 5.1.6]. 
 
 
 
 
Figure 5.1.6. The relationship between the telomere length at 15 months of age and median lifespan. 
The average median lifespan and telomere length were determined for each diet, then ranked by diet. 
There was a significant correlation between the rankings (Pearson’s coefficient = 0.42, P = 0.04). 
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Next, this study explored whether the association between telomeres, nutrition and lifespan is 
mediated by several mechanisms that are thought to link nutrition with aging (Solon-Biet et al. 2015b). 
There was no association with ATLR and circulating levels of insulin, FGF21 or IGF1, hepatic 
mTOR activation, nor hepatic mitochondrial activity, although this may reflect the power of the 
study. However, there was an association between ATLR and blood levels of amino acids including 
asparagine, glutamate and taurine. Previously it has been shown that the chronic circulating levels of 
most amino acids (except branched chain amino acids) are inversely correlated with protein intake 
(Solon-Biet et al. 2014). Therefore the positive association between some amino acids and ATLR in 
this study may simply reflect the effects of a low protein diet, although only glutamate remained 
significant after correction for multiple comparisons. On the other hand, taurine is an antioxidant 
which could influence telomere shortening (Ozsarlak-Sozer et al. 2010). There are few reports linking 
amino acids with telomere length. One report in humans studied the relationship between LTL and 
several circulating amino acids (alanine, glycine, histidine, phenylalanine, leucine, isoleucine, valine, 
and tyrosine) and found an inverse relationship with phenylalanine (Eriksson et al. 2017). 
 
In conclusion, mice maintained on low protein, high carbohydrate diets had longer hepatic telomeres, 
which correlated with a longer median lifespan. Nutrition has a powerful impact on aging and age-
related health, which might be mediated in part by its effects on telomere length. 
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Chapter 5.2: The relationship between dietary macronutrients and hepatic 
mitochondrial function 
 
Data from this chapter has been published in (Solon-Biet et al. 2014). 
 
Background 
Mitochondria are essential not only for providing energy in the form of ATP, but also for their 
involvement in multiple functions, many of which are associated with changes in nutrient sensing 
pathways (Sahin & DePinho 2012; M. B. Jensen & Jasper 2014). The primary function of 
mitochondria is to provide cellular energy through the process of oxidative phosphorylation via four 
respiratory chain complexes (complexes I-IV) and ATP synthase (complex V) (Bratic & Larsson 
2013). Changes in mitochondrial bioenergetics, reactive oxygen species (ROS) production, mutations 
in mitochondrial DNA and impaired respiratory chain function have been implicated in ageing, not 
only as a correlation, but these changes have even been suggested to be a potential a mechanism 
driving the ageing process (Sevini et al. 2014; Sahin & DePinho 2010; Scialò et al. 2016).  
 
Mitochondrial dysfunction is generally considered a hallmark of ageing, and has been well 
documented in mammals (López-Otín et al. 2013; Kujoth 2005; Trifunovic et al. 2004). These 
changes have been linked with altered regulation of SIRT1, mTOR and AMPK through a variety of 
mechanisms including pathways linked with altered regulation of mitophagy, mitochondrial 
biogenesis, NAD+ availability, PGC1α and p53 [Figure 5.2.1] (Kujoth 2005; Gomes et al. 2013; Green 
et al. 2011; Sahin & DePinho 2012). Increased ROS production as a result of mitochondrial 
dysfunction has been of particular interest, due to its association with oxidative stress and DNA 
damage (Hekimi et al. 2011; Fang et al. 2016). However, in many species, low levels of mitochondrial 
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dysfunction have actually been noted to extend lifespan (Ventura et al. 2009; Palikaras et al. 2015; 
Merkwirth et al. 2016; Munkácsy & Rea 2014), therefore suggesting that perturbations to 
mitochondrial function exert a hormetic effect on ageing (Hekimi et al. 2011; López-Otín et al. 2016). 
Mitochondrial dysfunction has also been shown influence ageing independently of ROS production 
through alteration of apoptotic pathways, as seen in animal studies with deficiencies caused by 
mitochondrial DNA mutations (Hiona et al. 2010; Edgar et al. 2009).  
 
Mitochondrial dynamics have also been studied with relation to nutrient exposure, and there is 
evidence that mitochondria in nutrient-rich states are more fragmented compared to the elongated 
mitochondria seen in nutrient starved tissues (Liesa & Shirihai 2013; Jacobi et al. 2015). Changes in 
hepatic mitochondrial number and function are therefore associated with an ageing phenotype, but it 
is unclear which of these, if any, is more important in healthy ageing (Prolla & Denu 2014; Aon et al. 
2016). In humans, CR has been shown to increase mitochondrial DNA content and mitochondrial 
biogenesis in skeletal muscle, and was associated with increased expression of genes associated with 
mitochondrial function including PGC1α, eNOS, SIRT1 and PARL (Civitarese et al. 2007). The 
benefits of intermittent fasting on health have also been linked to decreased mitochondrial 
degeneration (Castello et al. 2011; Raefsky & Mattson 2017). 
 
It has been recently reported that specific macronutrient intake rather than CR by dilution is linked 
with longevity and metabolic health in ad libitum-fed mice (Solon-Biet et al. 2014). Since diet also 
affects mitochondrial function, examination of this interaction could provide evidence for a 
mitochondrial mechanism underlying the beneficial effects of CR on longevity. Here, the effects of 
varying protein-to-carbohydrate-to-fat (P:C:F) ratios on mitochondria in mice were investigated, 
through assays of mitochondrial number and function. Mitochondrial number was assessed in two 
ways; PCR for expression of the mitochondrial gene cytochrome b for mitochondrial DNA copy 
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number, and an assay of citrate synthase activity as previously described (Larsen et al. 2012; Uddin et 
al. 2016). Mitochondrial function and bioenergetics were tested using the Seahorse XF24 Extracellular 
Flux analyser, which assesses oxygen phosphorylation through oxygen consumption rates after the 
addition of various substrates. Hydrogen peroxide, the beta-oxidative enzyme 3-hydroxyacyl-CoA 
dehydrogenase (HOAD), and citrate synthase were measured through spectrophotometry.  Since the 
same cohort of mice was used to collect longevity data, these findings were compared to lifespan to 
see if there was a correlation with diet and longevity.  
 
 
 
 
Figure 5.2.1. CR, CR mimetics and nutrient sensing pathways in mitochondrial dysfunction and 
ageing.   
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Methods 
Methods on animal husbandry and diet are outlined in full in Chapter 2. Here, additional studies were 
conducted to investigate the effects of macronutrient balance on hepatic mitochondrial number and 
function, and its correlation with longevity, as previously described (Solon-Biet et al. 2014).  
 
Briefly, mitochondrial function was studied using mitochondria isolated from liver tissue (n=170) of 
mice aged 15 mths, examining ATP production, basal respiration, maximum respiration and spare 
capacity using oxygen consumption rates after the addition of various substrates (pyruvate-malate, 
glutamate-malate, succinate-rotenone, palmitoyl carnitine-malate). Respiratory Control Ratios (RCR’s) 
were defined as State III/State IVo. Hydrogen peroxide production and enzymatic activities (HOAD, 
aspartate aminotransferase (AST) and aconitase) were measured via spectrophotometry. Citrate 
synthase activity was used to normalise the results, which are therefore expressed as mitochondrial 
function per mitochondrion. Mitochondrial copy number was estimated from genomic mouse 
mtDNA using a real-time quantitative PCR method normalised to the acidic ribosomal 
phosphoprotein PO (36B4) gene as previously described (Uddin et al. 2016). All PCRs were done in 
triplicate. Standard curves for 36B4 and cytochrome b were used for absolute quantitation. 
 
The data is displayed as 2D and 3D response surfaces generated by the Geometric Framework as 
described in Chapter 3, which were analysed with GAM statistics. The values reported for 
macronutrient intake axes are kJ/mouse/day averaged over intake during 6-15 months of age. 
Overall, 37 mitochondrial assays are reported here, 32 of which are related to mitochondrial function 
directly through measures of oxidative phosphorylation and free radical production, 3 of which are 
related to enzyme activity (HOAD, AST, and aconitase), and 2 related to gene expression.  
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Results 
To assess mitochondrial copy number (CN), cytochrome b expression was examined, normalised to 
the control gene 36B4 as previously described (Uddin et al. 2016). Mitochondrial copy number was 
found to be positively correlated with protein intake (p=0.0004) [Figure 5.2.2, Table 5.2.1]. Citrate 
synthase (CS) activity, which has been used as a surrogate marker to quantify mitochondrial number 
(Larsen et al. 2012), was also positively correlated with protein intake (p=0.00003.28), however, CS 
was also influenced by carbohydrate and fat intake [Figure 5.2.3, Table 5.2.1]. Encouragingly, both 
methods produced similar results, with Pearson’s correlation between these two markers was also 
significant (r=0.23, p=0.004) [Table 5.2.3]. However, correlation with median lifespan results in the 
same cohort did not produce any statistically significant findings, with correlation coefficients close to 
zero in both cases (CN: r=-0.058, p=0.47; CS: r=0.019, p=0.99). This indicates that while 
mitochondrial number is affected by diet, it may not be directly correlated with lifespan; however it is 
important to note that despite being in the same cohort, mitochondrial assays were performed on 
mice sacrificed at 15 months and are therefore the data sets are not from the same mice as the 
longevity data.  
 
 
Table 5.2.1. GAM statistics for mitochondrial copy number (normalised cytochrome b expression) 
and citrate synthase activity. Corresponding GF plots are shown in Figures 5.2.2 and 5.2.3. 
 
p-value P C F P:C P:F C:F 
Normalised Cytochrome b 
 Expression 3.98E-04 0.0831 0.3429 0.2901 0.2041 0.4106 
Citrate Synthase Activity 1.92E-05 1.93E-03 2.74E-02 0.4640 0.2415 0.3726 
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Figure 5.2.2. 2D and 3D GF plots for mitochondrial copy number (normalised cytochrome b gene 
expression). Corresponding GAM statistics are shown in Table 5.2.1. 
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Figure 5.2.3. 2D and 3D GF plots for citrate synthase activity correlated with macronutrient intake. 
Corresponding GAM statistics are shown in Table 5.2.1. 
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Of the 35 non-genetic assays performed on mitochondrial function and enzymatic activity, 21 assays 
(60%) were correlated with macronutrient intake or ratios in a statistically significant manner [Table 
5.2.2]. Of these, protein intake was by far the most significant factor influencing mitochondrial 
function (n=12). Interestingly, the general pattern of correlation with mitochondrial function was in a 
negative direction, with low dietary protein intake being associated with increased oxidative 
phosphorylation of substrates. While none of the mitochondrial functional assays were significantly 
correlated with directly lifespan, the diets that produced the longest lifespan were associated with 
increased hepatic mitochondrial activity and free radical production in the same cohort of mice.  
Table 5.2.2. GAM statistics from GF analysis on mitochondrial function assays correlated with 
macronutrient intake.  
Assay P C F P:C P:F C:F 
Aconitase 0.44 0.31 1 0.44 0.81 0.95 
AST 1.13E-02 0.34 0.57 0.46 0.70 0.31 
Glutamate Antimycin A 0.09 0.50 1 0.36 0.97 0.16 
Glutamate H2O2 4.44E-02 0.83 0.82 0.44 0.65 0.48 
Glutamate RCR III/IVo  0.09 1 0.56 0.52 0.64 1 
Glutamate Spare Capacity 1.10E-04 0.65 0.27 0.54 0.51 0.08 
Glutamate State II 0.4 1 2.62E-02 0.79 0.45 0.81 
Glutamate State III 0.81 0.87 0.49 0.90 0.54 0.18 
Glutamate State IIIu 1.14E-03 0.95 0.54 0.73 0.54 0.25 
Glutamate State IVo 0.52 0.78 0.76 3.22E-02 0.7 0.69 
HOAD 2.97E-02 0.73 0.50 0.71 0.32 0.19 
Palmitoyl carnitine Antimycin A 0.05 0.68 1 0.42 0.95 0.5 
Palmitoyl carnitine RCR III/IVo 1 1 0.92 1 1 1 
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Palmitoyl carnitine Spare Capacity 0.14 0.34 0.85 0.86 3.19E-02 0.53 
Palmitoyl carnitine State II 0.51 0.47 1 0.29 1 0.46 
Palmitoyl carnitine State III 0.38 0.79 1.77E-10 0.62 2.14E-02 0.40 
Palmitoyl carnitine State IIIu 0.65 0.2 0.25 0.62 0.1 0.83 
Palmitoyl carnitine State IVo 0.61 1 1.23E-03 0.74 0.38 1.74E-03 
Palmitoyl CoA H2O2 0.08 0.37 0.72 0.32 0.36 0.15 
Pyruvate Antimycin A 0.69 0.44 0.47 0.89 0.87 0.48 
Pyruvate H2O2 2.70E-02 0.90 0.78 0.50 0.60 0.48 
Pyruvate RCR III/IVo 0.78 0.49 1 0.71 0.91 0.96 
Pyruvate Spare Capacity 0.46 0.53 0.77 0.28 0.07 0.29 
Pyruvate State II 3.60E-02 0.57 0.29 0.44 4.70E-02 0.74 
Pyruvate State III 1.13E-02 0.14 0.59 0.43 0.66 0.27 
Pyruvate State IIIu 0.12 0.95 0.3 0.63 0.08 0.44 
Pyruvate State IVo 2.59E-02 0.99 0.7 0.59 0.56 0.38 
Succinate Antimycin A 0.15 0.8 0.51 0.85 0.42 0.52 
Succinate H2O2 3.72E-02 0.96 0.80 0.48 0.61 0.45 
Succinate RCR III/IVo  2.01E-02 0.17 0.60 1.48E-02 0.24 0.05 
Succinate Spare Capacity 4.52E-09 3.31E-02 1 0.34 0.90 0.09 
Succinate State II 0.27 1 0.33 1 1.22E-02 0.82 
Succinate State III 0.39 0.28 0.66 0.93 1.51E-02 0.66 
Succinate State IIIu 0.36 4.91E-02 0.69 0.8 0.32 0.14 
Succinate State IVo 1 0.49 0.73 1 4.79E-02 0.38 
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Discussion 
In order to control metabolism and energy homeostasis, mitochondria adjust substrate utilisation in 
relation to nutrient availability (Boutant et al. 2016; Barbato & Aquilano 2016; Minamino et al. 2009). 
The three main nutrient sources are amino acids, glucose, and fatty acids, and under physiological 
circumstances, mitochondria are able to switch their fuel source between substrates freely (Muoio 
2014; Pani 2010). Dysregulation of mitochondrial function on the other hand leads to metabolic 
inflexibility, decreased respiratory efficiency, and increased production of ROS (Payne & Chinnery 
2015). While ROS have historically been thought to have a deleterious effect on ageing (Harman 
1956), recent evidence has shown that these molecules may have key roles in cellular signaling 
pathways, and may in fact be beneficial to the ageing process in a hormetic fashion (López-Otín et al. 
2016; Sharma et al. 2010). Caloric restriction, which had been initially predicted to lower basal 
metabolic rate (BMR) and ROS production has actually been shown to increase mitochondrial 
biogenesis and increase BMR (Nisoli et al. 2005; Zarse et al. 2012). Mild increases in ROS production 
with caloric restriction have also been shown to exert longevity benefits in many studies (Sharma et al. 
2010; Rea et al. 2007; Munkácsy & Rea 2014), however these have also been shown to be 
accompanied by increased ROS scavenging mechanisms (Nisoli et al. 2005; Ristow et al. 2009). Here, 
it was shown that mitochondrial respiratory control ratios (RCR) and spare capacity, markers of 
mitochondrial function, were generally negatively correlated with protein intake. The notable 
exception was palmitoyl carnitine, where the spare capacity and RCR was driven more by the intake of 
fat and the P:F ratio, indicating that mitochondria adapted to increase capacity for fat utilisation as a 
substrate when dietary fat intake was high [Table 5.2.2]. As expected, these results are consistent with 
the literature where mitochondria optimise efficiency of substrate utilisation depending on nutrient 
availability in the cellular environment. Overall, the study shows that low protein intake was 
associated with increased mitochondrial activity and free radical production, while high protein intake 
was associated with increased citrate synthase, mitochondrial copy number. Therefore, animals on low 
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protein diets, which produced the greatest lifespan extension in the same cohort of mice, displayed 
increased mitochondrial activity, but a lower mitochondrial number. However, correlation of the 
results with lifespan data collected from the same cohort did not show any significant results. Given 
that mitochondrial number was associated with changes in pathways also influencing mitochondrial 
function, it can be hypothesised that the change in mitochondrial number may be a response to 
compensate for mitochondrial dysfunction, rather than a direct deleterious effect on longevity. 
Table 5.2.3. Pearson’s correlations between mitochondrial DNA copy number and nutrient sensing 
pathway data described in Chapter 4. *Longevity correlated via diet group in the same cohort. 
Correlation with: R p-value 
Circulating FGF21 -0.012 0.14 
Circulating IGF1 0.49 0.85 
Circulating Insulin 0.87 0.03 
Citrate Synthase (CS) 0.41 0.021 
FGF21 Gene expression 0.067 0.077 
IGF1 Gene expression 0.57 0.58 
Longevity* -0.48 0.45 
mTOR Activation -0.96 0.45 
mTOR Gene expression -0.18 0.21 
Prkaa1 Gene expression -0.67 0.027 
Prkaa2 Gene expression 0.59 0.2 
Sirt1 Gene expression -0.46 0.14 
Sirt2 Gene expression -0.95 0.018 
Sirt3 Gene expression 0.96 0.024 
Sirt4 Gene expression 0.83 0.63 
Sirt5 Gene expression 0.51 0.99 
Sirt6 Gene expression -0.92 0.065 
Sirt7 Gene expression 0.43 0.95 
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When compared with the growth pathway data from the same cohort of mice (described in detail in 
Chapter 4), mitochondrial DNA copy number, a marker for mitochondrial biogenesis was positively 
correlated with circulating insulin and gene expression SIRT3; and negatively correlated with AMPK 
and SIRT2 gene expression [Table 5.2.3]. Mitochondrial function on the other hand, was significantly 
correlated with multiple growth pathways; mTOR activation was positively correlated with RCR when 
pyruvate was used as a substrate, but negatively correlated with RCR when glutamate was used. 
Interestingly, while the geometric framework surface for mTOR activation showed a remarkably 
similar response pattern to that of mitochondrial copy number (i.e. positive correlations between 
protein intake and both mTOR activation and mitochondrial copy number), direct correlation 
between the two outcomes was not significant [Table 5.2.3]. While direct correlation was not 
statistically significant here, other studies have shown that inhibition of mTOR through gene 
mutations and rapamycin decrease mitochondrial copy number as well as expression of mitochondrial 
genes (Chen et al. 2008; Cunningham et al. 2007; Laplante & Sabatini 2009). Of the sirtuins localised 
to the mitochondria (SIRT3-5), the role of SIRT3, is the most well studied, and has been shown to 
play a role in mediating the effects of caloric restriction on lifespan (Someya et al. 2010; Houtkooper 
et al. 2012; Zhong & Mostoslavsky 2011). In the present study, SIRT3 gene expression was 
significantly correlated with 17 of the 32 mitochondrial activity assays (53%), while IGF-1 was 
correlated with 13 (41%), and AMPK with 10 (31%) [Figure 5.2.4, Table 5.2.4]. Interestingly, all three 
of these pathways were almost solely negatively correlated with mitochondrial function, except for 
SIRT3, which was positively correlated with mitochondrial spare capacity and H2O2 production when 
glutamate was used as a substrate. Taken together, these findings suggest that mitochondrial function 
is significantly influenced by diet, with alterations to IGF-1, AMPK and SIRT3 playing key roles in 
the regulatory process. This provides a plausible mechanism by which diet influences ageing, as diets 
associated with the highest longevity in the study, were also associated with changes to nutrient 
sensing pathways, mitochondrial function, and metabolic phenotype. 
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Figure 5.2.4. Pearson’s correlations between mitochondrial function assays and IGF-1, AMPK & 
SIRT3. Corresponding data is shown in Table 5.2.4. Blank results indicate non-significant correlations 
(p>0.05). 
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Table 5.2.4. Pearson’s correlations between mitochondrial function assays and IGF-1, AMPK & 
SIRT3. Values are expressed as Pearson’s correlation coefficient, with p-values shown in brackets. 
 
R (p-value) IGF1 AMPK SIRT3 
Glutamate Antimycin A 0.44 (0.83) -0.29 (0.21) -0.12 (0.67) 
Glutamate H2O2 0.38 (0.85) 0.24 (0.72) 0.76 (0.024) 
Glutamate RCR III/IVo -0.055 (0.78) 0.57 (0.59) -0.038 (0.48) 
Glutamate Spare Capacity 0.27 (0.89) -0.35 (0.082) 0.28 (0.0073) 
Glutamate State II -0.74 (0.014) -0.99 (0.00053) -0.76 (0.0001) 
Glutamate State III -0.68 (0.0081) -0.94 (0.0031) -0.9 (0.000023) 
Glutamate State IIIu -0.55 (0.071) -0.96 (0.000079) -0.77 (0.0011) 
Glutamate State IVo -0.6 (0.048) -0.97 (0.00047) -0.79 (0.00034) 
Palmitoyl carnitine Antimycin A -0.88 (0.033) -0.95 (0.1) -0.81 (0.12) 
Palmitoyl carnitine RCR III/IVo 0.79 (0.75) 0.32 (0.74) 0.1 (0.65) 
Palmitoyl carnitine Spare Capacity -0.3 (0.56) 0.0077 (0.37) 0.18 (0.45) 
Palmitoyl carnitine State II -0.82 (0.0033) -0.98 (0.0018) -0.82 (0.0024) 
Palmitoyl carnitine State III -0.43 (0.053) -0.87 (0.011) -0.79 (0.01) 
Palmitoyl carnitine State IIIu -0.55 (0.033) -0.94 (0.0087) -0.81 (0.0044) 
Palmitoyl carnitine State IVo -0.77 (0.016) -0.98 (0.0018) -0.84 (0.002) 
Palmitoyl CoA H2O2 -0.095 (0.27) -0.0082 (0.96) 0.54 (0.2) 
Pyruvate Antimycin A 0.57 (0.65) -0.047 (0.98) 0.47 (0.076) 
Pyruvate H2O2 0.7 (0.51) 0.018 (0.45) 0.2 (0.23) 
Pyruvate RCR III/IVo 0.42 (0.27) 0.47 (0.92) -0.21 (0.39) 
Pyruvate Spare Capacity 0.79 (0.81) 0.7 (0.28) 0.95 (0.00034) 
Pyruvate State II -0.8 (0.0027) -0.96 (0.0051) -0.87 (0.0021) 
Pyruvate State III -0.58 (0.038) -0.93 (0.017) -0.82 (0.011) 
Pyruvate State IIIu 0.031 (0.49) -0.63 (0.28) -0.33 (0.63) 
Pyruvate State IVo -0.71 (0.018) -1 (0.062) -0.66 (0.15) 
Succinate Antimycin A -0.48 (0.25) -0.89 (0.52) -0.35 (0.64) 
Succinate H2O2 0.078 (0.19) 0.69 (0.81) 0.59 (0.28) 
Succinate RCR III/IVo 0.44 (0.82) 0.49 (0.58) -0.17 (0.25) 
Succinate Spare Capacity 0.14 (0.22) 0.62 (0.97) 0.47 (0.023) 
Succinate State II -0.63 (0.019) -0.97 (0.091) -0.64 (0.032) 
Succinate State III -0.23 (0.047) -0.72 (0.093) -0.76 (0.014) 
Succinate State IIIu 0.037 (0.33) -0.44 (0.42) -0.57 (0.55) 
Succinate State IVo -0.5 (0.037) -0.91 (0.06) -0.8 (0.022) 
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Chapter 5.3: The relationship between dietary macronutrients and inflammation 
 
Data from this chapter has been published in (Solon-Biet et al. 2015a).  
 
Background 
The liver provides a plausible mechanistic link between diet and ageing, as it plays a crucial role in 
nutritional metabolism and displays age-related changes such as inflammation, which can be 
histologically assessed (Le Couteur et al. 2008; Schmucker 2005; Popper 1986). This relationship 
between ageing and systemic low-grade chronic inflammation, or inflamm-ageing, is a key area of 
research associated with nutritional intervention, and is crucial to understanding the process of 
healthy ageing (Franceschi & Campisi 2014). Inflammatory markers such as IL-6, TNF-α, IL-1β and 
N-glycans have been studied as biomarkers of ageing and disease with varying degrees of success 
(Dall’Olio et al. 2013; Maggio et al. 2006; Klein et al. 2014; Wei et al. 2016; Kiecolt-Glaser et al. 2003). 
Diet has also been seen to be a contributor to inflammatory changes, particularly in the liver (Kim et 
al. 2016; Baur et al. 2006; Le Couteur et al. 2010). Age-related pseudocapillairisation of the liver 
involves thickening and defenestration of the sinusoidal endothelium, collagen deposition, 
inflammatory changes, and fat accumulation in stellate cells (Le Couteur et al. 2010; Le Couteur et al. 
2008).  
 
While the liver is known to display these changes, the endocrine pancreas has been less well studied in 
terms of histological correlation with diet (Harvey et al. 2014). The pancreas is known have a role in 
metabolism through its secretion of insulin and glucagon, and has also been shown to be affected by 
ageing and caloric restriction (Reaven & Reaven 1981; Okauchi et al. 1995; He et al. 2012). In fact, 
well-regulated glucose metabolism, low levels of insulin resistance and pancreatic β-cell maintenance 
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have been shown to be conserved phenotypes in centenarians, suggesting that pancreatic function is a 
key component to healthy ageing (Paolisso 2001). Since both CR and LPHC diets have also been 
shown to improve measures related with metabolic and cardiovascular health (Solon-Biet et al. 
2015b), the impact of these diets on the liver and pancreas are assessed here. The effects of long-term 
CR or dietary macronutrient manipulation on the liver and pancreas have been established in many 
previous studies (Kim et al. 2016; Le Couteur et al. 2010; Valle et al. 2008; Jamieson et al. 2007; He et 
al. 2012; Okauchi et al. 1995), however whether these phenotypes can be induced by diet on a shorter 
time scale is unknown. In addition, while implementing long-term dietary regimes in humans is 
difficult, short-term diets are relatively common. Therefore, understanding the impact of short-term 
dietary manipulation and CR is useful not only to provide new insights into the mechanisms 
underlying the impact of nutrition on the body, but also add potential translational value to nutritional 
research. 
 
Therefore, this section investigated the short-term effects of varying dietary macronutrients on 
hepatic steatosis, fibrosis and inflammatory infiltration, and pancreatic islet function. Data from the 
liver is correlated with histological data collected previously in the long-term dietary study, as 
described in detail in Chapter 2. The short-term experiment is therefore based on the general 
phenotypic findings of the larger-scale study, with maximal dietary differences used to decide the ratio 
of P:C used. Here, two month old mice were assigned one of three diets varying in P:C ratio, and 
allocated to either ad libitum (AL) or 40% CR intake regimes. Thus, both CR and macronutrient ratio 
were assessed in the short-term study.  
 
 
Methods 
Animal and dietary interventions are discussed in detail in Chapter 2. Additional methods used in the 
short-term dietary study are discussed here, and are adapted from (Solon-Biet et al. 2015a) where the 
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data has been previously published. Data from the long-term study was analysed by the Geometric 
Framework as discussed in detail in Chapter 3. Short-term study data is presented as mean ± SEM, 
and differences are considered significant when p < 0.05. 
 
Male C57BL6/J mice (8 week old; n = 90; Jackson Laboratory) were grouped in cages containing five 
mice each at the National Institute of Aging, Baltimore, USA. All animal protocols were approved by 
the Gerontology Research Center Animal Care and Use Committee (352-LEG-2012) of the National 
Institute on Aging. Isocaloric (4kcal/g; Dyets) experimental diets were classified as low protein, high 
carbohydrate (5% protein; LPHC); medium protein, medium carbohydrate (33% protein; MPMC); 
and high protein, low carbohydrate (60% protein, HPLC). The ratio of fat was therefore fixed at 20% 
across the diets. Mice in each of these groups were assigned to an ad libitum (AL), or 40% calorically 
restricted (CR) group, where intake was limited to 60% of the caloric intake measured in the 
corresponding AL group. Mice were kept on these diets for 8 weeks, prior to being euthanised. Blood 
and tissue samples were collected for histological and biochemical analyses. On the day of the 
sacrifice, CR mice were not fed while AL mice were allowed to eat normally. A total of n=15 mice 
were in each dietary group. 
 
Paraffin-embedded liver tissue from both short and long-term dietary studies were sectioned and 
stained using Haematoxylin & Eosin (H&E), Periodic acid-Schiff (PAS), and Sirius Red. Embedded 
pancreatic tissue was sectioned and immunohistochemistry was performed using monoclonal anti-
glucagon antibody (Sigma G2654) and monoclonal anti-insulin antibody (Sigma I2018). The extent of 
change in the response variables (fatty infiltration, inflammation, glucagon and insulin intensity) was 
assessed and scored (0, 1+, 2+, 3+) by four independent observers, blinded to the tissue category, 
through light microscopy.  
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Results  
While histological changes were noted between groups in the short-term study, all diets displayed 
normal gross liver histology, as seen in Figure 5.3.1. H&E staining of these livers showed a positive 
correlation between P:C ratio and portal inflammation in AL animals, but not in CR animals [Figures 
5.3.2, 5.3.3, Table 5.3.1]. Sirius Red staining indicated no effect of P:C ratio on fibrosis, however there 
was a negative correlation between P:C ratio and steatosis in both the AL and CR animals. In the 
pancreas, the number of insulin-containing cells was not significantly different in CR animals 
compared to AL animals, however in the AL animals, there was an increase in intensity of staining for 
glucagon in the HPLC group compared to the other AL groups [Figure 5.3.4, Table 5.3.1]. This was 
accompanied by an increase in glucagon secretion, elevated blood glucose levels, and glucose 
intolerance, however those data sets were not analysed during the course of this thesis, and are 
described elsewhere (Solon-Biet et al. 2015a). 
 
 
Figure 5.3.1. Representative H&E stained livers from the short-term dietary study; (A) AL group, 
and (B) CR group. 
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Table 5.3.1. Histological scores in the liver and pancreas from the short-term dietary study. Data 
presented as mean+/- SEM. Grey boxes indicate statistical significance on t-test compared with the 
corresponding LPHC group; corresponding p-values shown in Table 5.3.2. 
 
Histology LPHC-AL MPMC-AL HPLC-AL LPHC-CR MPMC-CR HPLC-CR 
Sinusoidal 
inflammation 0.8+/-0.2 1.23+/-0.23 0.78+/-0.15 1.31+/-0.21 0.85+/-0.19 0.91+/-0.25 
Portal 
inflammation 1.1+/-0.18 1.23+/-0.17 2.11+/-0.11 1.62+/-0.18 1.38+/-0.18 1.91+/-0.16 
Central 
inflammation 0.1+/-0.1 0.15+/-0.1 0.22+/-0.15 0.23+/-0.17 0.23+/-0.17 0.55+/-0.21 
Steatosis 2.18+/-0.18 1.23+/-0.23 1+/-0.17 2.08+/-0.31 1+/-0.28 0.64+/-0.2 
Sinusoidal 
fibrosis 1.45+/-0.25 1.54+/-0.24 2.11+/-0.2 1.31+/-0.13 1.92+/-0.24 1.82+/-0.23 
Portal fibrosis 1.18+/-0.18 1.31+/-0.29 1.44+/-0.29 1.38+/-0.27 1.77+/-0.23 1.36+/-0.24 
Central 
fibrosis 1+/-0.27 0.69+/-0.24 0.89+/-0.31 0.54+/-0.18 0.92+/-0.21 0.82+/-0.23 
Insulin 2.1+/-0.28 1.96+/-0.24 1.56+/-0.18 1.46+/-0.23 2.54+/-0.14 1.36+/-0.23 
Glucagon 1.4+/-0.22 1.43+/-0.17 2.4+/-0.16 0.9+/-0.18 1.33+/-0.26 1.13+/-0.13 
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Figure 5.3.2. Histological scores for ad libitum-fed mice in the short-term dietary study. *indicates p<0.05 on t-test against LPHC group 
[Table 5.3.1]; **indicates p<0.05 on ANOVA [Table 5.3.2]. Corresponding data is shown in Table 5.3.1. Experimental diets were classified as 
low protein, high carbohydrate (5% protein; LPHC); medium protein, medium carbohydrate (33% protein; MPMC); and high protein, low 
carbohydrate (60% protein, HPLC).  
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Figure 5.3.3. Histological scores for 40% calorically restricted mice in the short-term dietary study. *indicates p<0.05 on t-test against LPHC 
group [Table 5.3.1]; **indicates p<0.05 on ANOVA [Table 5.3.2]. Corresponding data is shown in Table 5.3.1. Experimental diets were 
classified as low protein, high carbohydrate (5% protein; LPHC); medium protein, medium carbohydrate (33% protein; MPMC); and high 
protein, low carbohydrate (60% protein, HPLC).  
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Table 5.3.2. Statistics for histological scores in the liver and pancreas from the short-term dietary 
study. Data presented as p-values. Experimental diets were classified as low protein, high 
carbohydrate (5% protein; LPHC); medium protein, medium carbohydrate (33% protein; MPMC); 
and high protein, low carbohydrate (60% protein, HPLC). The ratio of fat was fixed at 20% across the 
diets, and mice were assigned to either an ad libitum (AL), or 40% calorically restricted (CR) group. 
 
 
Histology 
T-test compared to LPHC group ANOVA 
MPMC-AL HPLC-AL MPMC-CR HPLC-CR Combined AL CR 
Sinusoidal 
inflammation 0.73 1.00 0.24 0.40 0.31 0.17 0.33 
Portal 
inflammation 0.68 1.77E-02 0.49 0.20 9.36E-04 8.88E-04 0.26 
Central 
inflammation 1.00 1.00 1.00 0.10 0.45 0.17 0.67 
Steatosis 4.31E-02 6.60E-03 2.51E-02 3.53E-02 6.39E-05 2.25E-03 6.28E-03 
Sinusoidal 
fibrosis 0.22 0.06 4.55E-02 0.08 0.11 0.27 0.05 
Portal 
fibrosis 0.47 0.56 2.51E-02 0.80 0.67 0.78 0.21 
Central 
fibrosis 0.22 0.76 0.10 0.22 0.74 0.86 0.42 
Insulin 0.71 0.08 5.76E-03 0.63 1.93E-03 0.50 5.60E-04 
Glucagon 0.73 4.27E-05 0.36 0.61 1.23E-04 1.03E-03 3.99E-02 
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Figure 5.3.4. Representative glucagon stained pancreas samples from the short-term dietary study; 
(A) AL group, and (B) CR group.  
 
 
In the long-term studies, hepatic inflammation, both through fibrotic changes, as well as fatty 
infiltration was associated with the P:F ratio in the diet (p=0.00218 and p=0.006.86 respectively) 
[Figure 5.3.5, Table 5.3.3]. On the other hand, glycogen content, which is a marker for energy stores, 
was affected by C:F ratio, and was only mildly negatively correlated with steatosis, implying that this 
change was likely unrelated to inflammation. Histology in the long-term diets was influenced heavily 
by the ratio of fat in the diet, a factor which was not assessed in the short-term study. 
 
Table 5.3.3. GAM statistics for Geometric Framework analysis of the phenotypic results from the 
long-term mouse study. Corresponding surfaces are shown in Figure 5.3.5. 
Hepatic histology P C F P:C P:F C:F 
Steatosis (Sirius Red)  4.08E-02 8.67E-03 3.51E-03 0.17 2.18E-03 0.83 
Fibrosis (H&E) 0.14 0.33 0.18 0.10 6.86E-03 0.44 
Glycogen (PAS) 1.00 0.28 0.46 0.54 0.63 2.13E-02 
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Figure 5.3.5. 2D GF surfaces of hepatic histology from the long-term dietary study.  Corresponding 
statistics are shown in Table 5.3.3. 
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Discussion 
Chronic overnutrition is linked with increasing instances of obesity and metabolic disorders such as 
diabetes, cardiovascular disease and non-alcoholic fatty liver disease (Buettner et al. 2007). The 
amount of protein in the diet is one of the key drivers of food intake, as organisms are known to 
regulate their protein intake more heavily compared with other macronutrients; a concept known as 
protein leverage (Simpson & Raubenheimer 2005; Gosby et al. 2013; Lee et al. 2008), and this result is 
seen in both cohorts of mice used in this study (Solon-Biet et al. 2014; Solon-Biet et al. 2015a). While 
the results of the diets used here on metabolic outcomes have been discussed in the aforementioned 
publications, it is interesting to note that manipulation of macronutrient ratios did not provide 
additional benefits to 40% CR animals in the short-term, but did influence the outcomes in ad libitum 
fed animals (Solon-Biet et al. 2015a). This seems to indicate that food intake, particularly the ratio of 
P:C in the diet, is one of the key factors influencing metabolic outcomes; a result that has been shown 
throughout this thesis, and elsewhere (Fanson & Taylor 2012; Le Couteur et al. 2015; Jensen et al. 
2015; Simpson et al. 2003). 
 
In the long-term studies, hepatic steatosis was shown to be significantly correlated with protein and 
P:F ratio, while fibrosis was shown to be significantly correlated with the P:F ratio. These results are 
consistent with studies in both humans and mice, where fat plays a major role in hepatic histological 
changes (Benard et al. 2016; Buettner et al. 2007; Hill et al. 2000). In the short-term studies, protein 
and the P:C ratio were the key drivers of inflammation, with high P:C ratios being linked with 
increased portal inflammation, and low P:C ratios are linked with hepatic fat accumulation. However, 
it should be noted that the ratio of fat in the diet, which was a significant fact driver of histology in 
the long-term study, was not assessed in the short-term study, where the ratio of fat was fixed across 
all diets at 20%. This limitation makes it difficult to compare the results across the studies.  
 
  218 
Intensity of insulin staining was not significantly different between CR and AL animals, nor linked 
directly to macronutrient intake. Glucagon on the other hand, was significantly influenced by protein 
in the diet, and when correlated with blood glucose levels and oral glucose tolerance tests in the same 
mice, suggest that high protein intake is associated with increased glucagon secretion, higher 
circulating glucose levels, and glucose intolerance, as previously reported (Solon-Biet et al. 2015a). 
 
Taken together, these findings imply that in the short-term, dietary protein is the key driver of 
inflammatory changes, however fat intake seems to drive hepatic inflammation in the long-term, 
consistent with findings in the literature. CR animals displayed less inflammation than AL animals in 
the short-term, suggesting that protein restriction may be beneficial for healthy liver function. It is 
important however to note that macronutrient effects may vary with age, due to adaptation, and 
changes in metabolic and cellular function (Brown-Borg & Buffenstein 2016; Simpson et al. 2015). 
Thus, the results are consistent with the idea that high protein and fat intake is associated with 
inflammatory liver changes, while low protein intake (either low P:C ratio or CR) is hepato-protective. 
When combined with the larger panel of metabolic findings in these animals, it was shown that 
macronutrient balance, particularly LPHC diets, can mimic the benefits of CR on phenotypic end 
points even in the short-term (Solon-Biet et al. 2015a). Interestingly, short-term CR and intermittent 
fasting have also been shown to be equivalent to, or in some cases better than chronic caloric 
restriction for weight loss and indicators of chronic disease (Chen et al. 2016; Harvie & Howell 2012; 
Heilbronn et al. 2012). This study therefore represents an important area of research, as 
understanding the relationship between diet, ageing and age-related end points may help form 
guidelines to promote healthy ageing without the issues associated with long-term caloric restriction. 
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Chapter 6: General Discussion 
 
 
Nutrition has profound influences on aging. The major nutritional intervention that has been studied 
is caloric restriction (CR), whereby lifelong reduction in energy intake by 10-50% has been reported to 
increase lifespan and delay biological changes associated with aging in many species (Mercken et al. 
2012; Ingram & de Cabo 2017). Although CR has been a foundation of aging research for nearly a 
century, more recent studies have questioned whether it is CR per se that is responsible for the effects 
on health and lifespan (Brown-Borg & Buffenstein 2016; Fanson & Taylor 2012; Solon-Biet et al. 
2015b; Solon-Biet et al. 2014; Le Couteur et al. 2015). The effects of CR on aging have been shown to 
vary by species, strain and sex (Mitchell et al. 2016; Baar et al. 2015)  and while reduced energy intake 
is a key contributor to its benefits (Speakman et al. 2016; Gibbs & Smith 2016), other factors such as 
intermittent fasting (Liao et al. 2010; Y. Chen et al. 2016; C. Lee & Longo 2011) and reduced intake of 
macronutrients, especially protein (Lee et al. 2008, Solon-Biet et al. 2015) may also be important. 
Recent studies in insects and mice have increasingly focused on the ratio of macronutrients in the diet 
using the Geometric Framework, with most studies reporting that diets composed of low protein 
combined with high carbohydrates increase lifespan even in ad libitum-fed organisms (Lee et al. 2008, 
Solon-Biet et al. 2014, Le Couteur et al. 2016). From a translational perspective, this is important 
because ad libitum feeding is unavoidable in most humans.  
 
While the role of diet on life extension has been relatively well established in simple model organisms, 
apparently contradictory evidence has been seen when long-term CR was applied to rhesus monkeys 
at the National Institutes of Aging (NIA) (Ingram et al. 1990; Lane et al. 1992), compared to the 
University of Wisconsin-Madison (UW) (Ramsey et al. 2000). At the NIA, long-term 30% CR was not 
shown to increase lifespan, however did demonstrate significant impacts on disease prevention, 
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particularly metabolic disease and cancer (Mattison et al. 2012). On the other hand, the 30% CR diet 
instituted at UW resulted in a reduction in age-related mortality, with a hazard ratio of 2.9 in the 
control group compared to CR, and a hazard ratio of 1.78 for all-cause mortality on Cox regression 
(Colman et al. 2014). A joint initiative from the institutions was recently published (Mattison et al. 
2017), presenting a comparison of longitudinal data from both studies. Taken together, the data 
confirmed that CR does indeed confer health and survival benefits in non-human primates, and that 
differences in intrinsic trial designs could account for the differences in lifespan outcomes between 
the studies (Mattison et al. 2017). In particular, differences in diet (UW: semi-purified diet more 
similar to Western diet; NIA: minimally processed plant based diet more similar to Mediterranean 
diet), and macronutrient composition (UW: 13.13% P : 58.31% C : 10.6% F ; NIA: 17.3% P : 56.9% 
C : 5.0% F) led to all animal cohorts at the NIA, both control and CR, to consume calories at a similar 
rate to the CR group at UW, thereby implying that both groups at the NIA animals were likely 
calorically restricted, which impaired the ability to observe differences between the groups (Mattison 
et al. 2017). Supporting this, is the fact that both control and CR cohorts at the NIA had an average 
lifespan 45% longer than Rhesus monkeys kept in captivity (Rizza et al. 2014), thus highlighting the 
importance of both dietary intake and macronutrient composition.  
 
While similar trials to assess the impact of diet on longevity are not feasible in humans, correlation 
between data in primates and mice, with short-term dietary interventions in humans, for example the 
CALERIE study (Ravussin et al. 2015; Heilbronn et al. 2006), shows good concordance in health-
related outcomes. This suggests strong evidence to support conserved mechanisms across species, and 
a potential for translatable therapies to impact at the very least, age-related health, if not lifespan 
(Most et al. 2017; de Cabo et al. 2014). Given the importance of macronutrient balance, and the 
difficulty in disentangling the impact of dietary composition in isolation, here the Geometric 
Framework (GF) was used to facilitate interpretation of the effects of macronutrients and their 
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interactions on ageing and age-related end points (Simpson and Raubenheimer 2007, Simpson et al. 
2015). This thesis therefore combined two bodies of work to investigate the mechanisms that underlie 
ageing, and the ability of nutrition to influence this process.  
 
The first was the development of analytical methods as discussed in Chapter 3. These build upon the 
Geometric Framework to allow efficient and automated data collection, analysis, and visualisation 
across a variety of experimental structures. Two major issues were addressed here: 1) the discord 
between GAMs analysis and 2D visualisation, which was addressed by the development of a 3D 
visualisation method, and; 2) automation of the GF to large data sets, allowing multiple data types to 
be simultaneously analysed. These developments allowed the GF to be used as the primary analytical 
method across this Thesis, and be applied to various novel data sets such as PCR and microarray 
analysis of the transcriptome. The GF is an invaluable research tool, and further work in this area 
could help broaden the horizons of the GF beyond nutritional and ageing research, to a much more 
widely encompassing experimental paradigm. 
 
The second component was primary experimental work performed on nutrient sensing pathways, and 
investigation into their roles in ageing, lifespan and phenotypic age-related end points using the 
paradigm of a dietary study in mice. In Chapter 4, macronutrient balance was shown to play a 
significant role in the regulation of nutrient sensing pathways in both the liver and the hypothalamus, 
and produced patterns of change in both gene regulation, as well as signaling pathway activation, that 
were associated with improvements in health and longevity, in concordance with the literature (Evans 
et al. 2011; Lamming et al. 2013; Vaiserman et al. 2016; Wanders et al. 2014). In the liver, all major 
nutrient sensing pathways (mTOR, IIS, AMPK, sirtuins) were altered by dietary macronutrient intake 
ratios, with dietary protein in particular shown to be the main driver of gene expression. LPHC diets 
were shown to decrease mTOR activity, reduce circulating FGF-21 levels, and increase circulating 
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IGF-1, as previously reported (Solon-Biet et al. 2014; Solon-Biet et al. 2016). By contrast, intake of 
carbohydrates and fat had limited effects on gene regulation, most of which were in the opposite 
direction to changes seen with protein intake. In the hypothalamus, overall gene expression changes 
was most influenced by fat intake, a result that is consistent with previous studies (Jang et al. 2017; 
Yamamoto et al. 2009). Once again, protein was demonstrated to influence the gene expression in 
opposite directions compared to carbohydrates and fat. 
 
This is interesting because altering the concentration of one macronutrient in the diet also influences 
the ratio of the other intakes, as well as total energy density (Le Couteur et al., 2016). Given this 
interaction, the use of the GF allows differentiation between the effects of macronutrient intake, 
ratios and total energy, which are difficult to using univariate analysis. Furthermore, the difference 
between ratios in diet versus ratios of actual macronutrient intake must also be pointed out, 
particularly given the fact that low protein diets are known to increase food consumption due to 
titration of intake to protein targets, a concept known as protein leverage (Simpson and 
Raubenheimer, 2005). Discrepancies in analytical methodology and experimental design in this regard 
have led to seemingly diametrically opposite results. In particular, debate exists as to whether the 
effects of CR on longevity are primarily a result of a reduction of calories (Speakman, Mitchell, & 
Mazidi, 2016; Hu et al. 2018), or protein (Nakagawa et al. 2012; Solon-Biet et al. 2014; Fontana et al. 
2016). 
 
This discussion has been extensively reviewed previously (Ingram & Cabo, 2017; Picca, Pesce, & 
Lezza, 2017; Simpson et al. 2017b), which collectively conclude that while both CR and protein 
restriction lead to health benefits, and perhaps even modulate overlapping pathways, they are 
mechanistically different. Indeed, Speakman et al. also acknowledge that protein restriction can 
produce longevity benefits relative to reference diets independent of CR (Speakman, Mitchell, & 
  223 
Mazidi, 2016). In addition, taking a nutritional geometry approach to these same sets of data has been 
shown to reconcile the apparently disparate findings seen on conventional analysis (Simpson et al. 
2017b). Therefore, while debate still exists however around the degree of importance of CR versus 
protein restriction, the GF seems to be the most appropriate analytical tool available to evaluate study 
data given the complexity between macronutrient and interactions, compensatory feeding responses 
and interpretation of outcomes (Le Couteur et al., 2016; Simpson et al., 2017b). 
 
Given the differences in gene regulation between the liver and hypothalamus, further analysis using 
multiple tissue types could play an important role in consolidating the relationship between diet, gene 
regulation and ageing. Indeed, the variance in response between different tissue types raises the 
mechanistic questions of which pathways are responsible for driving outcome related changes, and 
how they are coordinated. While protein was seen to be the main driver for changes in gene 
expression in the liver, fat and total energy dominated the transcriptomic changes in the 
hypothalamus. Coordination of these pathways through feedback loops; both on the level of 
transcription vs. translation vs. post-translational modification, as well as the HPA and other 
endocrine axes; add another degree of complexity in interpreting results. One approach to disentangle 
these complexities is the use of a systems-level approach, which, when applied across a variety of 
species, has shown that age-related genes are highly expressed across most tissue types, and co-
expressed with essential tissue-specific functional genes, often acting as intermediaries for pathway 
cross-talk (Zhang et al. 2016). These findings imply that activation of the same gene pathways in 
different tissues can have very different effects, with higher degrees of complexity and 
interconnectedness amongst more complex organisms.  
 
A second approach is to look at functional enrichment analysis using platform databases such the 
KEGG longevity gene set and GO biological processes gene set, both of which were performed in 
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our studies. Here, it is shown that in both the liver and the hypothalamus, dietary manipulation 
influences gene expression in nutrient sensing pathways, however the complex and elaborate 
mechanisms of their regulation make it difficult to mechanistically describe the coordination between 
these two systems. Again, the literature suggests that while network characteristics are not typically 
tissue specific, their roles in each tissue may functionally differ (Jia et al. 2018). For example, 
longevity-related genes in the brain may be associated with neuronal functionality and neurogenesis 
(Zhang et al. 2016), associated with immunocompetency in haematopoetic cells (Passtoors et al., 
2015), and with metabolic processes in the liver (Newgard & Pessin, 2014).  
 
While both these approaches help expand our mechanistic understanding of the role of these 
pathways, it is important to frame these in the context of the larger question being studied here, 
namely the impact of these pathways on lifespan. Perhaps the most striking set of studies with regards 
to this are gene knockout/overexpression studies in model organisms, which have showed that 
alterations to nutrient sensing pathways can lead to dramatic changes in lifespan (Lamming et al. 2013; 
Johnson et al. 2013; Jia 2004; Kapahi et al. 2004; Junnila et al. 2013). Therefore, while a great deal of 
work is required to better understand the intricacies of mechanism, understanding variations in 
activation of nutrient pathways across a range of tissue sets under different nutritional conditions 
plays a crucial first step in better characterising the role of these pathways in the ageing process. 
 
The effects of diet on age-related end points were also studied. Here, hepatic telomere length was 
shown to be significantly influenced by dietary intake, with diets high in carbohydrates on a low P:C 
background being the most significant factor correlating with longer telomere lengths. The striking 
similarities between the response surfaces of telomere length and median lifespan is perhaps one of 
the finest results discovered in this thesis, with patterns of telomere length almost exactly mirroring 
median lifespan in the same cohort of mice. These results are consistent with the concept that long 
  225 
telomere length is associated with longer lifespan, which has been reported both in aged mice (Vera et 
al. 2012; Cherif et al. 2003; Ludlow et al. 2012) and humans (Mons et al. 2017; Cawthon et al. 2003). 
Since telomere length was shown to be sensitive to nutrition, further investigation of telomere length 
across various tissue types could provide important evidence supporting its use as a biomarker of 
ageing. Mitochondrial number and function were also investigated, and it was found that LPHC diets, 
which produced the greatest lifespan extension in the same cohort of mice, were correlated with 
increased mitochondrial activity, but a lower mitochondrial number. Mitochondrial function was also 
correlated with changes to gene expression of IGF-1, AMPK and SIRT3. These findings suggest that 
mitochondrial function is significantly influenced by diet, with nutrient sensing pathways playing key 
roles in the regulatory process. Finally, inflammatory phenotypes that were seen in the long-term 
cohort were investigated in a second cohort of mice, to see if these changes could be replicated in 
short-term studies. Here, it was shown that HPLC diets in ad libitum-fed animals were correlated with 
hepatic inflammation, and LPHC diets correlated with hepatic fat deposition. Manipulation of 
macronutrient ratios did not provide additional benefit to 40% CR in the short-term, implying that a 
combination of caloric restriction, and specific macronutrient restriction are important in healthy 
ageing of the liver.  
 
This body of work therefore shows that nutrient sensing pathways, key modulators of cellular 
function, display differential activation patterns as a result of varying dietary macronutrient intake. In 
particular, protein intake was seen to be a key regulator of nutrient sensing pathway regulation and 
downstream effects on age-related end points. These results, when correlated with lifespan and health 
data in the same cohort of mice, show that modulation of nutrient sensing pathways is a key 
mechanism mediating the effects of dietary restriction on ageing. This study therefore represents an 
important step in understanding the mechanisms by which macronutrient intake influences the ageing 
process, and provides support for the role of nutrition in promoting healthy ageing in humans. 
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